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Abstract.
This thesis involves the characterisation of Ru(II) polypyridyl complexes when 
covalently linked to proteins and a study of their propensity to monitor 
conformational variances which these proteins undergo in solution.
In the first section of this thesis, the Ru(II) complexes are covalently bound 
to various synthetic and natural proteins via selected binding sites on the 
biomolecules, and these protein-bound labels are extensively characterised via the 
spectroscopic and luminescent properties of the labels. Thereafter, these protein- 
bound labels are employed as spectroscopic probes of the conformational changes 
which the bound proteins undergo in solution via variations in the photophysical 
properties of these labels found to accompany structural changes of the proteins. 
Although the emission spectra of the labels are somewhat sensitive to the 
conformational properties of the bound protein, the decay lifetimes were found to 
be the most sensitive reporter, due to their sensitivity to their local environment. 
The a-helix to random coil transition of poly-amino acids were thereby probed by 
changes in the decay lifetimes of the labels. This section also investigates the 
potential of the decay lifetime of the labels as a probe of the unfolding process of 
natural proteins. Investigations into the effects of a number of parameters (i.e. label 
type and position on protein, temperature, chemical denaturants) on the probing 
potential of the labels were carried out.
The final section involves the labelling of an enzyme with the same Ru(II) 
complexes. Firstly, the effect of the labelling on the activity of the enzyme was 
studied to determine the effect of such modification on the natural conformational 
properties of the enzyme. Correlation between the acid-induced loss of activity (i.e 
denaturation) of the enzyme and changes in the decay lifetimes of the labels were 
found suggesting the potential application of such fluorescent complexes as probes 
in real biological matrices without adverse effects on the natural characteristics of 
the system.
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Chapter 1. 
Introduction
1
1.1 General introduction.
The overall aim of this thesis is the application of ruthenium polypyridyl complexes 
as fluorescent probes in biological systems, concentrating on the monitoring of 
conformational changes which the bound biomolecules naturally undergo in 
solution.
Firstly, in order to emphasise the usefulness of ruthenium polypyridyls in 
this field, it is natural to commence with a review of the properties of these 
complexes, in particular, those relevant to this thesis. This chapter will survey the 
literature in relation to the use of ruthenium complexes as fluorescent labels in 
various biological systems, notably DNA and proteins such as enzymes and 
antibodies. Other applications discovered involving specific interactions between 
ruthenium complexes and compounds of biological significance will be discussed, 
ranging from the use of such complexes as anti-cancer agents, to their use in the 
study of biological electron-transfer processes to the chemiluminescent detection of 
compounds of biological significance. The aim of such a review is to illustrate the 
broad applicability of ruthenium complexes in the fields of biology, biochemistry 
and medicine and hence to clarify why such complexes were chosen in the study of 
the conformational properties of biomolecules in this thesis.
1.2 The structural and physical properties of ruthenium polypyridyl 
complexes.
Ru2+ is a d6 system and the polypyridyl ligands are usually colourless molecules 
possessing a-donor orbitals localised on the nitrogen atoms and 7t-donor and n*- 
acceptor orbitals more or less delocalised on aromatic rings. The compound 
[Ru(bpy)3]2+where bpy = 2,2'-bipyridine and other [Ru(L-L)3]2+compounds where L- 
L=bidentate polypyridyl ligand, exhibit D3 symmetry and the n and n orbitals of the
ligands may be symmetrical (x) or anti-symmetrical (VF) with respect to rotation 
around the C2 axis, retained by each Ru(bpy) unit [1]. The x-ray crystal structure for 
[Ru(bpy)3]2+ shows that the metal to ligand (Ru-N) bond lengths are short, indicating 
significant back-bonding between Ru(II) and the 7t* orbitals of bpy [1], The 
structure of the parent compound [Ru(bpy)3]2+ is depicted in Figure 1.1 below.
Figure 1.1 Structure o f [Ru(bpy)3]2'  [4].
1.3. The photophysical properties of [Ru(bpy)3]2+ in solution.
The lowest excited state for most Ru(II) polypyridyl complexes is a 3MLCT (metal 
to ligand charge transfer) transition, [5, 6 , 7] which undergoes slow radiationless de­
cay, thus exhibiting long lived emission. [2] Due to the presence of an oxidising site 
on the metal and a reductive site on the ligands, the MLCT excited states possess 
two distinct redox sites. [1] Hence, the energy position of the MLCT state depends 
on the redox properties of the metal and ligands, in particular on the a-donor or 71-  
acceptor properties of the ligands [8], The difference in energy between the filled d 
orbitals and the lowest unoccupied ligand-based orbital is related to the absorption 
and emission energy of the complexes. By a careful choice of ligands in a series of 
complexes of the same metal ion, the orbital nature of the lowest excited state and 
hence, its energy, emission lifetime, redox properties, emission quantum yield, 
chemical stability and oxidation and reduction potentials can be controlled [1 ],
Due to their unique combination of photochemistry, electrochemistry and 
chemical stability, Ru(II) polypyridyl complexes find applications as (a) photolumi- 
nescent compounds; (b) excited state reactants in electron and energy transfer proc­
esses and (c) as excited state products in electron transfer chemiluminescence [9],
[Ru(bpy)s]2+ has been recognised as a potential catalyst for the decomposi­
tion of water into its elements by irradiation with solar light [10 ], and recently, very 
high solar energy conversion efficiencies at dye sensitised photoelectrochemical cells 
have been realised [11-13],
1.3.1 A bsorption spectroscopy.
The absorption spectrum of [Ru(bpy)s]2^  is illustrated in Figure 1.2. The intense 
transitions observed in the visible region are due to the metal to ligand charge trans­
fer (MLCT) transition between the metal centred t2g ground state and ligand ir*
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states. [3, 8, 9, 10] The intense bands in the ultraviolet region are due to intraligand 
iz-Ti* transitions, while the weaker absorption to the blue of the visible band has been 
assigned to a metal centred d-d* transition. The tail at longer wavelengths has been 
assigned to a weak spin-forbidden MLCT transition [2, 5],
It is believed that the excited electron is delocalised among the ligands in the 
1MLCT excited state but that as interaction between the ligands is weak, it localises 
on only one ligand when intersystem crossing to the 3MLCT excited state takes
place. [1] The photophysical pathway of [Ru(bpy)3 ]^+ is illustrated in Figure 1.3.
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Figure 1.2 Absorption spectrum o f [ R u ( b p y ) i n  aqueous solution.
Figure 1.3 Schematic representation o f  the decay photophysical processes o f
[Ru(bpy)3] 2+.
1.3.2 Emission spectroscopy.
There has been extensive investigation into the nature and multiplicity of levels in­
volved in the emission of ruthenium polypyridyl complexes and whether charge 
transfer in the electron is localised on one ligand or delocalised over all ligand or­
bitals. Recent results suggest that the best description is that of levels of MLCT 
nature which assume substantial triplet character and a single ligand localised ex­
citation (Kober and Meyer model) [1,14],
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reveals how the electron is excited to a ligand centred iMLCT manifold, singlet in 
character. Fast intersystem crossing occurs with unit efficiency from the singlet 
state to the triplet manifold of three closely spaced 3MLCT states, with a fourth 
state occurring several hundred cm ' 1 to higher energy. The three lowest lying levels 
are quite close together (AE~ 100cm'1) and have predominantly triplet character, 
whereas the presence of the fourth MLCT state is usually masked by the 
deactivating 3MC state [7,14],
At higher temperatures all of these states are populated, thus contributing to 
the excited state decay. Hence, a broad emission band results (excited state 
manifold considered an average). In contrast, at low temperatures the upper states 
contribute very little, and so a fine spectrum is observed due to a perturbed skeletal 
vibration of the aromatic ring due to the removal of the n* electron. The maximum 
wavelength of emission is found at higher wavelength (ie. lower energy) at room 
temperature compared to low temperatures. This phenomenon known as the” 
rigidochromic effect” is due to the relaxation of the rigid matrix perturbation [1],
Emission from the triplet state to the ground state (kr) or radiationless decay
(kjy-) to the ground state can take place. The ^MC state is responsible for a further 
deactivating pathway giving rise to either radiationless deactivation or 
photodecomposition of the complex.
Emission intensities are stronger at lower temperatures which is explained 
by the energy difference (AE) between the emitting 3MLCT state and the 
deactivating 3MC state [7, 16-19], At room temperature, thermal population of this 
3MC state is possible [8 , 20] resulting in a decrease in emission intensity (ie kr will 
decrease). At low temperatures, thermal population of the 3MC state is not possible 
and so emission is more intense due to an increase in kr. The 3MC dd state lies
about 4000cm'1 above the 3CT manifold and has a high rate of radiationless decay. 
As well as being responsible for thermal deactivation the 3MC state is accountable 
for photochemical reactions eg. racemisation and photosubstitution [21-23]. Non-
Figure 1.3 depicts the decay photophysical processes of [R u (b p y )3 ]2 + . It
radiactive decay occurs less efficiently from the 3CT manifold, is important at low 
temperatures and is dependent on the vibrational activity and on the solvent [24], 
For most complexes there is a radiationless deactivation path which is somewhat 
“frozen” at low temperatures when the solvent matrix is rigid, but which only 
becomes important when the solvent matrix becomes “fluid” at room temperature 
[25],
1.3.3 Temperature dependence o f emission lifetime.
Temperature dependence studies of luminescence behaviour can yield information 
concerning energy, electronic nature and deactivation rates of the luminescent and 
reactive states.
The main features concerning the temperature dependence of the 
luminescence decay of [Ru(bpy)3]2+ are as follows [26];
(a) an Arrhenius type behaviour in the rigid glass region (84-100K);
(b) a discontinuity in the glass fluid transition region (-100-150 K );
(c) an Arrhenius type behaviour in the 150-250 K temperature range having 
basically the same parameters as in the rigid glass and ;
(d) another steeper Arrhenius type region for temperatures over 250 K.
Equation 1.1 given below describes this complex behaviour, where K0’ is a 
temperature-independent term;
1/t = Kn- +_________ Bi___________ + A.e AE1/RT + A?e'AE2/RT (1 .1 )
1 + exp [C(l/T - 1/Tb)]
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Consequently, the lifetimes of many polypyridyl complexes of Ru(II) in fluid 
solution are highly temperature dependent, with the lifetimes expressible as the sum 
of a temperature independent and several temperature dependent terms, as outlined 
in equation 1 .1 .
The second term in equation 1.1 describes the behaviour in the glass-fluid 
transition while the two exponential terms account for the Arrhenius behaviour at 
low and high temperatures. Emission of [Ru(bpy)3]2+ and related complexes 
originates from a group of closely spaced MLCT levels with similar decay 
properties. On melting of the matrix, large amplitude vibrational modes play a part, 
enhancing the rate of radiationless deactivation processes, thereby resulting in a 
decrease in intensity and lifetime. On complete melting of the glass, the slightly 
activated Arrhenius behaviour continues because the emission always originates from 
the same group of MLCT excited states. As earlier mentioned, a JMC excited state, 
which lies about 4000cm'1 above the emitting levels becomes accessible at higher 
temperatures. As it is strongly distorted relative to the ground state, it undergoes fast 
radiationless decay including ligand substitution and racemisation reactions. The 
fourth MLCT excited state at several hundred cm' 1 higher than the other three levels, 
with mainly singlet character, is not involved in the temperature dependence 
behaviour as it is “ masked “ by the surface crossing to the '’MC level [1, 26], Figure
1.4 represents the temperature dependence of [Ru(bpy)3]2 in nitrile solution.
1.3.4 Chemistry and quenching reactions o f the [Ru(bpy) 3/ 2+ excited state.
On absorption of a photon by a molecule in any photochemical or photophysical 
process the excited state formed is a high energy unstable species which must 
undergo some type of deactivation process. Excited state deactivation can occur in a 
number of ways, as illustrated in Figure 1.5.
9
6 10 
1000 / T . K ' 1
Figure 1.4 Temperature dependence behaviour o f [Ru(bpy) 3f  in nitrile
solution.
Deactivation may occur via several processes including the following;
(i) the disappearance of the original molecule after undergoing some 
photochemical reaction ;
(ii) the emission of light as luminescence;
(iii) the degradation of the excess energy into heat (radiationless 
deactivation);
(iv) Some type of interaction with other species present in solution 
(quenching).
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Figure 1.5 Schematic representation o f the excited state deactivation processes.
Processes involving radiationless deactivation, quenching or photochemical 
reactions compete with the luminescence decay process of the excited state. A suf­
ficiently long lived excited state may become involved in energy and electron trans­
fer processes in fluid solution (ie. an encounter with a molecule of another solute 
and interacting bimolecularly, leading to quenching of the excited state.) This is 
true of the lowest excited state o f [Ru(bpy)3]2+ (3MLCT) which lives long enough 
for such encounters to take place. It also possesses suitable properties to play the 
role o f energy donor, electron donor or electron acceptor.
l l
(0 *[Ru(bpy)3]2++Q •> [Ru(bpy)3]2++ Q * (1-2)
(ii) * [Ru(bpy)3]2++ Q ■> [Ru(bpy)3]s+ + Q ' (1.3)
(iii)*[Ru(bpy)3]2+ + Q > [Ru(bpy)3]+ + Q+ (1.4)
The higher energy content of the excited state leads to its status as both a 
stronger reductant and stronger oxidant than the corresponding ground state [1 ], 
The excited state acts as (i) an energy donor as in equation (1.2); (ii) a reductant as 
in equation (1.3); and (iii) an oxidant as in equation (1.4) [1, 14],
Energy transfer in equation (1.2) above is a physical process where, through 
contact, an excited state molecule transfers its energy to another molecule. Equa­
tions (1.3) and (1.4) above involve electron transfer from or to the excited molecule 
and the simultaneous oxidation/reduction of another species in solution. The ability 
to undergo energy transfer is related to the zero-zero spectroscopic energy E°'° of 
the donor-acceptor pair (spectral overlap) and that of electron transfer to the redox 
potential. Kinetic factors are associated with the activation energy (Ea) needed to 
re-organise the inner/outer shells, before electron transfer can occur [2 ],
The designation of quenching processes to energy transfer requires direct 
observation of the acceptor phosphorescence or photoreactions from the excitation 
into the acceptor-excited states [15], Bimolecular quenching of the excited state of 
[Ru(bpy)3]2+ has been extensively investigated using metal ions, such as Eu3+, Cr2+ 
and quinones. One such example of energy transfer for [Ru(bpy)3] is by 
[Cr(CN)6]3' confirmed by the phosphorescence from the chromium complex. As 
[Cr(CN)6]3' is not easily oxidised or reduced both reductive and oxidative 
*[Ru(bpy)3]2+ electron transfer quenching by [Cr(CN)6]3' is thermodynamically for­
bidden [1, 2, 27], [Cr(bpy)3]3+ can however be easily reduced, hence oxidative 
electron transfer prevails over the energy transfer (hence, the application of 
[Cr(bpy)3]2+ absorption spectroscopy in flash photolysis experiments) [1, 2, 28],
Below, an example of reductive electron transfer quenching, by Eu2+ is displayed 
[29, 30],
[Ru(bpy)3]2+ + Eu2+(aqueous) > [Ru(bpy)3]1+ + Eu3+(aqueous) (1.5)
The increased absorption due to the formation of [Ru(bpy)3]+ occurs at the same 
rate as the luminescence emission depletion of *[Ru(bpy)3]2+ indicating kinetically 
that reductive quenching is involved [15].
The mean lifetime of an excited state is given by the following equation;
1/ t  = kobs (1 .6)
where kobs is the decay rate constant and x is the average lifetime of the excited 
state, decaying by all possible decay mechanisms, each with its own decay constant 
so that;
l/T=kr +kM+kq[Q] (1.7)
where kr is the rate constant for emission, km is the rate constant for non-radiative 
decay, kq is the rate constant for bimolecular quenching with Q, a quencher (eg.
30 2) and [Q] is the concentration of the quenching agent [31]. Therefore, by sub­
stitution, the Stem-Volmer equation is derived below;
1/t = 1/to+ kq[Q] (1-8)
which describes the effect of a quenching agent Q in solution on the emission life­
time [31-33], Thus, a plot (Stem-Volmer) of 1/ t  versus [Q] yields kq, the bimol­
ecular quenching rate constant (slope). Quenching of the excited state of 
[Ru(bpy)3]2+ has been widely investigated and is known to be quenched by a variety 
of inorganic species [1 , 2 ],
Compounds containing unpaired electrons can act as efficient quenching 
agents, notably molecular oxygen and other paramagnetic species. These are particu­
larly effective in removing energy from the triplet state molecules and therefore 
causes particular problems in phosphorescence and with molecules possessing rela­
tively long fluorescence lifetimes. Oxygen is one of the few molecules which effec­
tively quenches *[Ru(bpy)3]2+(kq =3.3 x 109 M 'ls‘1). Singlet oxygen formation by en­
ergy transfer and electron transfer mechanisms has been proposed. The lifetime of 
*[Ru(bpy)3]2+ is reduced by about a third in aerated aqueous solutions, however, 
bubbling with nitrogen or argon reduces oxygen quenching to less than 1% [4],
It is difficult to deduce from a single study which of the three mechanisms 
(eqnl.2-1.4) is responsible for quenching. One can clarify which process is respon­
sible for Stem-Volmer behaviour by examining the dependence of the quenching 
constants (kq) for a given quencher on the excited state reduction potential of a se­
ries of closely related Ru(II) polypyridyl complexes. A dependence indicates 
quenching by electron transfer while the absence of any dependence suggests 
quenching by energy transfer mechanisms [15],
1.4. Interactions of ruthenium polypyridyl complexes with biomolecules.
1.4.1 Metal-DNA Interactions.
The design of molecules targetted specifically for DNA sites is important as DNA 
molecules contain all the genetic information necessary for cellular function [34], 
The control or regulation of what genetic information is expressed on a chemical 
level must depend upon the binding of proteins or small molecules to specific sites 
along the DNA strand. There is much interest in understanding how this recognition 
process takes place, how the DNA structure varies along the strand to direct specific 
binding at some sites and not others and what factors determine this specificity in
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binding. Hence, in recent years extensive research has been carried out in this field 
in attempts to produce analogues to these DNA binding proteins in order to better 
understand such highly specific recognition processes.
DNA binding molecules can interact in both a noncovalent and covalent 
manner. They tend to interact noncovalently in the following ways;
(a) by full intercalation where the molecule is inserted between the 
hydrophobic base pairs of DNA and is subsequently stabilised through n- 
stacking;
(b) Hydrophobic/electrostatic/hydrogen bond interactions leading to binding 
to the minor or major groove and ;
(c) external binding on the surface of the helix.
The various binding modes of DNA binding molecules to DNA are illustrated in 
Figure 1.6. In order for intercalation to take place the base pairs of the helix must 
separate and the helix must unwind in order to accomodate the planar intercalator, 
one necessity for intercalation being that the intercalative moiety is flat [35], 
Intercalation is the most common mode of binding of small spectroscopic probes 
such as ethidium and small drugs like antimycin to DNA. Significantly, 
intercalating compounds can be useful as probes of DNA structure as the aromatic 
chromophore of the intercalating cation can provide a sensitive handle to monitor 
conformation and flexibility of the helix [35],
Many intercalators show antibacterial or anticancer activity and because the 
inserted residue often resembles a base pair in shape and thickness, intercalators are 
commonly frame shift mutagens [36], Several natural antitumour antibiotics, for 
example, daunomycins contain planar aromatic moieties and their pharmacological 
activity originates in particular from their ability to intercalate into DNA [37, 38], 
Significantly, metal complexes are uniquely suited for specific interaction with 
DNA, binding in both covalent and noncovalent manners. Their shapes, charges and 
propensity for binding to nucleic acid sites have rendered their co-ordination com
plexes suitable as probes to examine DNA structure and potentially useful reagents 
in site-specific drug design [37].
Covalent
Binding
External Binding 
with Stacking
Major Groove 
Binding
Minor Groove 
Binding
Intercalation
External
Binding
P artia l
Intercalation
Figure 1.6. Schematic representation o f the available binding sites o f DNA.
Co-ordination complexes offer unique well-defined geometries useful in 
designing reagents to match specific local DNA conformations. The high redox ac­
tivity of many metal complexes can also be exploited in directing chemistry at spe­
cific sites along the DNA strand. Furthermore, the inorganic photochemistry of 
certain cationic transition metal complexes may be harnessed to render them useful 
for footprinting and mapping experiments in-vitro and in-vivo [37]. The co­
ordination about the metal centre with easily varied ligands and stereochemically 
well-defined geometries further allows one to match structure of the anchored inter
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calator to the local shape of the DNA helix, and hence the intercalative binding 
mode is particularly important in their use as DNA probes [38].
The formation of metal complex-DNA adducts can have a significant effect 
on the biological function of DNA, as verified by the antitumour drug cis-platin of 
the structural form Pt(NH)3Cl2 [38], DNA binding drugs commonly exert their ac­
tivity by altering DNA structure either by covalent modification, forming adducts 
which inhibit DNA processing enzymes, or by the introduction of lesions that ir­
reparably damage DNA [38], Electron transfer reactions of metal complexes offer 
pathways for the oxidative cleavage of DNA structure and will be subsequently dis­
cussed in this literature review.
Lippard and co-workers were among the first to discover that metal com­
plexes could intercalate into DNA and RNA. [39] Initial studies were carried out on 
the square planar platinum(II) complexes containing aromatic terpyridyl or phe- 
nanthroline ligands. Generally, charged tetra co-ordinated planar platinum com­
plexes were found to intercalate into DNA whereas the neutral dichloroplatinum 
complexes could bind covalently to DNA through co-ordination to its nitrogen 
bases [39],
Methidium-Fe(II)-EDTA reagents have been reported as both well charac­
terised planar intercalators and DNA cleaving agents [40], while recently the cleav­
age of DNA by electrochemical activation of Mn111 and Fe11 complexes of meso- 
tetrakis(N-methyl-4-pyridiniumyl)porphine was reported [41], Non-planar metal 
complexes such as tetrahedral zinc complexes [Zn(phen)Cl2]2+and [Cu(phen)2]1+ 
were also found to bind to and cause efficient strand cleavage to DNA [40, 42, 43],
Covalent binding may also take place as in addition to the harder phosphate 
anion sites along the backbone which the cationic metals interact electrostatically 
with, the endocyclic nitrogen lone pairs on the purines and pyrimidines provide fa­
vourable sites for coordination to transition metal ions and particularly so for the 
softer heavier metal. In fact, DNA is an extremely good ligand for metals, hence the 
clinical success of the simple coordination complex cis-dichloro-diammine plati­
num ^) ie. cis-DDP. This complex acts as an antitumour drug whose mode of ac­
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tion involves direct co-ordination of cis-DDP to neighbouring guanines through 
their N-7 nitrogen atoms, hence forming intrastrand crosslinks [38, 44],
Octahedral transition metal (Ru, Zn, Co, Rh) polypyridyl complexes can 
also interact with DNA/RNA via both covalent and noncovalent modes [40, 42, 43] 
and extensive studies involving probes and cleaving agents for DNA in recent years 
has involved such complexes, in particular those of Ru.
Covalent attachment to biomolecules is particularly relevant in this thesis as 
all the binding methods used lead to covalent bond formation between the pro­
tein/polypeptide molecules and the ruthenium(II) polypyridyl complexes. Never­
theless, much of the literature in this thesis reviews the non-covalent interactions 
between ruthenium polypyridyl complexes and biomolecules, in particular the 
electrostatic and intercalative binding modes to DNA.
As the aim is to review DNA-ruthenium polypyridyl interactions, firstly the 
specific advantages and unique properties these complexes possess, in addition to 
those listed in general for transition metal complexes must be discussed. Then, their 
applications as probes and cleaving agents of DNA will be discussed, firstly in re­
gard to their chirality and their use as probes for DNA handedness and then in rela­
tion to their use as sensitisers for the photocleavage of DNA. It is also necessary to 
discuss the effects of binding on the physical properties of DNA as well as on the 
spectroscopic properties of the complexes, in order to appreciate how exactly these 
complexes work as such sensitive probes. Finally, the use of certain ruthenium 
complexes as anticancer agents, in terms of their effect on DNA is discussed.
1.4.1.1 Ruthenium polypyridyl-DNA interactions.
[Ru(bpy)3]2+ is a prototype example o f a polypyridyl complex and interactions of 
such complexes with biomolecules have been widely studied over recent years, in
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particular their interactions with DNA and polynucleotides, which have been the 
subject of active investigation and much controversy of late.
Ruthenium polypyridyl complexes are rigid, planar, chiral and contain a co- 
ordinately saturated metal ion at their core. These features are critical to their appli­
cation as DNA binders and photocleavage reagents but are also applicable to most 
transition metal polypyridyl complexes [40, 42], However, ruthenium polypyridyl 
complexes display intense MLCT absorption in the visible region which signifi­
cantly is distinct from where biomolecules absorb (UV region) and hence the spec­
troscopic properties of the biopolymer do not interfere with those of the label, and 
in the case of DNA binding, it provides a spectroscopic tool to monitor the binding 
process [1,45], Also, other critical properties include the intense emission they dis­
play, the large Stokes shift they possess, and the long lived luminescence emission 
they exhibit, with room temperature lifetimes in aqueous solution of 100-600ns [1 ], 
Furthermore, these complexes possess a redox active site essential for the ability to 
act as DNA photocleaving molecules [40, 43],
Ru(II) complexes, as for other octahedral transition metals, can bind cova­
lently and noncovalently to DNA [43], The common feature is the incorporation of 
planar aromatic ligands which can interact noncovalently, intercalatively and elec­
trostatically with biomolecules. Covalent linkage to DNA has also been reported 
using ruthenium phenanthroline compounds [46], Extensive investigations have 
been carried out studying the effects of various ligands on the mode of binding and 
the extent of changes in the bound ruthenium complexes photophysical properties, 
among other factors affecting DNA binding [47-55],
Intercalative binding leads to perturbation of the photophysical properties of 
ruthenium complexes such as emission lifetime, intensity and steady-state polarisa­
tion due to the close approach of the metal complex to the helix on sandwiching 
one of the ligands between the adjacent base pairs. Several methods of recognising 
the intercalative mode of binding exist based on the following basic features of this 
binding mode [51, 52];
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(a) the helix becomes stretched and unwound at each binding site which can 
be followed using electrophoretic mobility assays;
(b) the helix is stabilised upon intercalation which becomes evident by 
increases in melting temperature of DNA;
(c) the probe becomes oriented due to being held rigidly coplanar with the 
DNA base, and for these effects fluorescence depolarisation and anisotropic 
effects are used to indicate the retention of polarisation of emitted light only 
if  intercalation occurs;
(d) the spectroscopic properties of the probe are affected by intercalation.
In brief, the techniques used to study such binding modes are either based 
on the physical changes the DNA undergoes or the spectroscopic changes one sees 
in the probe [56], Using several of these monitoring techniques, initial studies led to
the distinction between intercalators, a prime example being [Ru(phen)3]2+ and 
external binders such as [Ru(bpy)3]2+, the differences being attributed to the insuf­
ficient n electron overlap provided by the bipyridine ligand for effective intercala­
tion into the DNA base pairs. Certain mixed complexes which exhibit intermediate 
behaviour include [Ru(bpy)2 (phen)]2+and [Ru(bpy)2(DIP)]2+ [48, 53], However, 
in recent years the exact mode of binding of [Ru(phen)3]2+ has become a very
controversial subject and is discussed in greater detail in the following section.
Studies of various Ru(L-L)3 complexes and their mixed complexes have
concluded that maximum intercalating ability is acquired with a ligand of greater 
capacity to stack and overlap with base pairs and that binding affinity increases 
with increasing hydrophobicity of the ancillary ligands. Also for complexes which 
bind appreciably, enantiomeric selectivity is observed (Section 1.3.1.2.) [51], For 
most complexes, binding to DNA leads to enhancement of luminescence, probably 
due to an increase in the average lifetime of the complex upon binding to DNA and 
also to the protection of the complexes excited state from oxygen [48], Multi­
20
exponential decay behaviour is observed for these bound complexes, with two decay 
components, one much longer and the other shorter than the unbound species. While 
the longer lifetime is probably the composite o f similar decays from the complexes 
when bound to different base sequences, externally and intercalatively, the nature of 
the shorter lifetime is more uncertain. In contrast, the luminescence quenching of 
[Ru(TAP)3]2 + when bound to DNA is explained by photoredox interaction with 
guanines (See section 1.3.1.3.) [47, 48],
2 ,2 ’-bipyridyl
(bpy)
4,7-diphenyl-1,10-phenanthroline 
(DIP)
1,4,5,8 ,9,12-hexaazatriphenylene (HAT)
3,4,7,8-tetramethyl-1,10-phenanthroline (TMP)
Figure 1.8. Structures and abbreviations o f ligands cited in the text.
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The nature of interactions of homoleptic and heteroleptic Ru polypyridyls 
containing such ligands as bpy, phen, DIP, trimethylphenanthroline (TMP), tetra- 
azaphenanthrene (TAP) and 1,4,5,8,9,12-hexaazatriphenylene (HAT) has yielded 
much information on factors affecting binding to DNA and on the properties re­
quired for DNA cleavage [48, 51]. Interestingly, [Ru(TM P)3]2+ is the only com­
plex, on addition of DNA not to exhibit double exponential decay behaviour and is 
explained in terms of its size, being too large to bind against the well defined 
groove of B-DNA, hence the single lifetime is that o f the unbound species [47],
Of particular interest is the discovery of a ruthenium polypyridyl complex 
[Ru(bpy)2(dppz)]2+, where dppz = dipyrido phenazine, which has implications as a 
highly sensitive reporter molecule for double stranded DNA [56], and whose struc­
ture is depicted in Figure 1.9. This compound does not exhibit any luminescence in 
aqueous solution at ambient temperatures but in the presence of DNA to which it 
binds avidly, it exhibits intense luminescence, subsequently revealed to be due to 
the protection of the phenazine ring from quenching by interaction with water [56, 
57], Hence, its description as a molecular “light switch“ for DNA. Work carried out 
by Barton and co-workers on related complexes has led to the discovery that sub­
stitutions could be made in the ancillary ligands while still maintaining the remark­
able “light switch“ effect. Substitution on the dppz ligand however leads to com­
plexes which all luminesce to some degree in aqueous solution in the absence of 
DNA and are therefore less efficient “light switches” [57], More recent reports de­
scribe the tethering of an oligonucleotide to a Ru(II) dipyridophenazine complex to 
yield a sequence specific molecular light switch since the oligonucleotide fimction- 
alised with a Ru(II)dppz complex can be used to target single-stranded DNA in a 
sequence specific fashion (See Figure 1.10) [58], Hence, their potential in the de­
velopment of novel hybridisation probes for heterogenous and homogenous assays.
Further studies of the interactions of enantiomeric forms of
2+
[Ru(phen)2dppz] with DNA have been carried out [59], illustrating the increasing
22
attention these novel Ru(II) dppz derivatives are receiving due to their unique spec­
troscopic probing qualities.
In relation to covalent linkage, [Ru(phen)2Cl2] shares with cis-dichloro- 
diammine platinum(II) (cis-DDP) characteristics of both structure and reactivity 
[46], Like cis-DDP the neutral [Ru(phen)2Cl2] contains two cis-oriented chlorine 
ions which are good leaving groups, allowing the chlorines to be exchanged and the 
metal to form covalent bonds with the base atoms of DNA. Hence, [Ru(phen)2 Cl2 ] 
represents an octahedral analogue for cis-DDP, but one that is chiral [46],
DNA oligomers and duplexes containing a covalently attached derivative of
[Ru(bpy)3 ]2 + have been described [60]. These display potential as photochemically
activated DNA cleavage agents, fundamental to their use in the construction of mac­
romolecules with specifically located redox active subunits [60], Bathophenan-
Figure 1.9. Structure o f the complex [Ru(bpy)i(dppz)f* [56],
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throline ruthenium complexes have also been covalently attached to DNA, and used 
as nonradioactive label molecules for oligonucleotides [61-63], [Ru(TAP)3 ]2 + and
related complexes have been receiving increasing attention of late, [55, 64] whereby 
evidence has been subsequently found of adduct formation between such complexes 
with DNA, being sufficiently oxidising to abstract an electron from guanine in DNA 
[64], A recent publication describes evidence for a new kind of photochemical ad­
duct between a metal complex and nucleotide where the binding of [Ru(TAP)3 ]2 +
proceeds through covalent binding of the guanine to one of the TAP ligands. Initial 
electron transfer from the guanine to the metal complex excited state has been pro­
posed to lead to such a compound [65].
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Figure 1.10. Schematic representation o f the tethering o f a dppz complex o f  
ruthenium(II) to an oligonucleotide [58],
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like three-bladed propellers and have two enantiomeric forms corresponding to right 
(A) and left (A) handed screws. (See Figure 1.11) [69-72].
Figure 1.11. Enantiomeric form s o f  [Ru(phen) j /2+ [42].
In order to understand the applications of ruthenium complexes as probes for 
DNA structure, the distinguishing factors between the various forms of DNA A, B 
and Z are stressed herein. The A and B forms are right-handed helical structured 
DNA whereas the Z form is the left-handed DNA. The general structure of a helix is 
two anti-parallel polymer strands with the bases paired through Watson and Crick 
hydrogen bonds. B-DNA is the most predominant form and is a regular right-handed 
helix with the base pairs oriented basically perpendicular to the axis of the helix and 
contains distinctive minor and major grooves of well defined width and depth. In 
contrast, A-DNA has a very shallow but wide major groove and is found in double 
stranded RNA segments. Z-DNA zig-zags and is basically a long slender helix with a 
wide and shallow major groove and a minor groove pinched down into the narrow 
crevice. As well as these regular forms however, various structural variations can be 
found along the DNA strands, such as bends, kinks, left-handed sites, hairpin loops 
and cruciforms [73],
Originally, ruthenium polypyridyl complexes were believed to bind 
electrostatically to single or double stranded (ds)DNA at low ionic strength as well 
as intercalatively to dsDNA [73], However due to much controversy surrounding the 
exact mode of binding which these complexes used as probes for DNA handedness 
undergo, a summary of different theories put forward will be given below.
Barton and co-workers had proposed that binding of ruthenium 
tris(phenanthroline) complexes occurs through two mechanisms: ( 1) intercalation, 
based on the observation that binding causes the DNA duplex to unwind, and (2) 
“surface” interactions [45, 52, 54, 74], Preliminary studies involving such complexes 
report that on binding of the chiral complexes by intercalation enantiomeric 
selectivity is observed with B-DNA with the A-enantiomer, a right-handed propeller 
like structure displaying a greater affinity than A-[Ru(phen)3]2+ for the right handed
helix [45, 52, 74], The basis for this selectivity is illustrated in Figure 1.12. With one 
phenanthroline ligand intercalated, the two non-intercalated ligands of the isomer fit 
closely along the right-handed helical groove, while the non-intercalated ligands of
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the A isomer are repelled sterically by the phosphate backbone of the duplex. This is 
because the disposition of the left-handed isomer is opposed to the right-handed 
helical groove of B-DNA [45],
Figure 1.12. Lamda (A) and delta (A) tris(phenanthroline) metal complexes, a 
schematic illustration o f such complexes intercalated into right-handed DNA [42J.
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Further studies show the isomers of [Ru(DIP)3 ]^+ to exhibit enhanced
enantiomeric selectivity, with only A-[Ru(DIP)3 ]2+ binding to B-DNA. This is
explained in terms of the increased bulkiness on the non-intercalated phenanthroline 
ligands which completely block the intercalation of the isomer into a right handed 
helix. Hence, its enantioselectivity is due to the steric effects of the phenyl “ wings “ 
of the chelate [54, 75],
The complex [Ru(phen)2 Cl2 ] already mentioned for its covalent binding to
B-DNA has been shown to exhibit striking enantiomeric selectivity distinct from that 
seen on intercalation [46], Unlike intercalation, it appears that the left-handed isomer 
is favoured, as is found for the groove bound mode. Similar alignment for covalent 
and intercalative binding is not possible as one of the non-stacked phenanthroline 
ligand is considerably crowded by the right-handed helical column. Further studies of 
such stereoselective covalent binding was recently reported by Thorp and co­
workers, who investigated an extensive series of aquaruthenium(II) complexes of the
type [L5Ru(OH2 )]2+ and [L4Ru(OH2)2 ]^+ [76], These mono- and diaqua
complexes are shown to bind covalently to calf thymus DNA and the results 
correlate well with those of Barton and Lolis on [Ru(phen)2Cl2] [46], The reactions 
proceed with a surprisingly high stereoselectivity that favours covalent binding of the
A isomer with [Ru(phen)2 (py)OH2 ]^+ showing an enantiomeric excess of 80% [76],
One interesting application found for these “DNA handedness probes“ is 
reported by Barton and co-workers where the potential o f these complexes as probes 
for DNA structure in a protein-bound complex was examined [77], The binding of 
the enzyme Restriction Endonuclease EcoRI to DNA is reported to alter the 
enantiomeric preference of the conformation-specific intercalators [Ru(phen)3]2 +
and [Ru(DIP)3 ]2+ for DNA, providing evidence under solution conditions that
binding by the restriction enzyme causes a conformational change in the DNA helix
[77],
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Another application is the combination of such chiral probes with DNA
photocleavage properties. An example of such a complex is [Ru(TMP)3]2+ which
shows preferential binding to A-DNA, displays enantiomeric discrimination in its 
binding and upon irradiation with visible light cleaves A-form helices preferentially
[78] (See section 1.4.1.3).
The possibility that these compounds could only partially insert one phe­
nanthroline ring was first raised by Barton et al. [45, 54,] and later by Kelly at al. 
[53], Gomer et al. [49] and Haworth et al. [79] who argued that complete insertion, 
as occurs with the classical intercalators ethidium and acridinium, is blocked by the 
two external phenanthroline rings which clash with the DNA backbone. Energy 
minimisation calculations revealed that each isomer has two binding modes, partial 
insertion (as opposed to classical intercalation) and external or electrostatic bind­
ing, with binding proposed to occur in the major groove of DNA [79], However, 
Norden et al. concluded from their studies that each isomer bound to DNA by a sin­
gle binding mode and that neither isomer is bound by intercalation [80] which was 
further supported by Eriksson et al. [81, 82] who showed that both isomers bind 
primarily in the minor groove. Binding is not by classical intercalation but rather 
involves the insertion of two phenanthroline rings into the minor groove, leading to 
slight distortions of DNA structure. Rehmann and Barton concluded from NMR 
studies that A Ru prefers intercalation while A Ru prefers surface binding [83], 
Hard et al. also studied the enantioselectivity of both isomers for both right and left 
handed DNA, reporting their findings that A Ru binds more tightly to both the B 
and Z forms than the A isomer [84],
Further studies undertaken by Satyanarayana and co-workers [85, 8 6] pro­
vide evidence that each isomer does indeed bind to DNA via a single mode, and 
that neither isomer bind by classical intercalation, seen as neither enantiomer 
lengthens short, rod-like DNA. In fact, the binding of the isomers to DNA was 
shown to be entropically driven, hence the interactions are largely electrostatic in 
nature and therefore unlike other DNA intercalating agents. Both isomers show a
30
modest site specificity with the A Ru preferring GC base pairs while the A isomer 
prefers AT base pairs. Notably, however, neither isomer was found to discriminate 
in any significant way between B and Z DNA.
Recent studies were carried out on Ru-dppz complexes, novel structural
analogues based on [Ru(phen)3]2+ (See section 1.4.1.) to determine their mode of
binding to DNA. Such studies provide reasonable evidence for an intercalative 
mode of binding for both isomers although the thermodynamics of their DNA 
binding is unlike those observed for the proven intercalators ethidium and dauno- 
mycin. The A isomer binds to DNA approximately twice as strongly as the A iso­
mer, which represents at best only a modest enantiomeric selectivity [59],
Based on these significant findings, the potential of ruthenium enantiomers 
as specific probes of DNA conformation would appear rather limited, as they bind 
weakly to DNA, have only a modest base specificity and cannot distinguish be­
tween very different DNA conformations. Although the question of the ability of 
such tris-chelate metal complexes to discriminate between B and Z forms of DNA 
has remained debatable and details of DNA complex interactions are far from well 
understood, it would appear that the exciting potential that these complexes were 
believed to exhibit has been greatly exaggerated and their applicability is much 
more limited than originally anticipated.
1.4.1.3 Ruthenium polypyridyl complexes as sensitisers for DNA photocieavaze.
As earlier mentioned, one means by which DNA binding drugs exert their activity is 
the introduction of lesions that damage DNA irreversibly. In addition to the rigid 
asymmetric framework provided by ruthenium coordination geometries and the 
spectroscopic sensitivity to assay binding through the metals electronic transitions,
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ruthenium polypyridyl complexes can also provide a rich source of reactivity through 
redox chemistry. Hence, the means exist to couple modes of recognition to site- 
specific reactions of ruthenium polypyridyl complexes along the helix, rendering 
them useful in the design of specific DNA cleaving agents and drugs.
The DNA cleaving abilities of [Cu(phen)2 ]2+ and other polypyridyl
complexes of Co, Ru, Rh. Pt, Fe, Cr and Mn have been realised. The investigation of 
ruthenium polypyridyl complexes containing bpy, bpz, phen, DIP, TMP, HAT and 
TAP ligands (See Figure 1.8) led to the discovery of unique complexes that bind to 
and photoinduce redox processes with DNA. Such novel complexes include 
complexes with two or more HAT/TAP ligands. This behaviour is due to their ability 
to oxidise guanine when bound to DNA [47, 48, 51], Significantly, the
photochemistry of [Ru(TAP)3]2+ (See Figure 1.13) with mononucleotides appears
to follow photosubstitutions that would take place on natural DNA or synthetic 
polynucleotides. In such cases, the photoreactions lead to a photoanchoring of the
[Ru(TAP)2 ]2+ moiety on DNA [87], The complex A-Ru(TAP)3]2+ and
[Ru(bpy)n(TAP)3_n]2+ have been studied and have also been found to be very
efficient DNA photocleavage agents [47, 48, 88],
As earlier reported, adduct formation occurs between these complexes and 
DNA. The radical cation of guanine (G) produced on abstraction of an electron from 
G in DNA appears responsible for the more efficient induction of single stranded
breaks in DNA [65], In contrast, [Ru(phen)3 ]2+, [Ru(bpy)3 ]2+ and related 
complexes proceed by different mechanisms ie. the mediation of the formation of 
singlet oxygen which results in the photocleavage of DNA [88 , 89],
[Ru(TMP)3]2+, already discussed as a probe for DNA handedness due to its 
preferential binding to A-DNA, also cleaves these helical forms with enantiomeric 
selectivity ie. the A-isomer cleaves the A-form with twice the efficiency of the right- 
handed isomer [79],
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Figure 1.13 Structures
CH3
(a) [Ru(TMP)3]2+
(b) [Ru(TAP)3]2+
o f  the DNA photocleavage reagents (a) [Ru(TMP)s]2+ and
(b) [Ru(TAP)2]2\
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The effects of [Ru(TMP)3 ]2 + and [Ru(phen)3 ]2 + on the photocleavage of
tRNA have been compared, revealing that they both indeed preferentially 
photocleave at the guanine residues, however showing contrasting efficiencies of 
cleavage due to the protection of some of the guanine residues as a result of the
molecular shape of [Ru(TMP)3 ]2+ [90], Hence, these complexes may be used as
probes of new tRNAs as well as being useful in the elucidation of major secondary 
and even tertiary structural features of other RNA molecules.
An alternative method to photosensitised DNA damage found using 
ruthenium complexes has been realised. This involves the damage of DNA via 
photosensitised radical production. [Ru(bpy)3]2+ bound to nucleic acids in the 
presence of K2 S2 O8 sensitises the production of the reactive species S04-' and
[Ru(bpy)3 ]3+ close to the strand which lead to single strand break formation [91],
A complex leading to double stranded cleavage through a metal-activated 
mechanism has also been reported. [Ru(DIP)2Macro]2+ is an analogue of
[Ru(DIP)3]2 + with one of the three DIP ligands modified with two polyamine
armlike segments that can themselves complex metal ions (See Figure 1.14). The 
complex binds to DNA while the two modified arms deliver complexed metal ions to 
each strand of the DNA helix for double stranded cleavage [92], It effectively 
cleaves double stranded DNA in the presence of the redox active Cu(II) and less 
efficiently for the redox inactive Zn(II) [92, 93], The metal activated cleavage by this 
complex may occur via nucleophilic attack at the phosphodiester backbone leading 
to hydrolysis of the anionic diester. Hence, the potential of such complexes as 
artificial restriction enzymes is indicated.
Finally, new families of DNA cleavage agents (electrocatalytic or thermal), 
based on oxoruthenium(IV) have been studied. Ru(II) is produced quantitatively 
which also binds to DNA covalently in a slow follow-up reaction [94, 95], These
active cleavage agents can be generated electrochemically or chemically via
2+
oxidation of the corresponding [Ru(tpy)(L)OH2] complexes, where tpy = 2,2’,2”-
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terpyridine with only the complex where L = dipyridophenazine (dppz) intercalating
classically. The excited state of [Ru(tpy)(dppz)OH2 ]2+ is not emissive in aqueous
solution but does emit in the presence of double stranded DNA, thereby exhibiting
the “light switch” effect earlier noted for [Ru(bpy)2(dppz)]2+ The cleavage reaction
leads to the release of nucleic acid bases, implicating sugar oxidation as the reaction 
pathway. [95, 96] The majority of the binding of these complexes to DNA is non­
covalent, however, over long time periods, a very small fraction becomes covalently 
bound to DNA via replacement of an aqua ligand by a nucleophile in DNA, pre­
sumably N7 of the guanine.
Figure 1.14. Structure o f the complex [Ru(DIP) 2 Macro]n+[92].
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1.4.1.4. Applications in cancer treatment.
Since the discovery of cis-dichloro-diammine platinum(II) ie. cis-DDP as the first 
organometallic complex to be used in chemotherapeutic treatment of human malig­
nant neoplasm, much research has been carried out on other transition metal com­
plexes such as ruthenium in an attempt to find equivalent compounds, in particular 
with lower host toxicity levels.
Ru(II) compounds reveal similarities to the antiviral, antibacterial and an­
tineoplastic activities of cis-DDP [97], Since this discovery, many Ru(II) complexes 
have been synthesised, showing promising antineoplastic activity for application in 
cancer treatment. Being directly below Fe in the periodic table and existing in both 
the di- and tripositive oxidation states in aqueous solution, there is evidence that ab­
sorption of [RUCI3 .3H2 O] into the body parallels that o f iron. It is concentrated by
the villi of the small intestine and then widely distributed. A portion remains in the 
blood for a relatively long period and may be taken up by the plasma protein trans­
ferrin because like Fe(III), Ru(III) has a high affinity for phenolate ligands which are 
involved in the transferrin-Fe binding site. Rapidly growing cells such as those in 
neoplasms have a high iron requirement and hence have a large number of receptors 
for transferrin. Release of Ru(III) from transferrin may be facilitated by cellular re­
duction to Ru(II) which then separates and binds to cellular structures, while the 
transferrin is free to migrate back out of the cell. Thus, the chemistry of specific ru­
thenium complexes leading to their accumulation in tumours is an important factor in 
their use as anticancer agents [98a].
The target molecule for ruthenium containing anticancer agents appears to be 
DNA. Besides intercalation, as already discussed, smaller complexes or those with 
shapes unsuitable for intercalation are more likely to attach to the surface of DNA 
either through electrostatic or Van Der Waals forces. Unlike the square planar ge­
ometry of the active form of platinum anticancer drugs, these Ru ions are usually six 
coordinate with octahedral structures. The two additional coordination sites allow
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new modes of binding to nucleic acids and with some ligands provide for the chiral­
ity in the complexes and so in their interactions with the DNA helix.
In addition to binding to DNA, many complexes can interfere with nucleic 
acid metabolism in some way or other. In vitro studies have demonstrated that 
Ru(II) and Ru(III) compounds are active in inhibiting DNA synthesis and possess 
mutagenic activity [98a]. Several mechanisms which have been suggested, following 
the preferential binding to G7 sites include the following ;
(1) the failure of replicating enzymes to recognise the metallated G;
(2 ) additional metal binding following or inducing helix disruption;
(3) Subsequent protein intra- or inter-strand crosslinking by the metal;
(4) chemical reactions of the guanine residue induced by the presence of the
metal ion;
(5) Fenton’s chemistry occurring at the metal ion to generate radicals capable
of strand cleavage;
Ruthenium compounds with nitrogen ligands localise in tumour tissue as well 
as exhibiting good antitumour activity. These ligands undergo solvent mediated li­
gand substitution in aqueous solution and the nitrogen ligands possess sufficient 
strength to remain intact following electron transfer. Such complexes with applica­
tions as “ prodrugs “, introduced into the organism as Ru(III) or Ru(IV) with nitro­
gen and acido ligands remain fairly stable to substitution as long as these oxidation 
states are maintained. Upon reduction to a lower oxidation state, the metal immedi­
ately loses the acido ligand and engages in rapid exchange of water molecules at the 
open site. Consequently, tissue binding is favoured in areas low in oxygen and high 
in reductants, such as the reducing hypoxic environment of many tumours where re­
duction but not reoxidation of Ru should produce a higher Ru(II)/Ru(III) ratio than 
in the surrounding more aerated tissue [98a],
The complex fac-[Ru(NH3 )2Cl2 ] was among the first discovered to display 
excellent antitumour activity, however its poor solubility precludes it from adequate
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formulation as a drug [98b], Because of this, complexes with one or two fewer ni­
trogen ligands and one or two more halides were developed to arrive at species 
which are more soluble due to their anionic charge. Although the mechanisms of ac­
tion involved are not clear, complexes of the form cis-[X2L4Ru]X, [X3L3RU] and 
M[X4L2Ru] give promising results, where X = Cl or Br, L = NH3 or a nitrogen het­
erocycle and M = any monopositive cation.
Of the more recent water soluble complexes coordinated with heterocyclic 
ligands in the trans position HB[(RuB2 Cl4)] and the corresponding pentachloro de­
rivatives (HB)2[(RuBCl5)] have been identified as the most active antitumour agents. 
Their general structural forms are presented in Figure 1.15. Representatives of this 
class are [RuIn^C^] and [RuImC^] where I = imidazole ring, shown in Figure
1.16. The antitumour activity of ImH(RuIm2CU) [99, 100b] and ImH2(RuImCl5) 
[100a] has been investigated and reveal promising properties for clinical use includ­
ing a non-toxic treatment of colorectal tumours.
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,C!
Cl
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Figure 1.15. Structures o f complexes HB[RuB£U] and. 2HB[RuBCh] where B=
nitrogen heterocycle.
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Another branch of tumour inhibiting complexes is cis-dichlorotetrakis 
(dimethylsulfoxide) ruthenium(II) and related compounds [101], Despite its octahe­
dral geometry and absence of amino ligands, this complex presents some interesting 
resemblances to cis-[Pt(NH3)2Cl2] such as neutrality, two cis-chloride ligands, high
stability o f 2 + oxidation state and a high affinity for nitrogen donor ligands [1 0 2 ], 
Furthermore, DMSO is known to cross the cell membrane easily while the complex 
is quite soluble in water.
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Ct Cl
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Cl Cl
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QHN —“
lmH(Ru(m2Cl4)
Cl
(lmH)2(RulmCl5)
Figure 1.16. Structures o f the complexes Rubn2CU and RuImCl$' where
lm —Imidazole ring.
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In vitro studies of cis- and trans-[RuCl2 (DMSO)4 ] have suggested that N7 
of the guanine is the major target of the cis-complex when binding to DNA. The 
trans isomer also covalently binds to DNA but with a markedly higher reaction rate 
and leads to marked modification of calf thymus DNA structure. The progressive 
destruction of the ordered DNA structure could be related to the formation of bi­
functional adducts along the chain. The trans isomer appears to have a remarkably 
higher reactivity than the cis isomer, due to differences in their structures. [98c] In 
vivo studies reveal both isomers to possess mutagenic activity against bacterial 
strains, with the trans form less so, while exhibiting a higher cytotoxicity and 
mutagenic activity when tested against a eucaryotic system [98c],
Experimental results indeed show that Ru(II) DMSO complexes possess a 
significant antitumour and antimetastatic activity, also exhibiting interesting thera­
peutic potential when combined with surgical amputation of the primary tumour 
[101-103], NMR structural characterisation of the reaction product between trans 
[RuCl2 (DMSO)4 ] and d(GpG) has been carried out revealing the formation of a
stable compound characterised by a covalent bifunctional coordination of the bases 
to the metal centre [104], The compound displays structural features similar to those 
exhibited by the corresponding cisplatin complex, indicating that such a way of inter­
action with DNA is not exclusive to Pt or to metals with square planar coordination 
geometries. The anti-metastatic effect of the trans isomer is of the same order as that 
obtained with an equitoxic dosage of cis-DDP.
The promising antimetastatic activity displayed by a related complex 
Na[trans-RuCl4(DMSO)Im] reported recently [105], as well as another novel com­
plex trans HInd[RuCl4 (Ind)2 ] [106] indicates the possibility that related complexes
may represent a new generation of antitumour compounds capable of selectively in­
teracting with metastasis formation of solid tumours. The structures of some interest­
ing Ru-DMSO complexes are illustrated below in Figure 1.17.
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The increasing attention ruthenium complexes are receiving as anticancer 
agents stresses the exciting potential they hold in this area and is yet another signifi­
cant application of the interaction of ruthenium complexes with DNA.
Figure 1.17. Ortep drawing o f  (a) cis-Ru(DMSO) 4CI2 and (b) trans-Ru(DMSO)4CI2
with the atom labelling scheme.
1.4.2. Study o f  Biological Electron Transfer Reactions.
The study of rates and mechanisms of electron transfer reactions is fundamental to 
understanding many vital processes as several important biological processes involve 
series of electron transfer reactions that are very efficiently controlled. An under­
c
standing of how electrons are transferred over large distances is therefore essential 
to the characterisation of fundamental redox processes in biology, such as oxidative 
phosphorylation and photosynthesis. Consequently, the study of intramolecular elec­
tron transfer across rigid and flexible polypeptides, proteins and DNA in solution has 
received much attention in recent years.
The active sites of the electron transfer centres only make up a small percent­
age by weight of the total electron transfer protein, indicating that the surrounding 
protein may play a major role in modulating the properties of these electron transfer 
centres, such as structural changes where the polypeptide chain allows specific pro- 
tein-protein interactions by direct electron transfer.
In order to obtain new information on the kinetics and mechanisms by which 
electron transfer proteins operate, the electron transfer redox reactions of cyto­
chrome c, iron-sulfur proteins and copper blue proteins have been studied using
various small molecule reagents including [Cr(OH2 )g]2+, [Fe(phen)3 ]2 +, a series of 
substituted [Co(phen-X)3 ]n+, and notably [Ru(NH-?)6]2 and related complexes [107- 
111].
The efficiency of electron transfer has been suggested to be attenuated by 
proteins, membranes and other biological structures [107, 108], Studies of electron 
transfer involving the interior of structurally characterised metalloproteins modified 
with pentammine ruthenium complexes have shown that electron transfer can occur 
over large distances through protein interiors [109, 110], Such factors as donor- 
acceptor distance, thermodynamic driving force and the nature of the intervening 
medium were deemed critical in determining rates of electron transfer.
Ruthenium complexes have been attached to surface histidines of structurally 
characterised proteins, including cytochrome c, myoglobin derivatives and hemo­
globins, so as not to modify the structure of the native protein. From these studies, it 
is apparent that the effects of the structure of the intervening medium (specific con­
formation between donor and acceptor groups) and the orientation of the donor-
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acceptor unit on electron transfer are far less understood than other factors such as 
solvent environment and distance [109-115],
Beratan, Onuchic and coworkers have examined the effects of protein 
structure on distant electronic couplings via the pathway analysis of various protein 
electron-transfer reactions [116], Although such theoretical methods contain the 
minimal description needed to adequately model the basic mechanisms of protein- 
mediated electron tunnelling, it makes reasonable predictions about primary, sec­
ondary, tertiary and quaternary structural effects on electron transfer rates. Meas­
urements of electron transfer rates in ruthenium-modified proteins have been car­
ried out to test the methods reliability [116],
Electron-tunnelling in ruthenium-modified cytochrome c has been reported 
whereby the rates and the couplings correlate well with the lengths of sigma- 
tunnelling pathways comprised of covalent bonds, hydrogen bonds and through 
space jumps from the histidines to the heme group [117], Site directed mutants of 
human myoglobin [Mb], an oxygen-storage protein have been prepared in order to 
investigate the electron transfer in ruthenium zinc porphyrin derivatives of recom­
binant human myoglobins, so as to compare this to the data obtained for Ru- 
modified cytochrome c [118,119],
The characterisation of a Ru-modified derivative of the [2Fe-2S] ferredoxin 
Fdl component of A. variabilis by attachment of [Ru(NH3)5]3+ to a surface histidine 
has been carried out [120], Ferredoxins isolated from higher plants and algae are 
involved in redox processes including those related to photosynthesis and are char­
acterised by a one electron redox change. Such results further correlate with the 
theory that the electron transfer is indeed highly sensitive to the intervening protein 
medium, but the exact role that the protein matrix plays in mediating the electron 
transfer process is not well understood [119,120],
Electron transfer across polypeptides has also been studied, by studying 
electron transfer in osmium-ruthenium binuclear complexes bridged with oli- 
goproline peptides [121, 122], Significantly, these are suitable as rigid chemical 
spacers in studies of long-range intramolecular electron transfer as a function of
43
distance between donor and acceptor. The results reveal that rapid rates of electron 
transfer across polypeptides can be observed for a metal-to-metal separation of > 20
A [121].
A report by Mecklenburg discusses the photoinduced electron transfer in 
amino acid assemblies [123], where various combinations of donor, acceptor and 
chromophores to yield multifunctional amino acids and peptides are constructed in 
order to explore excited-state electron transfer in such amide-based complexes
[123].
In addition to various proteins, DNA is used as a biological medium through 
which long range electron transfer is investigated. Barton and co-workers have 
studied several donor-acceptor systems, including Ru(II) and Co(II) polypyridyls, 
which undergo photoinduced electron transfer. From these systems, the role of the 
DNA double helix in mediating electron transfer has been investigated and various 
aspects of the DNA environment, such as local electrostatic fields, hydrophobic 
patches, lipophilic interactions and the dimensionality of space surrounding the 
double helix have been monitored [124-126], A reduced dimensionality in diffusion 
of DNA-binding proteins appears to be a major factor contributing to their ability to 
rapidly locate sequences along the DNA. Firstly, stereoselective electron transfer in 
the presence of DNA is reported [124], Due to the long range of movement and de­
creased dimensionality, the electron transfer rates are greatly enhanced in the pres­
ence of DNA, with the DNA essentially acting as a catalyst of electron transfer
[124],
Further reports by Barton suggest that the apparent rate enhancement in the 
presence of DNA could be due to a combination of factors including (1) the in­
crease in local concentration of bound donor-acceptor pairs; (2 ) facilitated diffusion 
of the bound pair along the DNA helix in a reduced dimensional space and; (3) long 
range electron transfer between donor and acceptor pairs with DNA as the inter­
vening medium [125], The more mobile surface-bound ruthenium complex pro­
motes long range transfer with greater efficiency than the intercalated species, de­
spite the closeness of the intercalated form to the extensive framework of the
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stacked bases. Hence, the efficiency of electron transfer apparently depends upon 
the binding mode, ie. the orientation of donor and acceptor on the biopolymer, as 
well as upon the electronic states of donor and acceptor, and how well these elec­
tronic states couple with the intervening DNA [125],
Rapid photoinduced electron transfer over a distance of greater than 40 A
between metallointercalators, a donor [Ru(phen)2dppz]2+ and acceptor
[R h (p b i)2p h e n p “  that are tethered to a DNA duplex have been reported [126], Sig­
nificantly, complete quenching is observed only when the acceptor is covalently 
bound to the same duplex as the donor, indicating that the intervening DNA helix 
facilitates the donor-acceptor interaction despite the large distance separating the 
metallointercalors on the helix [126],
Meade and coworkers have recently reported a novel approach of preparing 
ruthenium-modified duplex DNA derivatives, where the donor and acceptor are 
separated by any number of base pairs [127]. (See Figure 1.18.) The stacked aro­
matic heterocycles of the DNA duplex apparently serve as an efficient medium for 
coupling electron donors and acceptors over very long distances, indeed compara­
ble to distances found in biological systems [126, 128], Furthermore, the electronic 
coupling between donor and acceptor for modified DNA derivatives appears to dis­
play a remarkable dependence on nucleic acid sequence [128],
In brief, the many publications concerning the use of ruthenium complexes 
in the study of electron transfer across biological materials are indicative of the 
heightened interest in this field in recent years, and the exciting potential ruthenium 
complexes hold in the study of such natural biological processes.
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Figure 1.18. Schematic representation o f duplex DNA labelled with ruthenium 
based donors and acceptors [127],
1.4.3. Chemiluminescent reactions with biological compounds.
During the early studies of ruthenium complexes of the form [Ru(L-L)3 ]3+, where L 
= bpy or phen, the most striking behaviour observed was their ability to undergo 
chemiluminescent reduction. Addition of acidic solutions of [Ru(L-L)3]3 + to aque­
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ous NaOH solution results in orange chemi luminescence, clearly visible in a dimly 
lit room. Further studies of Ru(II) and Ru(III) compounds revealed that Ru(II) 
complexes also exhibit intense luminescence emission and that the 
chemiluminescent spectrum obtained from the Ru(III) complexes is fundamentally 
identical to the luminescence spectra for its Ru(II) equivalent compounds.
[Ru(bpy)3]3+ can react with a variety of compounds, including oxalate and
other organic acids to yield chemiluminescence, thereby allowing the detection of 
such compounds. [129, 130] The detection of oxalate has biological significance, 
particularly in medical analysis, as high concentrations of oxalate in the blood 
accompany a number of maladies including renal failure, vitamin deficiencies and 
intestinal diseases.
Chemiluminescence (CL) is observed when part of the energy of an 
exothermic chemical reaction is released as light. This occurs between oxalate and 
[Ru(bpy)3]3+ with a rather specific electron transfer. The mechanism of the 
reaction is as described below.
[Ru(bpy)3]2+ -—> [Ru(bpy)3]3 + + e- (1.9)
[Ru(bpy)3]3+ + C20 42- - - >  [Ru(bpy)3]2+ + C20 4- (1.10)
C20 4-
C0 2 ‘ + [Ru(bpy)3 ]3+
---■> C 0 2 + C 0 2- (1.11)
— > C 0 2 + [Ru(bpy)3]2+* (1.12)
( . )
Alternatively, [Ru(bpy)3]2+ * may be produced as follows;
C 02‘ + [Ru(bpy)3]2+ —-> CO2 + [Ru(bpy)3]+ (1.13)
[Ru(bpy)3]+ + [Ru(bpy)3]3+ — > [Ru(bpy)3]2+ + [Ru(bpy)3] 2+* (1.14)
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Above is an example of electrogenerated chemiluminescence where the re­
action between electrogenerated [Ru(bpy)3]3+ and oxalate yields luminescence in 
aqueous solution. The key factors in the production of the excited state are the large 
free energy change associated with the rapid electron transfer reactions (1 .1 1 ) and 
(1.14) and the production of a strong reductant, CO2 " by oxidation of oxalate
(C2 O4"). These unique factors contribute to the specificity of the reaction. Intense 
orange emission results when the excited state decays to the ground state. The 
emission intensity is shown to be directly proportional to the concentration of ox­
alate, thereby rendering [Ru(bpy)3]3+ a useful probe for oxalate in biological ma­
trices [130],
A more recent application for [Ru(bpy)3 ]3+ involves the chemilumines­
cence detection of amino acids, peptides and proteins [131], The sensitive detection 
of over 20 amino acids, some peptides and a few proteins has been studied with the 
flow injection analytical technique. Amino acids generally are not well suited for 
detection without prior derivatisation due to the absence of a strong chromophore,
whereas the [Ru(bpy)3]3+ reagent has the potential to be generated in line prior to 
the detection cell, which can make the system more rugged and easy to use. Hence, 
the advantages of using chemiluminescence reagents such as [Ru(bpy)3 ]3+ includes 
fast reaction kinetics, a high reaction efficiency to enhance selectivity and the capa­
bility of reacting directly with amino acids thereby increasing sensitivity.
The observed CL for the reaction of [Ru(bpy)3]3+ with amines is related to 
the first ionisation potential of the non-bonding orbital of the nitrogen atom. The 
observed CL results from the formation of an amine radical by reaction of the 
amine with [Ru(bpy)3]3+ The radical then reacts with a second [Ru(bpy)3]3+ ion, 
producing an excited [Ru(bpy)3]2+\  which subsequently decays to the ground state 
with the emission of a photon [131]. A similar mechanism has been proposed for 
the reaction with amino acids and is revealed below [132],
48
H3N+CH RC00‘ + OH' — > H2NCHRCOO' (1.15)
H2NCHRCOO' + [Ru(bpy)3]3+ —->
H2N +CHRCOO' + [Ru(bpy)3]2+ (1.16)
H2N +CHRCOO- + [Ru(bpy)3]3+ — >
NH=CRCOO‘ + [Ru(bpy)3]2+* + 2H+ (1.17)
[Ru(bpy)3]2+* 
NH=CRCOO + H20
— > [Ru(bpy)3]2+ + hv600 (1-18)
--> RCOCOO” + NH3 (1.19)
Brune and co-workers have investigated the effect of pH on the reaction of 
[Ru(bpy)3 ]3+ with amino-acids and found this to be the key experimental parame­
ter in the application of this reaction as a detection technique [132],
Early studies of the oxidation of amino acids suggest that the reactive spe­
cies is the anion of the amino acid. If so, the reaction should be faster at pH values 
> pKa of the N-terminal amine of the amino acid. In accordance with this, the 
maximum chemiluminescence signal for amino acids occurs at pH values above pH 
7. In fact, optimum chemiluminescence emission is observed between pH 10 and 11 
(where a significant percentage of the amino acid exists in anionic form). A back­
ground reaction between the hydroxide ion and [Ru(bpy)3 ]3+ is observed to be less 
pH-dependent and does not occur with the same efficiency as the amino-acid reac­
tion and hence does not limit this technique. An example of results found are for 
glutamic acid whose pKa = 9.2 (See Figure 1.19). At pHs more than pH 8 , the reac­
tion occurs with greater facility than with the hydroxide ion and therefore, chemi-
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luminescence increases dramatically over the pH range 9-11. This system is very 
sensitive with a detection limit of about 30 pmole found for valine.
It was further concluded from these initial studies that the presence of pep­
tide bonds may not be essential for peptide or protein detection rendering such a 
technique feasible for some peptides and proteins including insulin, myoglobin and 
ribonuclease, as studied by Danielson and co-workers [131],
Figure 1.19. pH  Dependence o f  Chemiluminescence o f  Glutamic Acid
[132]. (a) Background-corrected glutamic acid signal; (b) background signal from  
OIF reaction; (c) signal to noise ratio (SNR) obtained from (a) and the noise meas­
ured on (b).
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More recent studies were carried out, again by Brune and co-workers on the 
role of electron-donating/withdrawing character, pH and stoichiometry on the
chemiluminescent reaction of [Ru(bpy)3 ]3+ with amino acids [133], According to 
Brune, electron-withdrawing R groups tend to decrease chemiluminescence (ie. 
alcohols, serine and threonine) while electron-donating R groups have the opposite 
effect (ie. alkyl side chains, leucine and valine) A postcolumn chemiluminescent 
technique for the detection of underivatised amino acids indicates the potential of 
such a system following a protein digest. As smaller amounts of protein are being 
isolated for sequencing, new and improved methods for separating and detecting the 
amino acids are constantly in demand and hence its implications in protein 
sequencing.
In such systems, the chemiluminescence derived from such a technique 
should be directly proportional to the quantity of amino acid present, the method 
should have a wide dynamic working range and it should be sensitive to the
detection of all amino acids. The characteristics of the [Ru(bpy)3]3+/amino acid
reaction, consequently render it suitable. The reaction of aliphatic tertiary amines
using the chemiluminescence reagent [Ru(bpy)3 ]3+ has also been applied to the
detection of antibiotics such as clindamycin and erythromycin [131].
Downey and Niemen have studied the chemiluminescence detection of
NADH using [Ru(bpy)3 ]3+ immobilised on a Nafion film, this being the first
research carried out concerning NADH detection using [Ru(bpy)3 ]3+ 
electrochemiluminescence [134], NAD+ is required to catalyse enzyme reactions of 
dehydrogenases, while NADH is produced by the enzyme reaction, the amount being 
related to the substrate concentration (hence substrate concentration can be 
determined by measuring NADH concentration). Recent reports have been made on 
the construction of a flow injection analysis system for a reduced form of nicotamide 
adenine dinucleotide (NADH) by electrogenerated chemiluminescence using
[Ru(bpy)3 ]3+ [135], Such a system has significant advantages, in particular its
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requires no enzymes for NADH determination.
Finally, the electrogenerated chemiluminescence (ECL) yielded from the 
oxidation of [Ru(phen)3]2+ at a gold electrode in the presence of oxalate has been 
used to characterise the nature of the interaction of the Ru(II) chelate with calf 
thymus DNA [136], The decrease in ECL emission from the excited state, 
[Ru(phen)3]2+*, in the presence of DNA has been attributed to the binding of the 
chelate to the DNA strand. Detection of luminescence is possible with high 
precision, and compared to voltammetric and spectrophotometric measurements, 
very low concentrations of complex can be used ie. micromolar to nanomolar [136],
simplicity as only [Ru(bpy)3 ]2 + is needed as a reagent since its chemiluminescence
1.4.4 Covalent linkage o f ruthenium polypyridyl complexes to proteins.
In our last section aimed at discussing the usefulness of ruthenium polypyridyl com 
plexes, the covalent linkage of ruthenium based labels with proteins will be the main 
concern. In order to fully understand the reactions carried out, and to visualise where 
on the proteins the labels are bound to, a brief discussion of the reactive groups of 
proteins and how these labels couple to form stable covalent bonds is essential.
1.4.4.1 Reactive groups o f proteins j 137-139}.
Proteins/peptides are amino acid polymers containing a number of reactive side 
chains which can be used to attach reporter molecules. Under appropriate 
conditions, each reagent normally reacts only with the indicated target side chain(s). 
Depending on the protein, the reagent and the particular conditions, however, 
complete modification of all such side chains is not always obtained.
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As well as, or as an alternative to these intrinsic reactive groups, specific 
reactive moieties can be introduced into the polymer chain by chemical 
modification, whereby these groups serve as “ handles “ for attaching a wide variety 
of molecules. Conjugation usually involves binding to the amino side-chains, in 
particular the e-amino group of lysines, the phenolic moiety o f tyrosines, the 
carboxyl groups of glutamate and aspartate and the sulphydryl groups of cysteines. 
As a general rule, modifications that have the least effect on side-chain character 
should have the least effect on protein structure and properties. Modifications of 
lysine residues that retain their usual cationic charge, for example, generally have 
relatively little effect on the biological activities and other properties of many 
proteins. However, a lack of specificity o f the reactions is a common feature.
One of the most reactive groups of a protein is the aliphatic e-amine of the 
amino acid lysine. Lysines are usually present and are often quite abundant while, 
among the 20 or so amino acid side chains normally present in proteins, e-amino 
groups of lysine residues are usually among the most common and most accessible 
of the potentially reactive groups. Lysine amines are good nucleophiles above pH 8 
(pKa = 9.18) and therefore, react cleanly and easily with a variety of reagents to 
form stable bonds. The a-amino groups of the N- terminal amino acid are also 
reactive, are less basic and so are reactive at approximately pH 7.0. Sometimes they 
can be modified selectively, in the presence of lysines. There is usually at least one 
a-amino acid in a protein, and in the case of proteins that have multiple peptide 
chains or several subunits, there can be more. Therefore, the most commonly used 
method of protein modification is through these aliphatic amine groups.
Protein-NH2 + RX — > Protein-NHR + HX. (1.20)
Proteins contain carboxylic acids at the COO' terminal position and within 
the side chains of the amino acids aspartine and glutamine. Due to their low 
reactivity in water, thay are usually converted into reactive esters by use of a water 
soluble carbodiimide, when used in the selective modification of proteins, and then
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reacted with a nucleophilic reagent such as an amine or hydrazide (See equation 
1.21.).
O O 0
Prot C — “OH
II II
► Prot C — OX + RNHNH ► ProtCNHNHR
2
( 1.21)
The amine reagent should be weakly basic so as to react specifically with 
the activated carboxylic acid in the presence of the other amines on the protein, as 
protein cross-linking can occur when the pH is raised to above pH 8.0, i.e. when the 
protein amines are partially unprotonated and reactive. Hence the suitability of 
hydrazides, which are weakly basic, in coupling reactions with carboxylic acids.
Another common reactive group in proteins is the thiol residue from the 
sulphur containing amino acid cystine and its reduction product cysteine, which are 
counted together as one of the 20 amino acids. Cysteine contains a free thiol group, 
which is more nucleophilic than amines and is generally the most reactive 
functional group in a protein. It reacts with some of the same modification reagents 
as for amines and can also react with reagents that are not very reactive towards 
amines. Thiols, unlike most amines, are reactive at neutral pH, hence they can be 
coupled to other molecules selectively in the presence of amines, as described in 
equation 1 .2 2 .
This selectivity makes the thiol group suitable as a linker for coupling two 
proteins together, as other methods only coupling amines may result in the 
formation of unwanted products, such as homodimers and oligomers. In the absence
NH2-Protein-SH + RH ■> NHr Protein-SR + HX (1.22)
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of cysteine, some proteins also have the amino acid methionine. Since selective 
modification of methionine is difficult to achieve, it is seldom used to attach small 
molecules to proteins.
Chemical modification of other amino acid side chains has not been 
extensively used. The high pKa of the guanidine functional group of arginine (pKa = 
12-13) requires more drastic reaction conditions than most proteins can survive. 
Also, tryptophan modification requires harsh conditions and is rarely used except as 
a method of analysis in structural or activity studies.
1.4.4.2. Protein modification reagents f 1391.
Reactive groups may also be introduced by chemical modification. The basic 
principles for understanding how to use such reagents are ( 1 ) the recognition of the 
reactive groups on the protein that can be modified; (2 ) knowledge of the type of 
chemical reactions these reactive groups will take part in; and (3) the nature of the 
chemical bonds that will result from these reactions.
Amine reactive reagents react primarily with lysines and the a-amino groups 
of proteins and peptides under both aqueous and nonaqueous conditions. The 
choice of amine modification reagent chosen for a reaction depends upon the 
reactivity and specificity required for that specific protein. Fluorochromes which 
modify these groups include the isothiocyanates, succinimidyl esters, isocyanates 
and sulphonyl halides (chlorides).
Reactive esters, for example N- hydroxysuccinimide (NHS) esters are very 
common reagents used for the modification of amines, with high selectivity towards 
aliphatic amines. The aliphatic amide products formed are very stable (optimum pH 
8-9) and the reaction scheme is described in equation 1.23. The NHS esters formed 
are slowly hydrolysed by water but are stable to storage if  kept well dessicated. 
Almost all molecules that contains a carboxylic acid or that can be chemically 
modified to contain a carboxylic acid can be converted into NHS esters, as shown
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in equation 1.24, thereby rendering these reagents among the most powerful protein- 
modification reagents available.
0 %
Protein- NH + RC ■
>  
O
0 VII
-► Protein- NHCR + HO'N
O
( 1.23)
O
II
RCOH +
O
HO- N
yo
o
DCC o  V
II /
RCON
r ( 1.24)
Isothiocyanates are other amine modification reagents of intermediate reac­
tivity, forming thiourea bonds with proteins and such a reaction procedure is out­
lined in equation 1.25. They are more stable in water than the NHS esters and react 
with protein amines in aqueous solution at optimum pHs 9.0-9.5 . Due to this high 
pH, isothiocyanates may not be as suitable as NHS esters when modifying proteins 
that are sensitive to alkaline pH conditions.
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s
II
Prot NH + RN =  C =  S ------------► Prot NH C--------  NHR
2
(1.25)
Aldehyde groups can also react with aliphatic and aromatic amines under 
mild aqueous conditions to form an intermediate known as a Schiff base, which can 
be selectively reduced by the mild reducing agent , such as sodium 
cyanoborohydride to give a stable alkylamine bond. This method, however, is not as 
frequently used as the activated ester method. Equation 1.26 below describes the 
reaction procedure involved.
NaBH CN
Prot NH + R C H = 0  ------------► Prot N =  CHR  ^  ProtNHCH R
2 2
(1.26)
Sulphonyl halides are other highly reactive amine-modifying reagents. 
Although unstable in water, they form very stable sulfonamide bonds. As well as 
amines, sulfonyl halides also react with phenols (tyrosine), thiols (cysteine) and 
imidazoles (histidine) on proteins and are less selective than either the NHS esters 
or isothiocyanates.
Thiol reactive reagents which couple to thiol groups on proteins to give 
thioether-coupled products, react rapidly at neutral pH and can therefore be reacted 
with thiols selectively in the presence of amine groups. Examples include 
haloacetyl derivatives and maleimides, both which react with cysteine groups to 
form thioether bonds,
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Other important modifications are carboxylic acids and aldehyde reactive 
reagents. One such example are amines and hydrazides which can be coupled to 
carboxylic acids of proteins via the activation of the carboxyl group by water 
soluble carbodiimide followed by reaction with an amine or hydrazide leading to 
stable amide bonds (See equation 1.27).
N OII
P r o t e i n  -  C O H  +  R N  =  C = N R '  ----------- - ►  P r o t e i n  -  C  O C =  N R
H N R ’
R"NJ^ 9  O
----------------------------------------P r o t e i n -  c  N H R "  +  R N H  C  N H R 1 ^  27 )
Amines and hydrazides can also react with aldehyde groups which can be 
generated on proteins by periodate oxidation of the carbohydrate moieties of the 
proteins. A Schiff base intermediate is formed which can be reduced to an 
alkylamine by reaction with NaBH4, a mild and selective water soluble reducing 
agent. This reaction procedure is outlined below in equation 1.28.
Prot- gly + NalO^ ------------► ProtCH =  0  ► Prot CH NHR
(1.28)
4 2
Much work has been carried out involving covalent linkage of ruthenium 
complexes to biomolecules and their use as probes of the systems in question. 
However, such applications will be discussed in greater detail in Chapter 4 where
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our work involves similar probing studies and conjugation reactions. A summary of 
unusual applications found for ruthenium-modified biomolecules is given to 
demonstrate the broad applicability of such complexes in biological matrices.
1.4.5 Diverse ruthenium-protein applications.
Varied miscellanous applications have been found for ruthenium complexes, when 
bound to natural proteins, such as enzymes and antibodies, ranging from stabilising 
agents to their use as models o f novel drugs.
One useful function of ruthenium complexes is the significant enhancement 
in conformational and thermal stabilisation of a protein obtained by cross-linking 
an engineered metal-binding site with a ruthenium complex inert to substitution
[140], Cross-linking two histidines on opposite strands of a P-sheet with 
[RuH(bpy)2] significantly increases the unfolding free energy of Saccharomyces
cerevisiae iso-1 -cytochrome c and increases its melting temperature with a minimal 
change in the cytochrome c FeIII/II reduction potential [140], (See Figure 1.20)
A significant medical application for ruthenium complexes is based on their 
complexation to drugs, one example being the drug clotrimazole which acts against 
the tropical disease trypanasoma-cruzi, as they lead to enhancement o f the drug’s 
efficacy as well as exhibiting a low toxicity [141], However, more detailed studies 
on the mechanisms of action of this complex, as well as further modifications of 
this and other related metal derivatives, are still in the early stages.
Regulation of protein and enzyme activities by external stimuli is necessary 
for the design of biocatalysts with a variety of potential biotechnological and 
medical applications. Chemical modification of enzymes with nonnatural 
functional groups such as photochromic or redox active molecules has been 
revealed as a promising approach. Hamachi and coworkers report light-driven acti
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vation o f a semi-synthetic myoglobin [Mb] that is directly modified at the heme co­
factor active site [142], The reconstituted protein with a photo-sensitisable 
[R u(bpy)3]2+ at its heme is activated by visible light to function as a dioxygen stor­
age protein. The active centre of Ru-Mb (protohemin) is reduced from the ferric to 
ferrous state by photoinduced electron transfer, followed by the reaction with di­
oxygen gas [142], As opposed to earlier approaches, (a) a cofactor reconstitution 
method is applicable for the active site directed introduction of nonnatural func­
tional groups and (b) a long range electron transfer rate can significantly influence 
the overall activity o f the semisynthetic protein (See Figure 1.21).
Figure 1.20 Energy-minimised model o fR il12-H39 H38 cytochrome c [140],
6 0
;R u ( b p y )2
•<CI04)2
Figure 1.21 Structure o f  the protoheme derivative covalently bound to
[Ru(bpy)3f  [142],
The binding of a complex cobalt ruthenium polyamine (see Figure 1.22), by 
DNA and a lipopolysaccharide has been investigated with implications as a model 
for a novel class of drug [143], The aim was to study the value of heavy metal poly­
cations compared to polyamines such as spermine, in their binding to macromole­
cules such as DNA and lipopolysaccharides, and consequently an attempt to design 
a prototype drug which would displace biological polycations from polyanion
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partners. As simpler metal complex ammines such as [Co(NH3 )]3+ bind quite 
strongly to such anions, this study involved testing to see if the affinity of polyamines 
could be matched by extended flexible complex metal cations such as the Ru-Co 
complex illustrated below (Figure 1.22). As expected, this complex binds strongly to 
DNA and lipopolysaccharides and it does not saturate the negative charge of the 
anions. Surprisingly however, the anions increase both the reagents photosensitivity 
and sensitivity to oxidation in air. As the Ru undergoes reversible one electron oxi­
dation, implications include the attack by a drug based on the design of Ru-Co since 
DNA is susceptible to attack by free radicals [143],
5  +
\
Co
/
H N 7  " h !H ^NH
Figure 1 . 2 2  Structure o f Ru-Co complex {Co[H3CsarNHCH2pyRu(NH3) 5]} [143].
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1.5. Scope of thesis.
This thesis is concerned with the study of ruthenium(II) polypyridyl complexes 
incorporated into biological systems in a covalent manner. There are two main goals 
of these studies. The first objective is the preparation and characterisation of 
ruthenium modified-proteins via specific sites along the biopolymer. The second and 
indeed converse goal is to use the existing extensive knowledge on the photophysics 
of these complexes to probe the conformational variances that the bound 
biomolecules undergo in solution.
In Chapter 3, the properties of the ruthenium labels bound to specific binding 
sites on the poly-amino acids and proteins are described. The main aim of this 
chapter is to verify the success of the conjugation procedures attempted and to study 
the effects of reaction conditions, label form and protein structure on the extent of 
these conjugation reactions.
The decay behaviour of ruthenium polypyridyl complexes is known to be 
very sensitive to its local environment. Therefore, in Chapter 4 and 5 the pH 
sensitivity of the emitting properties of the labels, in particular the emission 
intensities and lifetimes when bound to selected proteins is investigated. The aim 
here is to determine how the emission properties of such fluorescent labels can be 
used as a sensitive reporter, to follow acid-induced conformational changes of the 
bound biomolecules in solution due to variances in the nature of its surroundings. 
Chapter 4 investigates the probing potential of the absorption and emission spectra 
of the labels while Chapter 5 examines the potential of the decay lifetimes. The effect 
of chemical denaturants on the decay lifetimes of the protein-bound labels is also 
examined in an attempt to investigate the possibility of monitoring the unfolding of 
real proteins.
Finally, the photophysical properties, particularly the decay lifetimes of the 
labels are examined when bound to the enzyme lysozyme as enzyme activity studies 
should allow us to study the effects, if any, of such labelling on the function and 
conformational properties of the enzyme. In addition, this allows the establishment of
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the extent of usefulness of such complexes in real biological processes as the de- 
naturation of the protein is implied and hence can probably be monitored by the 
loss of activity of lysozyme towards its substrate.
Finally, Chapter 6 aims to bring the information in this thesis together and to 
give an overview of how exactly ruthenium polypyridyl complexes succeed in fol­
lowing certain conformational variances of the bound biomolecules, including sec­
ondary structure changes of polypeptides and the unfolding of proteins. Brief sug­
gestions of further work which could be done in the future to extend the applicabil­
ity and usefulness of such complexesin biological matrices are also given.
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Experimental Procedures.
Chapter 2.
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2.1 Introduction.
The synthetic procedures for the preparation of the ruthenium polypyridyl complexes 
and the methods of their conjugation reactions to various biomolecules are described 
in the following section. All synthetic reagents and solvents were of commercial 
grade and no further purification was employed. The instrumentation and chemical 
techniques used to characterise the prepared samples are also discussed herein,
The complexes and their respective bioconjugates are listed in numerical 
order for further reference and the table summarising the reference numbers of each 
complex/conjugate studied is listed in Table 3.1.
2.2. Synthesis of ruthenium polypyridyl complexes.
2.2.1 Preparation o f the complexes [Ru(L-L)2 (NH2  p h e n )p + 1.
where L-L= 1,10-phenanthroline (phen) 2,2’-bipyridine (bpy) and 4,7’-diphenyl, 1,10- 
phenanthroline (dpp).
The complexes were prepared according to literature methods [1],
2.2.2 Preparation o f the complexes [Ru(L-L)2 (NCSphen)]^+ 2.
These complexes were prepared as described in the literature [2], 0.20 mmol of the 
ruthenium amino complexes were placed in 10 ml distilled water and stirred in the 
presence of an anion exchange resin (Amberlite exchange resin Cl', activated by 
treatment with 2M NaOH, washed thoroughly and then treated with 2M HC1 and 
washed thoroughly again.) in order to exchange the PF6- anion for Cf ions, thus 
rendering the compound soluble in aqueous solution. On removing the resin from the
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filtrate, the dichloride compound was reacted with 0 .0 1 M thiophosgene in acetone, 
by adding dropwise to the aqueous solution over 30 min. It was necessary to keep 
the reaction vessels in an ice-bath to prevent the evaporation of the thiophosgene.
All procedures were carried out with care due to the toxicity of thiophos­
gene, including the wearing of gloves and due to the volatility of thiophosgene, each 
reaction stage was carried out in the fumehood. The resulting solution was left 
overnight at room temperature in a covered vessel. The complexes
94- 9 +[Ru(dpp)2 (NCSphen)] and [Ru(phen)2 (NCSphen)] precipitated and were iso­
lated by filtration and dried under vacuum, on completion of the above reaction. In
O i _
contrast, the complex [Ru(bpy)2 (NCSphen)] remained in solution at this stage, 
and was isolated by evaporation of the excess thiophosgene under reduced pressure, 
followed by precipitation using a saturated aqueous solution of NH4PF6 . The com­
pounds were then dried in vacuo. Recrystallisation of these isothiocyanate deriva­
tives was not carried out due to their instability in aqueous solution.
2.2. S. Synthesis o f [Ru(bpy)2(COOH2bpy)J(Pb'6)2 •3
The ligand 4,4’-carboxylic acid-2,2’bipyridine was prepared from 4,4’-dimethyl-2,2’ 
bipyridine according to literature methods [3], Synthesis of the ruthenium complex
(a) and its conversion to the active ester (b) were carried out according to Bard [4],
2.3 Conjugation Procedures.
The various procedures involved in covalently binding ruthenium polypyridyl com­
plexes to specific sites on selected biomolecules are described in this section.
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2.3.1 Conjugation o f [Ru(L-L)2 (NH2Phen) f t + to BSA and lysozyme. Ia, Ib
(a) Conjugation of [R u(L-L)2(N H 2phen)]2+  to albumins via carbohydrate moieties13
firstly involves the periodate oxidation of the albumin followed by conjugation to the 
amino complex. BSA (bovine serum albumin) 10-25 mg, was dissolved in 0.10M 
carbonate buffer (1-2 ml) and treated with 2.5 ml of 16 mmol NaI0 4  for two hours
at 4 °C in the dark. [8] The ruthenium complex was dissolved in the minimum vol­
ume of dimethylformamide (DMF) and 0.10 M carbonate buffer, pH 9.2, keeping the 
total reaction volume to a minimum. The label solution was then added (50 molar 
excess unless otherwise stated) dropwise to the gently stirring protein solution using
a micro-syringe. The conjugation reaction was allowed to proceed overnight at 4 °C, 
in the dark, with minimal agitation. Unbound ruthenium compound was removed by 
extensive dialysis against 0.10 M carbonate buffer, pH 9.2 (at least 4 changes of 
buffer). The oxidation of the protein leads to the formation of an unstable Schiffs 
base which was subsequently stabilised by adding 4/20 volumes of NaBH4 (5 mg/ml)
and reacted for one hour at 4°C, in the dark. Finally, the conjugate was further dial- 
ysed against two changes of carbonate buffer. [8]
(b) Conjugation of [Ru(L-L)2(NH2phen)]2+ to albumins via glutamic acid residues
lb involves the activation of the glutamic acid carboxylic acid side groups which are 
naturally quite inactive in aqueous solution. This was achieved by treating the albu­
min, already dissolved in 1-2 ml 0.05 M acetate buffer pH 4.8, with 0.05 ml of 1 x 
10'3 M carbodiimide. [9] The ruthenium complex was then dissolved in the minimum 
volume of DMF/0.10 M carbonate buffer pH 9.2, added dropwise to the protein so­
lution and the reaction allowed to proceed overnight at 4°C in the dark. Extensive 
dialysis was carried out against 0.10 M carbonate buffer pH 8-9.
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2.3.2 Conjugation o f  [Ru(bpy)2 (NH2phen)J2+ to goat anti-mouse IgG. lc
Conjugation of the amino complex to IgG is as outlined in 2.3.1 except that 0.5 ml 
of IgG in PBS (phosphate buffered saline) ie 1-2 mg was used per conjugation. The 
buffer used was 0.05 M phosphate buffer pH 7.4 and the anti-IgG was oxidised us­
ing 1ml of 10 mmol NaIC>4 [10].
2.3.3 Conjugation o f  [Ru(L-L)2 (NH2 phen)]2 + to Poly-L-Glutamate (PLGlu). ld
10 mg P-L-Glu was dissolved in 1-2 ml of 0.05 M acetate buffer pH 4.8 and then 
treated with 0.5 ml of 1 x 10'3 M solution of a water soluble carbodiimide for two
hours at 4 ®C in the dark, as undertaken in 2.3.1. The ruthenium complex was then 
dissolved in the minimum volume of DMF/0.10 M carbonate buffer pH 9.2, added 
dropwise to the protein solution and the reaction allowed to proceed overnight at
4°C in the dark. Extensive dialysis was carried out against 0.10 M carbonate buffer 
pH 8 .
2.3.4. Conjugation o f  [Ru(L-L)2 (NH2 phen)]2 + toPLL. Ie
This was carried out as described for PLGlu above (See 2.3.3.) as these amino com­
plexes were bound to the terminal carboxylic acid groups of the polypeptide chain.
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2.3.5. Conjugation o f [Ru(L-L)2 (NCSphen)J^+to BSA, PLL and lysozyme 2a [11].
lOmg BSA/PLL/lysozyme was dissolved in 1-2 ml 0.10 M carbonate buffer, pH 9.2. 
The isothiocyanate complexes were dissolved in 30:70 DMF/0.10M carbonate 
buffer pH 9.2 and were added dropwise in volumes equivalent to a 50 molar excess 
of the label to biomolecule (unless stated otherwise). The conjugation reaction was 
allowed to proceed overnight at 4 °C in the dark, with minimal agitation. The con­
jugate was extensively dialysed against 0.10 M carbonate buffer pH 9.2 [11],
2.3.6 Conjugation o f  [Ru(L-L)2 (NCSphen)]2 + to PLGlu. 2h
This was carried out as for PLL in section 2.3.5. However, 0.10M carbonate buffer 
pH 8-8.5 was employed throughout the procedure as opposed to the usual pH 9.2. 
This is due to the fact that the terminal amino groups have a lower pKa of 8 com­
pared to that of the lysine residues (pKa=9.5).
2.3.7 Conjugation o f the active ester o f [Ru(bpy)2 (COOH2bpy) to BSA and 
(PLL).3a
10 mg albumin/PLL was dissolved in 1-2 ml 0.10 M carbonate buffer, pH 8.2. The 
active ester solution was added dropwise in volumes equivalent to a 50 molar ex­
cess of the ester to biomolecule (unless stated otherwise). The conjugation reaction 
was allowed to proceed overnight at 4 °C in the dark, with minimal agitation. The 
conjugate was extensively dialysed against 0.10 M carbonate buffer pH 8.2 [11],
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2.4. Chemical procedures.
2.4.1. Absorption and emission measurements.
UV/vis spectroscopy was carried out using a Shimadzu UV 3100 or UV3101PC in­
strument interfaced with an Elonex PC-433 personal computer. Emission spectra 
were obtained on a Perkin-Elmer LS50 or LS50B luminescence spectrometer inter­
faced with an Epson PCAX2E personal computer, employing Fluorescence Data 
Manager custom built software and equipped with a red sensitive Hamamatsu R 
928 photomultiplier tube. An emission slit of lOnm was used at room temperature 
and the results were not corrected for photomultiplier response.
Quantum yields of emission, <j)em were carried out according to the method 
of optically dilute measurements described by Demas and Crosby [5], The standard 
2+used was [Ru(bpy)3] , known to have a quantum yield of 0.028 in aqueous air 
equilibrated solution [6 ], Normalisation of absorbance intensity was carried out 
prior to emission measurement and <|>em the emission quantum yield was deter­
mined by using the following equation (2 .1);
<j>em=0-028(As/Aref)(ns/nref)^ (2.1)
where As and Aref are the integrated areas of the emission band of the sample and 
reference complex respectively and ns and nref are the solvent refractive indices of 
the sample and reference solutions respectively.
2.4.2pKa measurements.
Measurements were carried out in Britton-Robinson buffer (0.04 M acetic acid, 
0.04 M boric acid and 0.04M phosphoric acid) using the instrumentation described
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above. The pH of the solutions was adjusted using 2 M H2S 0 4 or 2 M NaOH solu­
tion. Ground state pKa values were determined by monitoring the intensity changes 
in absorption as a function of pH, using a Phillips PW9421 pH meter. The point of 
inflection of a plot of percentage change in absorbance versus pH was used to de­
termine this value. To facilitate dissolution of samples in aqueous solutions a 
minimal volume of acetone was added. Measurements were carried out at room 
temperature.
2.4.3. High performance liquid chromatography (HPLC).
The purity of the ruthenium complexes was verified using an analytical cation ex­
change Waters HPLC system, consisting of a Waters pump, model 6000 or 501, 
fitted with a 20 u litre injecter loop, a Partisil SCX radial PAK cartridge and a 990 
photodiode array detector connected to a NEC APCIII computer. The mobile 
phases used were (a) CH3 CN:H2 0  (80:20) containing 0.08M LiC104  (about pH 6 -
7); (b) mobile phase (a) adjusted to pH 2-3 with HCIO4 . The flow rate was 2.5
ml/min.
2.4.4. Size exclusion chromatography.
As for the HPLC system described above, a Waters 990 Photodiode array system 
was employed, with a NEC A P C lll computer for characterisation of the bio­
conjugates prepared. The column used was a BioSep-SEC-S2000 size exclusion 
column. The mobile phase used was 0.05M phosphate buffer pH 6 .8, UV detection 
of 215nm was used and flow rates of 1.0 ml/min were applied, unless otherwise 
stated.
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2.4.5. Column chromatography.
It was possible to use gel filtration chromatography to separate the free and protein- 
bound ruthenium complexes, as an alternative to dialysis, using Sephadex G-100 in a 
1 by 10 column and phosphate buffered saline or 0.05M phosphate buffer pH6.8  as 
the eluents.
2.4.6 . Infra-red spectroscopy.
Infra-red spectra were recorded on a Perkin-Elmer 983G Infrared Spectrometer us­
ing pressed KBr discs. This technique was used primarily to check for the presence 
of the isothiocyanate group in the complexes which were subequently used for con­
jugations to biomolecules, but also for the general characterisation of labels.
2.4.7 NMR spectroscopy .
1h NMR spectra were recorded on a Bruker AC400 (400 Mhz) spectrometer. The 
measurements were carried out in (CD3)2 CO and DMSO. The peak positions are
relative to TMS.
2.4.8 Lifetime measurements.
The lifetime measurements were carried out using a Q-switched Nd-YAG laser sys­
tem as the excitation source, which operates at 1064 nm but can be frequency dou­
bled, tripled or quadrupled to generate a second, third or fourth harmonic frequency 
at 532, 355 and 266 nm respectively. The third harmonic was exclusively used in
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these experiments. The power of the laser pulse can be varied by applying different 
voltages across the amplifier flash tube. The pulse time is approximately 8 ns. The 
circular laser pulse is directed via two Pellin-Broca prisms upon the sample cuvette. 
When the pulse passes through the power meter, situated after the first prism but 
before the sample holder, the oscilloscope is triggered. The output of the sample cu­
vette and the emerging beam is focussed through two circular lens onto a F/3.4 
monochromator. The detector, a Hamamatzu five stage photomultiplier is operated 
at 850 volts. The signal output is connected via a variable load resistor to the tran­
sient analyser, a Hewlett Packard 54510A oscilloscope. The oscilloscope is then 
linked to an Olivetti PCS 286 computer, whereby transient data can be stored and 
analysed.
The measurements were carried out in Britton Robinson buffer at 23 ^ C , as 
aerated solutions, unless otherwise stated.
2.4.9 Data analysis.
The fluorescence lifetime of a substance usually represents the average time duration 
the molecule remains in the excited state prior to its return to the ground state. The 
exponential decay of isolated fluorescent molecules can be described as follows;
<5>(t) = exp {-tlx) (2 .2 )
where x is the emission lifetime.
However, the luminescence of molecules emitting from heterogenous sys­
tems such as proteins, frequently depart from first order kinetics [7], Thus, a plot of 
the logarithm of emission intensity versus time is nonlinear. In kinetic studies of 
these systems the nonlinear semi-logarithmic plot is usually fitted to a multi-
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exponential decay model. For the delta function excitation (ie. zero duration) with 
independently emitting noninteracting species the detector response is:
Q>(t) = 1 ' I N Kjsxp (-t/ti) (2.3)
Tj = Mkj (2.4)
where N  is the number of emitting components. For the /th component, tl is the 
lifetime and Ki is the pre-exponential factor contributing to the signal at zero time. 
The fC are functions of the spectral response of the detector, the concentration, 
emission and absorption characteristics of each component, the spectral transmis­
sion properties of the filters and the spectral distribution of the exciting light. [7]
For the studies reported in this thesis two different models were used to cal­
culate the different lifetimes. The first is a simple monoexponential decay law [7], 
used to analyse the free labels lifetime;
where Ai is the pre-exponential factor and k i is the decay rate constant.
A multi- exponential decay expression was used to analyse the data for the 
conjugate solutions, and is as follows;
where Ai and A2 are the emitting components respective pre-exponential factors 
and k i and k2 are the decay rate constants. This model above assumes two popula­
tions of emitters, one which decays with rate constant k i and another which decays
<P(t) = A i(l-exp(-£;0) (2.5)
®(t) = [(Ai(l-exp(-£;0)+(A2(l-exp(-£20)] (2 .6)
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In order to ascertain which decay behaviour is indeed observed, it was impor­
tant to be able to judge the quality of the fit. From the best fit parameters, the ex­
pected curve was calculated. Even for the correct model, the theoretical and ob­
served decays differed slightly due to noise. To visualise these discrepencies, a plot 
of the percentage errors versus time was made
% error = [(F(ti)-D(ti )/D(ti)] x 100 (2.7)
where D(ti) and F(ti) are the calculated best fit and observed decay data, respec­
tively. For a good fit, the differences were small with a low % range (< 5%) and ran­
domly distributed plot, whereas a bad fit yielded a cosine wave distribution. As men­
tioned earlier, the absolute values of the pre-exponential factors depend on the ex­
perimental set-up. However, changes in the ratio of these factors A l and A2 
throughout an experiment may be deemed as significant so long as the experimental 
conditions remain constant throughout.
2.4.9.1 Calculations.
In order to understand more clearly the significance of the ratios of the various pre­
exponential factors in a multi-exponential decay model and their dependence on the 
relative concentrations of their emitting species, as well as testing the precision of 
the lifetimes obtained, a set of appropriate experiments were carried out.
This involved the mixing of two fluorescent complexes of known single ex­
ponential decay behaviour. The relative concentations of the two complexes were 
varied and the effect of this variable on the percentage of Ai and A2 examined and 
hence the reliability of the lifetime values deduced.
with a rate constant k2. It was possible to add on more terms for higher exponential
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However, before studying a mixture, in order to ascertain the relationship 
between the concentration of an emitting species and its pre-exponential factor, a 
preliminary study on how A is influenced by the absolute concentration for one sin­
gly emitting fluorescent species in solution was undertaken. The experimental condi­
tions (i.e. slit widths, path length etc.) were kept constant throughout, such that the 
concentration of the complex itself would be the only variable. Below in Table 2.1 
the pre-exponential factors and lifetimes obtained for several concentrations of 
[Ru(bpy)s]2+ using the mono-exponential decay model (see equation 2.3) are listed.
As can be seen from Table 2.1, the value of A is significantly dependent on the con­
centration of the complex. Although the higher concentrations yield the higher values 
of A, one is not directly proportional to the other. Hence, all this experiment verifies 
is the close association between the amount of an emitting species and its pre­
exponential factor, with only one emitting component present. Significantly, how­
ever, it is to be noted that the variances between the lifetimes calculated for any two 
concentrations are within instrumental error (+- 10%) , all in the range 330-360ns. 
This indicates that the amount of an emitting species should not greatly affect it’s 
decay lifetime.
Tables 2.2 and 2.3 below display results from a series of mixtures of two ru­
thenium complexes. Firstly, as presented in Table 2.2, 0.5 x 10'4M solutions of 
[Ru(bpy)3]2+ and [Ru(dpp)3]2+ in water were prepared and the mixtures made by 
taking various ratios of both solutions. Also, similar mixtures of 
[Ru(bpy)2(NH2phen)]2+ (NH2phen) and [Ru(bpy)2DHptr]2+ (dhptr) were prepared 
and analysed and their decay data are presented in Table 2.3. It was not possible to 
keep all experimental conditions constant throughout these experiments, however, as 
it was necessary to change the slit widths throughout it’s course, to render analysis 
of the decay lifetimes possible.
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Table 2.1. Decay profile data for various concentrations of [Ru(bpy)3]2+ using 
the single exponential decay model.
[Ru(bpy)3f H (mol/1) A* "  ' ' Lifetime (ns)
1 x lO'3” 6130 340
2 x 10’5 7970 340
3 x 10‘5 14730 355
4 x 10'3 17291 330
5 x 10’5 21600 360
s Pre-exponential factor o f the emitting species using the mono-exponential decay 
funciton (P(t) = A ](l-exp(-k]t)).
- ^ |
Table 2.2 reveals how, as the concentration of [Ru(bpy)3] decreases, the 
contribution of its pre-exponential factor (i.e. %Aj) also decreases, suggesting that 
there is indeed an inherent relationship between the concentration and the pre­
exponential factor of an emitting component. However, the relationship would not 
be expected to be linear or even as closely related as found for a single emitting 
compound, due to certain variable contributing factors associated with such ex­
periments, such as changes in slit width and applied voltages which complicate the 
analysis.
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Table 2.2. Decay data for a series of solutions of varying ratios of [Ru(bpy)3] 
(bpy) to [Ru(dpp)3] (dpp).
Bpy:dpp ratio Lifetime bpy (ns) % A! 4 Lifetime dpp(ns) % a 24
10:0 340 100
9:1 355 92 750 8
7:3 388 85 760 15
5:5 378 74 800 26
3:7 410 63 770 37
1:9 410 51 800 49
0:10 740 100
$ Pre-exponential factors calculated using the multi-exponential decay function
® (t) =  [(A l( l-e x p (-£ ;0 )+(A 2(l-exp (-£2 0 )]'
Table 2.3. Decay data for a series of solutions containing varying ratios of 
[Ru(bpy)2 (NH2phen)]2+ (NH2phen) and [Ru(bpy)2 DHptr]2+ (dhptr).
NH2phen: dhptr 
ratio
Lifetime 
NH2phen (ns)
% Ai
$
Lifetime dhptr (ns) %
A2$
10:0 375 100
9:1 375 93 90 7
7:3 360 82 100 18
5:5 410 52 110 48
3:7 390 38 90 62
1:9 350 34 90 66
0:10 100 100
$ Pre-exponential factors calculated using the multi-exponential decay function
®(t) = [(A 1 (l-exp(-/c/0)+(A2(l-exp(-£20)]-
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Also, although both complexes absorb to a similar extent across the UV re­
gion, [Ru(bpy)s]2+ absorbs slightly more at the excitation wavelength, 355nm. This 
would explain why at a 1:1 ratio of bpy to dpp, rather than both pre-exponential 
factors contributing to the same ex ten t, the pre-exponential factor of bpy contrib­
utes three times more than that of dpp. The lifetimes calculated for both complexes, 
when in the mixtures, were found to be quite reproducible, when compared to their 
corresponding lifetimes, when pure. From these results, it appears that the function 
used to analyse several lifetimes simultaneously is accurate and practical, even 
when one emitting species dominates greatly over another in concentration. Similar 
accurate results were obtained for the second mixture as presented in Table 2.3. 
The absorption of the [Ru(bpy)2(NH2phen)]2+ solution was 0.433 at 355nm while 
that of [Ru(bpy)2DHptr]2+ was 0.326. In any samples in this thesis revealed to dis­
play multi-exponential decay behaviour, it would be expected that all emitting spe­
cies would absorb similarly at 355 nm and hence this method of data analysis would 
seem appropriate for our work. The samples containing solely one complex were 
analysed using a single exponential model. Attempting to analyse a known single 
exponential decaying sample with the multi-exponential decay function (eqn 2.4) 
yielded two identical lifetimes and a wave function residual fit i.e. not a good fit.
Experiments were also carried out mixing two fluorescent complexes, one 
of which absorbs very much greater than the other at 355nm. As may be expected, a 
higher concentration of the greater absorbing component leads to problems in 
solving the lifetime of the minority species, due most probably to the masking of 
this species by the dominant component. For example, a 10:1 ratio of NH2phen 
(400ns) to dpp (750ns), whose absorbances are at a ratio of 3:1 respectively at 
355nm, the solving of the double exponential decay function with our model 
yielded two identical lifetimes close to that of NH2phen i.e. approximately 400ns, 
indicating single exponential decay.
In conclusion, this model used shows certain limits and restrictions when 
one emitting species dominates greatly over the other, particularly in terms of absor 
bance, but this would not be expected to be a major factor in our solutions in this
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thesis and hence permits us to assume our lifetime results reasonably accurate and 
reliable.
2.4.10. Molecular modelling.
Basic modelling of complexes and biomolecules was carried out using Hyperchem 
software. Molecular mechanics optimisation of complex structures was carried out 
using the Hyperchem Polak-Ribiere algorithm.
2.4.11 Stern- Volmer quenching studies.
The quenching rates of both the unbound labels and the bioconjugates by chemical 
denaturants were calculated by noting the height/area of the emission spectra of the 
quenched and unquenched after addition of increasing concentrations of quenching 
agents. In order to calculate the Stem-Volmer rate constant for every quenching 
agent, a plot of An q /Aq  v s  Cq  was obtained, where An q  = Area of emission 
spectrum of sample before addition of any quencher and Aq  = Area of emission 
spectrum after addition of X amount of quencher. This equation was also valid 
with the insertion of decay lifetimes rather than emission spectra areas/heights.
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2.5. Biological procedures.
2.5.1 Buffers.
The buffers used were (a) 0.01M-0.10 M carbonate buffer, prepared from 0.01M- 
0.10 M sodium hydrogen carbonate/0.01M-0.10 M sodium carbonate in distilled 
water pHs 8.0-9.2 (b) 0.05-0.10 M phosphate buffer, pH 6.8 and 7.4, prepared from 
0.05-0.10 M sodium dihydrogen phosphate/0.05-0.10 M di-sodium hydrogen 
phosphate in distilled water; (c) 0.05M-0.10 M acetate buffer pH 4.8, prepared from 
0.05M-0.10 M glacial acetic acid/0.05M-0.10 M sodium acetate in distilled water 
and (d) Britton-Robinson buffer prepared from 0.04 M boric acid, 0.04 M 
phosphoric acid and 0.04 M glacial acetic acid in distilled water.
2.5.2. Estimation o f the conjugation ratio.
The amount of ruthenium complex present was determined by its absorption at Vax 
(450-480nm). The extinction coefficients of the unbound labels were previously 
measured in 0.10 M carbonate buffer pH 9.2 and no allowance was made for a 
change in the extinction coefficient upon binding to the biomolecules. The protein 
concentration was determined using methods subsequently described. The 
conjugation ratio was estimated according to Nairn [12], as described by equation
2.8 below:
Moles Fluorochrome/Moles Protein = x. Abs./Cp (2.8)
where x = molecular weight of protein/extinction coefficient of label, Abs. = 
Absorbance of label at Xma)C. and Cp = concentration of protein in mg/ml (as 
determined by protein assays described in 2.5.3.)
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2.5.3 Determination o f protein concentration.
Three methods were used to determine the amount of protein in the conjugate solu­
tions, (a) The Folin-Lowry method [13] and (b) the Bradford method [14] were used 
in the determination of both PLL and bsa while (c) the glutamine/glutamate assay 
was employed specifically for the determination of PLGlu.
2.5.3.1 Folin-Lowry assay.
Standard protein solutions ranging from 0.0 to 0.20 mg/ml were prepared and suit­
able dilutions of the unknowns were made up. 5.0 ml of “ alkaline solution “ pre­
pared from a 50:1 ratio of alkaline sodium carbonate solution (20g/l Na2CC>3 in 
0.10M NaOH) to copper sulphate-sodium potassium tartrate solution (5g/l 
CuS0 4 .5H2 0  in 10g/l Na, K tartrate) was added, the solution was allowed to stand 
at room temperature for 10 minutes. 0.50 ml of 1:1 diluted Folin-Ciocalteu reagent 
was added with immediate mixing. After 30 mins the absorbance at 750nm was read. 
A standard curve was prepared and the protein concentration of the unknown sample 
was estimated.
2.5.3.2 The Bradford assay.
2.5 ml of the 1 in 5 diluted Bio-rad Bradford reagent was added to 0.10 ml of each 
sample/standard. The resulting solution was vortexed. The absorbance was read at 
595 nm after 5 and before 60 minutes. The standard curve was plotted and the un­
knowns estimated.
2.5.3.3. Poly-glutamic acid assay.
A glutamine/glutamate determination kit based on the spectrophotometric measure­
ment of L-glutamine and/or L-glutamate via enzymatic deamination of L-glutamine 
and dehydrogenation of L-glutamate with conversion of NAD4 to NADH. was used 
to ascertain the amount of poly-l-glutamate in the bioconjugates prepared.
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Materials:
(1) 1,0 ml of tris-EDTA-hydrazine buffer pH 9.0, prepared from a 1 in 19 ratio of 
hydrazine hydrate to tris-EDTA buffer, adjusted to pH 9.0)
(2) 0.10ml of 30mM p-Nicotinamide Adenine Dinucleotide (NAD) solution
(3)0.01 ml of 100 mM Adenosine 5’Diphosphate ADP solution.
Procedure.
Standard PLGlu solutions 0.0 to 0.5mg/ml were made up to 0.89 ml and added to 
solutions (1), (2) and (3), bringing the total reaction volume to 2.0 ml. Suitable 
dilutions of the unknowns were also prepared. The samples were mixed by 
inversion and their absorbances were read at 340 nm to obtain background reading. 
0.02 ml of 1200 U/ml Glutamic Dehydrogenase (L-GLDH) was added to each 
sample, the solution again mixed by inversion and held at room temperature. The 
absorbances were read at 340 nm after 40 minutes until they remained constant. 
The background was subtracted from this for the net absorbance value. A graph of 
the poly-l-glutamate standards using mg/ml versus absorbance was drawn and the 
unknowns were determined from this graph.
2.5.4 Determination o f lysozyme activity.
The enzymatic activity of lysozyme was measured by a modification of the assay 
developed by Shugar [15] and Perkins [16], 0.02 ml of a 2 mg/ml lysozyme solution 
was added to 4.98 ml of a 40 mg/ml solution of M. lysodeikticus cells (or equivalent 
ratios), mixed for 10 seconds and then placed in a spectrophotometer. The decrease 
in turbidity at 450 nm was recorded at 30-second intervals for 3 minutes. The 
samples were mixed by inversion during the 30-second intervals. All results were 
expressed as the percent decrease in turbidity using the time zero turbidity to define 
the 100% level [17],
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Characterisation of Ru(II) polypyridyl complexes covalently bound to
biomolecules.
Chapter 3.
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3.1 Introduction.
In chapter 2, we described the procedures involved firstly in the preparation of 
various ruthenium polypyridyl complexes to be used as fluorescent labels, and 
secondly in their conjugation to selected biomolecules. Before one can apply these 
fluorescent complexes as probes of the dynamic behaviour of proteins, by using 
certain photophysical properties as the sensitive reporters, extensive characterisation 
of both the free labels and their protein-bound forms is necessary.
Firstly, the purity of the conjugates must be ascertained as one of the 
requirements of a good fluorescent probe is one which can easily be separated from 
the unbound label [1]. Otherwise, the photophysical properties of the free label may 
interfere with those of the bound form. One must also know how the spectroscopic 
properties of the ruthenium complexes are affected by their subsequent binding to 
biomolecules, hence the extensive characterisation of both forms. Finally, in order to 
understand the limits of the probes, one must verify the exact positioning of the 
labels on the protein and their affinity to the protein. For this reason, extensive 
studies regarding the effect of various conditions on the extent of various 
conjugation reactions were carried out.
This chapter will therefore deal with the chemical and biological 
characterisation of both the unbound ruthenium polypyridyl complexes and their 
corresponding bio-conjugate forms.
Compounds of the type [Ru(L-L)2(NH2phen)]2+ and their isothiocyanate
derivatives [R u(L-L)2N C Sphen]2+, where L = 2-2' bipyridyl (bpy), 1,10- 
phenanthroline (phen) and 4,7'-diphenyl-l,10'-phenanthroline (dpp), in addition to 
[Ru(bpy)2(COOH2bpy)]2+ where COOFbbpy = 4,4’-dicarboxylic acid-2,2’-
bipyridine and its succinimide ester derivative [Ru(bpy)2(esterbpy)]2+  were
extensively characterised using chromatography, NMR, UV/vis, IR spectroscopy and 
fluorescence spectroscopy. The structures of some of the above mentioned 
complexes are depicted in Figure 3.1.
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\2+
[Ru(bpy)2NH2phen]2+
[Ru(dpp)2NH2phen]|2+ [Ru(bpy)2esterbpy]
,2+
Figure 3.1 The structures o f  the Ru(II) polypyridyl complexes studied in this chap­
ter.
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Most of these same methods were used to characterise the protein-bound 
forms of these complexes where feasible, to investigate the effects of the binding to 
biomolecules on the spectroscopic properties of these fluorescent labels. In addition, 
the extent of the various conjugation reactions carried out was determined for all 
bioconjugates to examine the success of the various conjugation procedures. Finally 
the effect of the reaction conditions, the size and nature of the labels, the binding 
sites of the biomolecules chosen and the protein structure, on the conjugation ratio 
were investigated to more clearly understand the conjugation processes.
Below is a summary of all labels used and their various protein-bound forms, 
specifying the site of attachment of the labels on the biomolecule prepared. These 
compounds are listed in numerical order for further reference. Before the characteri­
sation of the bioconjugates prepared is discussed, an introduction into the most 
widely used characterisation methods of proteins is appropriate.
Table 3.1. Table of complexes and bioconjugates cited in this text.
Ref. No. Complex Ref. No. Conjugate Protein binding site
1. [Ru(L-L)2(NH2phen)]2+ la. Ru(L-L)2(MH2phen)2+: BSA Carbohydrate moieties.
lb. Ru(L-L)2(NH2phen)2+: BSA Glutamic acid residues.
lc. Ru(L-L)2(NH2phen)2+: IgG Carbohydrate moieties.
Id. Ru(L-L)2(NH2phen)2+: PLL Terminal carboxylic acid.
le. Ru(L-L)2(NH2phen)2+: PLGlu Glutamic acid residues.
2. [Ru(L-L)2(NCSphen)]^2a. Ru(L-L)2(NCSphen)2+: PLL/BSA Lysine residues.
2b. Ru(L-L)2(NCSphen)2+: PLGlu Terminal amine.
3. [Ru(bpy)2(esterbpy)]2+ 3a. [Ru(bpy)2(esterbpy)]2+: PLL/BSA Lysine residues.
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3.1.1 Characterisation methods o f  proteins.
Various methods are used to characterise and/or follow changes in protein structure, 
which is indeed the eventual aim of this thesis, based on changes in their physical and 
chemical properties. Such variables include their hydrodynamic, spectral and 
chemical properties. Based on their hydrodynamic properties, one can study the 
folded state from their compactness, that is, their lower resistance to movement 
through the solvent, thus lower viscosity and greater rates of both translational and 
rotational movement and of sedimentation [2], Due to a variety of environments of 
the chromophores o f a folded protein and unique stereochemistry of the polypeptide 
chain, various spectral effects can be readily used to characterise, as well as to follow 
changes in the folded conformation in solution.
The absorbance of UV light is not very sensitive to conformation or 
environment, except for aromatic rings, such as phenylanaline, thyrosine and 
tryptophan residues where a shift in absorbance to a longer wavelength is observed 
in non-polar environments (i.e. the interior of proteins) and also when buried. This 
absorbance is not sensitive to changes in solvent, whereas that of aromatic groups on 
the surface may be perturbed significantly by the addition of glycerol, ethylene glycol 
and sucrose [2].
Fluorescence by aromatic groups is a much more sensitive method where the 
quantum yield may be either increased or reduced upon folding, a folded protein may 
therefore have higher or lower fluorescence intensity than the unfolded form. The 
close proximity of the aromatic groups in folded proteins usually results in very 
efficient energy transfer between them, therefore light absorbed by one chromophore 
may be transferred to another at higher wavelength, resulting in fluorescence [2],
Another spectral property which may be directly sensitive to polypeptide 
conformation is the optical rotatory dispersion of a polypeptide/protein, which can 
be studied by circular dichroism (CD). The polypeptide backbone absorbs, and is 
optically active in the far UV region, 240nm, with the magnitude of absorbance 
somewhat dependent upon conformation. These spectral characteristics are primarily
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detected by polypeptide backbone conformation, especially secondary structure [3], 
Figure 3.2 shows the CD spectra of poly-l-lysine (PLL) in a-helical, (3 and random- 
coil conformation [4], This reflects primarily the conformation of the backbone. 
Folded proteins generally have significant absorbance in the near UV region owing 
primarily to the presence of aromatic side chains in assymetric environments.
Proton NMR is used to study protein structure in solution whereby different 
types of secondary structure are detected as the magnitude of specific interaction 
between hydrogen atoms depends upon the distance between them. Since specific 
interaction also occurs between atoms close in space but non covalently bonded, 
this provides semi-quantitative information about folded conformations [5],
The unique environment of reactive groups in folded proteins can have very 
substantial effects on their chemical properties. Notably, the environment can have 
an effect on the electronic state of the group, that is, its intrinsic reactivity or the 
steric effects on access to modifying reagents [2],
X in  m/A
Figure 3.2 CD spectra o f  PLL in random-coil,j3and a-helix conformation [4].
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Such reagents include 2,4,6-trinitrobenzene sulfonate (TNBS) used to quanti­
tate amino groups of the basic amino acid residues of proteins, such as lysine and 
arginine residues. This is accomplished via the spectrophotometric appearance of a 
new derivative which absorbs strongly at 367 nm [2],
Altered intrinsic reactivities of functional groups are often apparent from the 
perturbation of their pKa values, which are affected by a wide variety of environ­
mental and electrostatic effects. The titration behaviour of many proteins can be 
studied and followed by NMR [2], pKa values of different amino acid residues can 
vary widely, often over a range of 3-4 pH units (presumably owing to their different 
environments). Electrostatic interactions between such various groups can make 
their ionisation behaviour quite complex with unusual titration curves, since the pKa 
values of a group will depend upon the ionisation of its neighbours [2].
The flexibility of protein structure can also be observed by various methods. 
Hydrogen exchange provides evidence for the mobility of the protein structure, as 
the internal groups of proteins react at a finite rate [2], Aromatic side chains on the 
surface of a protein are quenched by diffusion controlled encounters with small 
molecules such as 0 2 but also many internal residues are quenched only slightly less 
efficiently by neutral molecules, suggesting that they can diffuse through the interiors 
of proteins [2]. Such studies of fluorescence quenching of proteins are complicated 
by many factors, including varying quantum yields and possible energy transfer be­
tween different groups within the protein. Side chains on the surfaces of proteins 
have mobilities comparable to those in unfolded proteins, rotating at 10'11 to 10'8 sec.
[2], Such phenomena can be observed by fluorescence depolarisation, discussed in 
chapter 5.
X-ray diffraction is the only technique at present that can provide detailed 
structural information at an atomic scale. By collecting diffraction data over a range 
of temperatures or by using short pulse x-ray sources, one can learn something about 
dynamic aspects of the protein structure, averaged out by traditional methods [6], 
Recently, protein secondary structure has been studied by fourier transform infra­
red/photoacoustic spectroscopy [7], For secondary structure studies, the amide I
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band (i.e. C=0 structural vibration of the polypeptide backbone) is the most useful. 
Correlations between frequency and intensity of these bands with the various types 
of secondary structure of polypeptides such as a-helix and {3-sheet, turns and 
random structures have been established, thus yielding quantitative estimation of 
protein secondary structure [7], Photo-acoustic spectroscopy is suited because of its 
high sensitivity and it can be directly applied to solid samples. However, its 
usefulness for the study of protein secondary structure has not as yet been 
extensively explored.
A technique useful for experimental investigation of the energetics of 
folding/unfolding is direct scanning calorimetry (D.S.C.) which renders the direct 
determination and energetic description of protein folding possible. Protein 
folding/unfolding experiments are routinely conducted under conditions of reduced 
native state stability, which can be achieved by alteration of solution pH, the addition 
of chemical denaturants, or the chemical modification of proteins [8], Because their 
unfolding is accompanied by positive heat capacity change, proteins can exhibit what 
is called cold denaturation (unfolding upon a decrease in temperature) [8].
Protein modelling by computer graphics is a modem method whereby protein 
structures can be fitted to electron density map by simultaneously displaying both 
with an interactive colour graphics program [6], Much of the theoretical work on 
protein structure has concerned itself with attempting to accurately predict the final 
3-D conformation of a protein from its amino acid sequence [6], It is, however, only 
in recent years that significant progress has been made in obtaining detailed 
structural information on proteins using such a method.
In this chapter, no such modern techniques to characterise the dynamic 
aspects of proteins are used as the primary objective is to monitor how the 
luminescence behaviour of our fluorescent ruthenium complexes are affected by local 
structural variations of the bound biopolymer. However, such methods would have 
been useful in verifying that any changes in normal luminescence properties of the 
labels were indeed due to subsequent distortions induced in the covalently bound 
protein.
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3.2. Results and discussion.
3.2.1. Chromatographic characterisation.
(1) High performance liquid chromatography (HPLC).
HPLC was used to characterise the unbound ruthenium polypyridyl complexes. The 
purity of the amino and isothiocyanate compounds was analysed using the HPLC 
method described in Section 2.2.3, while [Ru(bpy)2(COOH2bpy)]2+ and its “active 
ester” were analysed using the same mobile phase at a lower pH of 2-3 using 
perchloric acid. The retention times of each compound are listed in Table 3.2.
Table 3.2 Retention times for the ruthenium polypyridyl compounds using 
HPLC.
Compound Retention Time (min.)
1 Ru(bpy)2(NH2phen)](PF6)2 3.34
[Ru(bpy)2(NCSphen)](PF6)2 2.53
[Ru(phen)2(NH2phen)](PF6)2 2.58
[Ru(phen)2(NCSphen)]Cl2 2.10
[Ru(dpp)2(NH2phen)]Cl2 1.65
[Ru(dpp)2(NCSphen)](PF6)2 1.50
LRu(bpy)2(COOH2bpy)]Z+ 3.20
|Ru(bpy)2(esterbpy)]2+ 3.00
Retention times o f  the compounds as listed above after separation in 80:20 
CH3 CN.H2 O, with O.IOMUCIO4  as mobile phase. The flow rate -was 2.5 ml/min.
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The amino compounds were found to be 100% pure by HPLC after 
recrystallisation. The HPLC analysis of the isothiocyanate compounds [Ru(L- 
L)2NCSphen](PF6)2 revealed impurities of approximately 2% , in some cases, which 
were due to the precursor amino compound as found in the literature [9], However, 
these compounds were not recrystallised due to their instability in aqueous solution, 
and hence were used in their unrecrystallised forms for subsequent characterisation 
and conjugation procedures. The two isothiocyanate derivatives, 
[Ru(phen)2NCSphen]2+ and [Ru(dpp)2NCSphen]2+ were isolated as the dichloride 
salts while [Ru(bpy)2NCSphen]2+ was isolated as the PF6 salt form.
(2 ) Size exclusion chromatography
Although some of the conjugates studied herein have previously been characterised, 
no attempts have been made to determine their purity, which upto now has been 
somewhat assumed [9], As such assumptions need to be verified to determine the 
potential of our probes when bound to biomolecules, a method has been developed 
which allows the separation and identification of such conjugates using a size 
exclusion chromatographic technique.
The purity of the aqueous bio-conjugates prepared was determined using the 
size exclusion chromatographic technique described in section 2.2.4. There were two 
ultimate objectives behind using this technique. Firstly, it is obviously necessary to 
verify the success of dialysis as a means of purification i.e. to ensure that no free 
label is present in the conjugate solution. This is crucial if we wish to compare the 
photophysical properties of the protein-bound label to those of the unbound label. 
Secondly, it is necessary to be able to differentiate between the free protein and its 
modified form to ensure that the label is not merely bound to the protein 
electrostatically but indeed covalently bound. One may also be able to differentiate 
between various covalently modified proteins due to varying extents of modification.
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Gel permeation chromatography, a particular type of size exclusion 
chromatography is a separation technique based on the application of a pressure to 
force macromolecules in solution form through a chromatographic column filled with 
porous beads [10], The larger polymer molecules tend not to enter the pores of the 
beads and so pass through the column relatively quickly, whereas the smaller 
polymer molecules tend to diffuse through the pore structure of the beads and so 
take longer to pass through the column [10], The eluted polymer is detected by its 
absorption in the UV region, say 215 nm where proteins absorb strongly. The 
relationship between retention time and relative molecular mass can be determined 
by calibrating the apparatus with polymer fractions, previously characterised by other 
methods, such as osmotic pressure, light scattering or viscosity [10], However, for 
the purpose of our studies, qualitative analysis is adequate.
Based on this mechanism of separation, the larger macromolecules, in this 
case, the proteins, ranging in molecular mass from 65,000 to 100,000 should elute 
first with the free ruthenium complexes of molecular weights ranging from 900 to 
1300 being eluted at a significantly slower rate. Indeed, on covalently binding the 
labels to the proteins, a further increase in size of the modified protein should be 
detected by a faster retention time. Depending on the sensitivity and resolution of the 
column used, it may also be possible to separate the same protein, modified to 
varying degrees due to different loadings of label bound to the biopolymer.
The retention time of each bioconjugate prepared is listed and is compared to 
the retention time of the appropriate free label and unconjugated protein in Table 
3.3. From this table, we see that S.E.C. can indeed be used to substantiate the 
conjugation of the biomolecules in question, as it is possible to distinguish between 
unmodified and modified protein. In most cases, the difference in retention time 
between free and conjugated protein is less than one minute. As indicated previously, 
it may be theoretically possible to estimate the degree of conjugation of each protein, 
as through appropriate calibration, one could equate a certain decrease in retention 
time to a particular increase in molecular weight. From this, the number of labels 
bound could be calculated and the results obtained could be used to verify the real
104
conjugation ratios as calculated according to Nairn [1], This would be useful as the 
method by Naim does not take into account the presence of non-covalently bound 
label. Such quantitative analysis was not undertaken but is a possibility in further 
studies.
As outlined in Table 3.3, the retention times of the free labels studied are in 
the range 15 to 17 minutes, corresponding to molecular weights of the range 900 to 
1250. In contrast, the proteins of molecular weights 60,000 to 100,000 are eluted 
more quickly, all eluting after approximately 8-10 min. The chromatogram typical of 
the protein BSA is depicted in Figure 3.3.
Table 3.3. Retention times of free Ru(II) complexes and proteins, 
and the conjugated proteins using size exclusion chromatography.
Complex/protein/conjugate Retention Time (min) 
L=bpy L=phen L=dpp
BSA 9.50
PLL 9.20
PLGlu 9.0
[Ru(L-L)2NH2phen]2+ 16.2 16.0 16.0
[Ru(L-L)2NCSphen]2+ 16.5 16.4 15.9
[Ru(L-L)2NH2phen: PLGlu 7.2 7.1 8.5
[Ru(L-L)2NH2phen:PLL 9.2 8.9 8.6
[Ru(L-L)2NH2phen:BSA (1) 8.3 9.2 7.6
(2) 8.0 8.2 8.4
[Ru(L-L)2NCSphen: PLL 8.1 9.0 8.6
[Ru(L-L)2NCSphen:PLGlu 9.5 9.2 8.8
[Ru(L-L)2NCSphen:BSA 8.9 8.0 7.6
Mobile phase used was 0.05Mphosphate buffer pH  6 .8 .
Flow rate o f 1.0 ml/min and the detector wavelength used was 215 nm.
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As was found for all the biomolecules studied, the chromatogram of BSA 
reveals the presence of more than one peak. This may be due to presence of 
impurities or in the case of the protein BSA may be due to the proteins various 
separate components or subunits. However, in all such cases the predominant peak is 
the one which is listed and is used for reference. The primary objective in this section 
is the verification of the covalent modification of the proteins by the Ru(II) 
complexes and thereby to confirm the success of the conjugation procedures 
developed. As stressed earlier, this is possible by observing the shifts in the retention 
times of the proteins when the labels are covalently linked. On studying the 
chromatograms of several labelled proteins the retention time of the main peak of 
BSA is reduced on binding to labels as anticipated. One of the most significant shifts 
in retention time is achieved when [Ru(dpp)2NH2phen]2' labels are bound to BSA via 
glutamic acid residues, indicating that a large number of such labels bind to BSA in 
this manner and this chromatogram is displayed in Figure 3.4. Figure 3.4 
demonstrates how the primary absorption peak of BSA of approximately 9.5 min is 
now apparent at a shorter retention time of 8.8 min. Again the smaller peaks at 12.0 
min and 13.8 min may be impurities of the protein and do not appear to be due to 
free label because of their shorter retention time.
Another main objective o f  this study is the verification o f  the purity o f  such 
conjugates, thus ensuring that no free label is still present in the conjugate solution 
but that this indeed has been rem oved by dialysis as anticipated. It should therefore 
be possible to distinguish between free label, free protein and the covalently modified 
protein due to differences in their degree o f  retention in the separating column. For 
the purpose o f  this study and in an attempt to identify any unknown peaks the 
chromatogram o f  a conjugate is run and the peaks obtained are compared to those o f  
the chromatogram o f  the same conjugate but with free ruthenium com plex and/or 
free protein added to the sample. This should allow  one to identify peaks due to free 
protein and/or free label in the chromatogram o f  the conjugate. A s  an example, 
Figure 3.5 depicts the chromatogram o f  Ru(dpp)2N C S p h e n :B S A  while
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Figure 3.3 Typical chromatogram o f  BSA using size exclusion chromatography.
Figure 3.4 Typical chromatogram o f  [Ru(dpp)2NH2phen:BSA (b) using size
exclusion chromatography.
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Figure 3.6 represents that of the same conjugate spiked with free label i.e 
[Ru(dpp)2NCSphen]2+. On comparing both chromatograms the primary absorption 
peak for the conjugate is unaffected at 8.9 min which would be anticipated as the 
conjugate should not be affected by the addition of ruthenium complex as this 
would not be covalently bound to the protein. There are also small peaks at 12.5 
min and 14 min, the nature of which is uncertain. However, on adding the unbound 
label (See Figure 3.6) a significant peak appears in the chromatogram after 
approximately 18.5 min. Although this retention time does not correspond exactly 
to that of [Ru(dpp)2NCSphen]2+ (See Table 3.3), it is evident that this peak must be 
due to this label. Hence it would appear that the conjugate Ru(dpp)2NCSphen:BSA 
does not contain impurites due to unbound label as no peak is evident in the range 
16-20 min thereby confirming the usefulness of such studies in the identification of 
various peaks and the verification of the purity of a conjugate.
It must be noted that most chromatograms revealed small amounts of 
impurities due to free label, protein and other unidentified impurities, but for the 
purpose of our work the conjugates were deemed adequately pure for further 
studies. It would be difficult to determine the percentage purity of the conjugates 
from the chromatograms at the conditions used. This is because at 215nm both 
label and protein absorb strongly. In order to estimate the quantity of unbound label 
a wavelength unique to the absorption spectrum of the label would be necessary, eg 
450 nm. This was not done however and hence rough estimates of the purity were 
made by comparing the peak sizes. In Table 3.3 the retention time of the 
predominant peak of each sample is listed for simplification.
It should also be possible to distinguish between biomolecules labelled to 
varying extents, due to contrasting increases in their molecular mass. However the 
difference in retention time would be minimal and hence this was not attempted.
It must be emphasised that these preliminary studies are merely an 
introduction into SEC and the results achieved are simplified. However initial 
results appear quite promising, allowing the separation of pure and labelled proteins 
and hence open the door to more advanced and complete analysis in future studies.
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Figure 3.5 Typical chromatogram o f Ru(dpp)2NCSphen:BSA using size exclusion
chromatography.
Figure 3. 6  Typical chromatogram o f Ru(dpp)2NCS2phen:BSA spiked with unbound 
label [Ru(dpp) 2NCS2phen]2+ using size exclusion chromatography.
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Infra-red spectra were used in a purely qualitative manner to ensure the success of 
the derivatisation of the amino compounds to their respective isothiocyanate com­
plexes, as the presence of the isothiocyanate group was confirmed by the presence of
an infra-red band at about 2050cm \  The infra-red spectrum of the acidic complex 
[Ru(bpy)2 (COOH2bpy)]2+ was also obtained for characterisation purposes and is
presented in Figure 3.7. The bands at 3400 cm’1 and 1650 cm are typical of car­
boxylic acids. Meanwhile, Figure 3.8 depicts the infra-red spectrum typical of 
[Ru(dpp)2(NH2phen)]2+ while that of its isothiocyanate derivative is presented in 
Figure 3.9.
3.2.2. Infra-red spectroscopy.
c s o h b p y  2 B  A p r  9*4 13: 3S: AS 3 2  scans. 4 cm-l . G a i n
Figure 3.7. Infra-red spectrum o f [Ru(bpy)2(COOH2bpy)]2+
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Figure 3.8. Infra-red spectrum o f  [Ru(dpp)2(NB^>hen)(PF^2].
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Figure 3.9. Infra-red spectrum o f  [Ru(dpp)2(NCSphen)Chi­
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3.2.3. Proton nuclear magnetic resonance spectroscopy.
The proton resonance signals obtained for the compounds have been assigned to the 
different protons by comparison with the literature for similar compounds [9], NMR 
studies were essentially used to ascertain the purity of the ruthenium complexes 
prepared and to verify the formation of the isothiocyanate derivatives of the amino 
complexes studied.
The proton resonance signals of the compounds [Ru(bpy)2(NH2phen)](PF6)2] 
[Ru(phen)2(NH2phen)](PFs)2] and [Ru(dpp)2(NH2phen)](PF6)2] are reported in the 
literature [9]. As an example, the NMR spectrum of [Ru(bpy)2(NH2phen)](PF6)2] is 
depicted in Figure 3.10.
Figure 3.10. NMR spectrum o f the complex [Ru(bpy)2 (NH2phen)]2+.
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The NMR spectra of the isothiocyanate compounds were not assigned due to 
possible impurities o f their amino precursors. Below, the NMR spectrum of the 
complex [Ru(bpy)2(COOH2bpy)]2* is depicted in Figure 3.11. Again, the proton 
resonance signals obtained for this compound have been assigned to the different 
protons by comparison with the literature [9]. The NMR spectrum of its 
hydroxysuccinimide ester was not however carried out as this complex was not 
isolated but remained in solution form.
Figure 3.11. NA/fR spectrum o f  the complex [Ru(bpy)2(COOH2bpy)]2~.
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3.2.4. Determination o f  extent o f conjugation reactions.
3.2.4.1. Introduction.
In this thesis, the conjugation of ruthenium polypyridyl complexes to various bio­
molecules is carried out. The complexes have been bound at different sites on these 
biomolecules, using a variety of conjugation methods, the basis of which are dis­
cussed in Section 1.3.5.1. In Chapter 1, the difference between site-selective and side 
chain selective modifications of biomolecules is described. Much of the work carried 
out here involves side chain selective modification of the biomolecules in question, 
and as stressed earlier, under appropriate conditions, the reagents normally react 
only with the intended target side chain. An important point to be noted is the fact 
that complete modification of all targeted side chains in any conjugation reaction is 
not usually possible but the labelling efficiency does depend upon the protein, the 
modifying reagent and the reaction conditions [11], and these factors will be studied 
and discussed in this section.
In most cases, the extent of a conjugation reaction can be determined by ei­
ther direct spectrophotometric measurements, amino acid analysis, or the use of ra­
dioactive reagents [11], The extent of a reaction may often be increased by the use 
of more vigorous reaction conditions, for example, longer reaction times, larger ex­
cesses of reagent and the presence of denaturing agents such as urea. However, the 
use of more severe conditions usually leads to some decrease in side chain selectiv­
ity, greater risk of conformational change, and other disadvantages [11]. In this the­
sis, the methods chosen to measure the extent of the conjugation reactions involved 
direct spectrophotometric measurements. Three protein assays used to determine the 
concentration of protein in the bio-conjugate include the Folin-Lowry method [12], 
the Bradford method [13] and the glutamate assay kit, whose procedures are dis­
cussed in Section 2.3.4., while the conjugation ratios were calculated according to 
Naim [1], as discussed in Section 2.3.3.
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The Folin-Lowry method of protein determination is based on the Biuret 
reaction where proteins react with Cu2+ in an alkaline medium to produce Cu+ and 
the detection of the phenolic moieties of tyrosine residues as well as the tryptophan 
residues by use o f the Folin-Ciocalteu reagent, composed of phosphotungstic and 
phosphomolybdic acids [12], The cupric ions form a coordination complex with the 
four nucleophilic amine groups from the peptide bonds, of the protein/PLL molecule. 
A Cu-protein/PLL complex yielded leads to the reduction of the phosphotungstic 
and phosphomolybdic acids to tungsten blue and molybdenum blue. Approximately 
75% of this reduction process is due to the copper-protein complex, the remainder 
of which is due to tyrosine/tryptophan residues [12]. Therefore, the lysine residues 
are not involved in the protein binding process, which has significance, particularly in 
the accurate conjugation ratio determination of PLL.
The dye used in the Bradford assay is Coomasie Brilliant Blue G, and earlier 
reports suggest that the dye binds to the protein by electrostatic interactions of the 
sulphonic groups of the dye with protonated primary amino groups of the protein eg. 
lysine, N-terminal groups [14]. Other reports suggest an interaction with the arginine 
and lysine residues [15], In any case, the dye appears to interact appreciably with 
lysine residues, which is to be noted, again particularly in the analysis of PLL, as this 
would lessen the effectiveness of this assay.
For the determination of the concentration of PLGlu, a glutamate/glutamine 
assay kit was employed which was based on the spectrophotometric measurement of 
poly-l-glutamate. The dehydrogenation of L-glutamate to a-ketoglutarate is 
accompanied by the conversion of NADf to NADH [10], which can be subsequently 
measured spectrophotometrically and is proportional to the amount of glutamate that 
is oxidised.
Generally, modifications that have the least effect on side-chain character 
should have the least effect on protein structure and properties, which is an obvious 
priority in our study [11]. Modifications of lysine residues that retain their usual 
cationic charge have, for example, generally been found to have relatively little effect 
on the biological activities and other properties of many proteins. Because of this
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and the fact that the 8-amino groups of lysine residues are usually among the most 
abundant and most accessible of the potentially reactive groups [16], the amino side 
group of the lysine residues are the side chains which are involved in much of the 
conjugation procedures of this thesis. Another side chain to be modified is the 
carboxylic acid side chain of glutamic acid residues, while site-selective 
modifications undertaken include the carbohydrate moieties o f glycoproteins and the 
terminal amines and carboxylic acids of the polypeptide backbones of the 
biopolymers. The theory behind the various conjugation procedures used throughout 
this thesis is discussed in more depth in Section 1.3.5., while the procedures involved 
in carrying out such reactions are described in Section 2.3.2.
Initial studies were carried out in this area by Ryan, where the optimisation of 
conjugation conditions for some ruthenium-bound proteins was carried out [17]. The 
conjugation ratios of all bioconjugates prepared were determined in this thesis, 
rendering the comparison of the labelling efficiencies of various conjugation 
procedures possible. Furthermore the aim was to investigate the effects of the 
reaction conditions, (such as pH, temperature, reagents), as well as the structural 
forms of both the labels and the biomolecule on the reaction extents.
The effect of varying the nature and the size of the label, the structure of the 
protein and the exact binding site chosen on the protein on the extent of the 
conjugation reactions were investigated and are subsequently discussed.
3.2.4.2 . Effect o f original loading. label form and biomolecule.
Firstly, for most bioconjugates prepared, various loadings of ruthenium label were 
reacted with each biomolecule, and the resulting conjugation ratios of the 
bioconjugates determined. The biomolecules involved in such studies included the 
poly-amino acids, poly-l-lysine (PLL) and poly-l-glutamate (PLGlu), and the protein 
bovine serum albumin (BSA). In most cases initially, 10:1, 50:1 and 100:1 ratios of 
ruthenium label per protein molecule were originally reacted and the extent of the
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reaction determined. [Ru(bpy)2NH2phen]2+ was bound to PLGlu via the glutamic 
acid residues le, and to the protein BSA via the carbohydrate moieties la while 
[Ru(bpy)2NCSphen]2+ was bound to both BSA and PLL via the lysine residues 2a. 
The conjugation reaction conditions employed are discussed in Section 2.3.2. This 
study allowed us to compare the effectiveness of the different conjugation 
procedures and study the effect of the binding site and biomolecule form on the 
labelling efficiency as well as determining the reproducibility of initial work reported 
in the literature [9],
Table 3.4 lists the real conjugation ratios obtained for the 
[Ru(bpy)2(NCSphen)]2+-PLL conjugates 2a, while Table 3.5 lists the real conjugation 
ratios for the [Ru(bpy)2(NCSphen)]2+-BSA conjugates 2a. Similarly, Table 3.6 
represents such results for [Ru(bpy)2(NH2phen)]2 -BSA la, each calculated using 
methods reported by Naim [1] and Folin-Lowry [12],
The results presented in Table 3.4 show that, given that there are 
approximately 750 lysine residues on a PLL molecule, (molecular weight 109,000) 
the labelling efficiencies for each loading attempted are low. From an original 
loading of 10 moles of label per protein molecule, a final conjugation ratio of 5 was 
obtained, yielding a 50% labelling efficiency. This means that less than 1% of the 
total number of lysine residues in a PLL molecule have been covalently bound to the 
ruthenium labels, which is obviously a very low percentage. Of course, the labelling 
efficiencies have been calculated on the basis that all 750 lysine residues are 
available, which is never possible due to the conformation of the biomolecule, 
thereby increasing the actual labelling efficiency significantly. On attempting to bind 
100 moles of label per PLL molecule, only 13 were found to actually bind, which is 
similar to the results achieved with a 50:1 loading. These low loadings only 
incorporate the modification of approximately 2 % of the lysine residues present in a 
PLL molecule which appears minimal. These findings correlate well with initial 
reports from Ryan [9],
Hence, as can be seen from Table 3.4, the maximum conjugation ratios 
achieved for these PLL conjugates are between 10 and 15 moles of label per
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biomolecule, achieved with initial loadings of 50-100:1. These low conjugation ratios 
would suggest that there is limited accessibility of the labels to the lysine moieties, 
most likely due to the structural conformation of the biopolymer, in this case PLL 
which will be studied in greater detail subsequently. Significantly, this study showed 
that attempting initial loadings beyond 10 0 :1  ratios did not lead to higher 
conjugation ratios, as a saturation point appears to have been reached at loadings of 
50-100:1. Furthermore, problems such as precipitation and other disadvantages are 
likely to increase, with too great an excess of reagents, thereby justifying our choice 
of 50:1 ratio as an optimum loading for further studies in this field. For this reason, a 
50:1 loading was deemed suitable in the binding of the side chains of another poly­
amino acid PLGlu. Even lower conjugation ratios are obtained for the PLGlu 
conjugates with a highest conjugation ratio of 5 achieved from an initial loading of 
50:1. In addition to the hindering conformation of the biopolymer, another limiting 
factor in their modification would be the low reactivity o f the carboxylic acids in the 
polypeptide in water [16], For this reason, PLGlu was treated with a water soluble 
carbodiimide to activate these potential binding sites so that modification would be 
possible. However, the extent of the success of this activation reaction was not 
estimated and hence a low yield in this esterification process would result in fewer 
“available reactive binding sites” than originally anticipated. This is in contrast to the 
side chain modification of PLL where no prior activation of the lysine residues was 
necessary. This is due to the fact that the binding sites of these residues are more 
accessible due to the longer side chain length and the higher reactivity of their s- 
amino groups thereby capable of reacting directly with the isothiocyanates to form 
stable thiourea bonds.
Another possible factor contributing to the low conjugation ratios of the 
poly-amino acids is the predominant conformation of the selected biomolecule, under 
the chosen reaction conditions. For example, PLL is known to adopt two different 
conformations, depending on the pH of the reaction. A helical form is adopted under 
basic conditions whereas a random coil structure is favoured under acidic and neutral 
conditions [1 0 ],
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Table 3.4 Conjugation ratios obtained for various loadings of [Ru(bpy)2 
(NCSphen)]2+:PLL conjugates. ^
Original ratio 
of Ru:PLL
Conjugation 
ratio (a)
Conjugation 
ratio (b)
Labelling 
efficiency*(a)
% lysines 
bound.*(a)
10:1 5 2 50% < 1 %
50:1 14 5 28% 2 %
100:1 13 3 13% 2 %
assuming there are 750 lysine residues per molecule o f  PLL (mol. wt. 109,000).
(a) Protein concentration determined using the Folin-Lowry method [12].
(b) Protein concentration determined using the Bradford method [13].
Table 3.5 Conjugation ratios for various loadings of [Ru(bpy)2(NCS 
phen)]2+:BSA conjugates.2a
Original ratio 
of Ru:BSA
Conjugation 
ratio (a)
Conjugation 
ratio (b)
Labelling
efficiency.
% lysines 
bound $
10:1 8 9 90% 15%
50:1 23 22 45% 45%
100:1 25 28 28% 50%
(a) Protein concentration calculated by Bradford method [13].
(b) Protein concentration calculated by Folin-Lowry method [12]. 
$ assuming 57 lysine residues per molecule o f BSA [9].
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Table 3.6 Conjugation ratios for [Ru(bpy)2(NH2phen)]2+:BSA. conjugates. 1(1
Original
Loading
Final Conjugation 
ratio (a)
Final Conjugation 
ratio (b)
10:1 3 5
50:1 4 4
100:1 4 5
(a) Protein concentration was determined by Bradford method [13].
(b) Protein concentration was determined by Folin-Lowry method [12].
In preliminary studies, pH 9 was deemed the optimum pH of conjugation [9, 
17]. However at this pH, PLL is in a transition state, between the random-coil and 
a-helix conformations, and so may not be very reactive towards conjugation in this 
state, as well as being marginally stable. The same may be true of PLGlu, whose 
optimum pH for conjugation chosen as pH 4.8 (see section 1.4.4) is again in the pH 
range of the transition state. Hence, in later sections, similar conjugation reactions 
are carried out on regular biomolecules such as PLL, under different reaction 
conditions, such that the biomolecule is bound to the same labels when in different 
structural forms. This allows the investigation of how the secondary structure of a 
biomolecule may affect the extent of a particular conjugation reaction. Finally, 
another factor affecting the extent of a conjugation reaction may be the size and 
nature of the label, as steric hindrance of the ancillary ligands protruding from the 
backbone of the biomolecule may limit the number of labels which could bind to 
the biomolecule, in addition to the fact that some labels may be more reactive to 
certain modification sites than others, due to differences in hydrophobicity. From 
studying hyperchem structures o f such PLL conjugates (see Chapter 5), however,
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steric hindrance alone would not appear to be an adequate explanation for the low 
loadings achieved.
Moreover, to study the significance of the label structure and size, the same 
conjugation procedures were carried out, varying the ancillary ligands from 
bipyridine to phenanthroline to diphenylphenanthroline (i.e. increasing the 
bulkiness and hydrophobicity of the ancillary ligands) and the conjugation ratios 
compared and these experiments are described later in this chapter.
Table 3.5 presents the conjugation ratios achieved for [Ru(bpy)2NCSphen]2+ 
bound to the lysine residues of BSA 2a. BSA was chosen for investigation as it is a 
natural protein with a more complex structure than synthetic polypeptides. This 
may give an insight into the effect of biomolecular form on the extent of 
conjugation reactions when bound to the same binding sites, as well as evaluating 
the potential of these labels in real biological processes.
At first glance, the loadings achieved may seem low, as for PLL. However, 
whereas the original 100:1 ratio yielded only a 13% labelling efficiency (13 moles 
of label per biomolecule) for PLL, the 100:1 ratio of BSA conjugate yielded almost 
30% labelling efficiency. Also, significantly, there are only 57 lysine residues on 
the BSA molecule compared to 750 lysine residues per PLL molecule. Therefore, 
one would expect the conjugation ratios to be a lot higher for the PLL conjugates. 
This would seem to indicate that it is the structural form of PLL and/or the low 
reactivity of PLL towards the labels, that greatly restricts the number of 
fiuorochromes which can bind to the lysine moieties of PLL. For both the PLL and 
BSA conjugates, the protein concentration was determined using both the Bradford 
method and the Folin-Lowry method. As for the PLL conjugates, the Bradford assay 
results in conjugation ratios that are lower than those obtained using the Folin- 
Lowry method, but one notes that the difference is greater for the PLL conjugates, 
due to the higher number of lysines, This correlates well with experiments of this 
kind in the literature, where the difference was explained in terms of where the 
reagents actually bind on the protein molecule [12, 14, 15], The binding of the 
Bradford reagent to the lysine residues limits the validity of the results using this
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method, particularly for PLL, as both the Bradford reagent and the Ru(II) 
complexes interact with the same groups on the protein/PLL molecule [15]. For this 
reason, the results discussed are those derived using the Folin-Lowry method of 
protein determination.
The labelling efficiencies achieved are quite high for BSA, with a maximum 
conjugation of 28 moles of label obtained, out of a possible 57 binding sites, hence 
50% of all the lysine residues were modified. However, it is in fact known that less 
than half of these lysine residues are not available for reaction in albumins, 
although relatively hydrophilic, probably due to the complex structure o f the folded 
protein [18], hence the labelling efficiency is actually much higher, approaching 
100%. As the same labels and reaction conditions were used for PLL, it would 
appear that the variances in the secondary structures of PLL under the reaction 
conditions contribute significantly to such low conjugation ratios. Table 3.5 reveals 
a similar trend for these analogue BSA conjugates, whereby similar conjugation 
ratios were achieved starting from either 50:1 or 100:1 ratio of label to biomolecule. 
Again, the 50:1 loading was deemed optimum for further studies.
Table 3.6 presents similar data for [Ru(bpy)2NH2phen]2+:BSA la and again 
both the Bradford assay and the Folin-Lowry methods were used for analysis. In 
these cases, as the carbohydrate moieties have been modified, and these are not 
involved in the binding mechanisms of either the Bradford reagent or the Folin- 
Lowry reagents, both assays appear suitable for the determination of the protein 
concentration, and good correlation between both assays would be expected. Very 
similar results are indeed found, but for further work results from the Folin-Lowry 
method were employed.
The conjugation ratios are found to be somewhat lower than those obtained 
when labels were bound to the lysine residues of BSA 2a, with maximum 
conjugation ratios of 6 in this case compared to 23 previously (See Table 3.5). This 
however correlates well with initial studies in the literature [9], and would be 
expected, as the number of carbohydrate moieties in proteins such as albumins 
would be relatively small, fewer and less reactive than the lysine residues.
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The protein BSA was treated, for this conjugation procedure as a 
glycoprotein. Other well known albumins such as ovalbumin are well recognised as 
glycoproteins, containing 1 % by weight of carbohydrate where the oligosaccharide 
groups of most are covalently attached to the R groups of specific amino acid 
residues in the polypeptide chain [19], Assuming the carbohydrates moieties are 
attached to BSA as to ovalbumin, they are found on the asparagine residues which 
are few in number but well spaced out on the BSA molecule. BSA, however, is not 
generally considered a glycoprotein, but for this purpose, was treated as such, and 
the above mentioned conjugation procedure was deemed to be successful for BSA. 
Although it is difficult for us to confirm the selective modification of the 
carbohydrate moieties in our case, using such a method, this procedure is specific 
for carbohydrate moieties and in the case of antibodies allows one to direct the 
label to a site removed from the antigen-binding region producing a more 
homogenously labelled antibody preparation [2 0 ],
For these conjugates, very similar results are achieved for initial loadings of 
both 50:1 and 100:1 and for further work the initial 50:1 loading was used, as 
beyond this ratio a saturation point is reached whereupon no corresponding increase 
in conjugation ratio is achieved and precipitation results. In brief, the low loadings 
achieved for the poly-amino acids as opposed to the natural proteins may be 
significant in learning more about the structures of such biopolymers in solution. 
However, the advantage of achieving such low loadings is that it renders studies on 
conformational changes more realistic since the presence of such few labels would 
have a minimal effect on the natural processes involved with biomolecules.
As mentioned earlier, to further our understanding and study the effect of 
both the reactivity and size of the labels on the extent of conjugation reactions, the 
same conjugation reactions were carried out on both PLL and BSA using [Ru(L- 
L)2(NCSphen)]2+ labels, where L = phen and dpp, thereby increasing the bulkiness 
and hydrophobicity of the labels. Figure 3.12 (a), (b) and (c) depict the 
computational models of [Ru(L-L)2(NCSphen)]2+ where L=bpy, phen and dpp 
respectively.
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Figure 3.12 (a) Computational model o f  [Ru(bpy) 2 (NH^phen)]2+, where pale blue 
= carbon, dark blue = nitrogen and white = ruthenium. The hydrogens have been
removed for simplification purposes.
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Figure 3.12 (b) Computational model o f [Ru(phen)2(NH2phen)J2^ , where pale blue 
= carbon, dark blue = nitrogen and white = ruthenium. The hydrogens have been 
removed for simplification purposes.
125
Figure 3.12 (c) Computational model o f  [Ru(dpp)2(NB2phen)]2+, where pale blue = 
carbon, dark blue = nitrogen, white — ruthenium. The hydrogens have been re­
movedfor simplification purposes.
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This clearly illustrates the increase in bulkiness of the complex on varying the ancil­
lary ligand from bpy to phen to dpp. Table 3.7 presents the conjugation ratios ob­
tained for various loadings of [Ru(L-L)2(NCSphen)]:PLL2a while Table 3.8 presents 
those of [Ru(L-L)2(NCSphen)]:BSA 2a (L= bpy, phen and dpp).
Table 3.7 Conjugation ratios calculated for various loadings of 
[Ru(L-L)2 (NCSphen)]2+:PLL conjugates.2a
Original
loading
Conjugation 
Ratio L=bpy $
Conjugation 
Ratio L=phen $
Conjugation 
Ratio L=dpp $
10:1 5 4 4
50:1 14 10 12
$ Protein concentration determined by Folin-Lowry method. [12]
Table 3.8. Conjugation Ratios obtained for various [Ru(L-L)2 
(NCSphen)]2+:BSA conjugates. 2a
Original
Loading
Conjugation 
Ratio L=bpy $
Conjugation 
Ratio L= phen $
Conjugation 
Ratio L=dpp $
10:1 9 6 9(3)
50:1 25 20 28 (6 )
$ Protein concentration determined by Folin-Lowry method. [12]
(  )  Conjugation ratio determined in 0.01M carbonate buffer, pH  9.2
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From Table 3.7 one can see that similar conjugation ratios are achieved on 
increasing the nature of the ancillary ligand of the labels from bpy to dpp ligands for 
the PLL conjugates. This would be expected as, at most, only 2% of all lysine 
residues present have been covalently modified and therefore the modified lysines 
would not be expected to be close enough to be further affected by steric hindrance. 
This also demonstrates, however, that the low loadings for PLL are not primarily 
due to the hydrophobicity or size of the label.
Table 3.8 reveals that the conjugation ratios determined where L= dpp are 
somewhat higher than those achieved with the smaller ligand bpy for equivalent BSA 
conjugates 2a. This was not anticipated as almost maximum loading had already been 
achieved with the smaller less hydrophobic [Ru(bpy) 2 (NCSphen)]2+ (i.e. almost all 
available lysine residues bound). Furthermore it would seem likely that the lysine 
residues are situated sufficiently close to each other in the compact folded structure 
of BSA to be affected by a slight increase in bulkiness of the attached label. 
Therefore, lower conjugation ratios would be anticipated for
[Ru(dpp)2(NCSphen)]2'. Meanwhile, the same effect would not be anticipated for 
the larger PLL molecule. However, another determining factor may be the lower 
affinity of these labels towards the hydrophilic lysines, due to the increased 
hydrophobicity of these labels, from L = bpy to dpp.
However, two possible explanations for our observations are (1) the presence 
of unbound label in the conjugate solution and (2 ) the intercalative/non-covalent 
binding of some labels to the biomolecule in addition to the covalently bound form, 
both leading to apparently higher conjugation ratios. Firstly, it is apparent that 
dialysis is less effective when separating hydrophobic molecules and this may affect 
the purification of proteins bound to such complexes as [Ru(dpp)2(NCSphen)]2+. 
Secondly, reports on ruthenium-DNA interactions concluded that intercalative 
binding affinity increases with increasing hydrophobicity of the ancillary ligands [2 1 ] 
possibly explaining higher than anticipated loading of the more hydrophobic label 
[Ru(dpp)2(NCSphen)]2+ to BSA. Furthermore, the same trends would not be 
expected when dealing with PLL due to its more open structure and lack of nega­
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tively charged side groups on a PLL molecule. BSA, on the other hand, would be 
more susceptible to electrostatic interactions and intercalation due to its more 
compact folded structure and the presence of amino acids with negatively charged 
side groups facilitating electrostatic interactions with the positively charged Ru(II) 
complexes.
A chromatogram obtained for Ru(dpp)2NCSphen:BSA (28:1) depicted in 
Figure 3.4 indicates impurities present apparently due to unbound label. However, 
extensive dialysis should have removed most of the unbound label. If  these impurities 
were in fact due to electrostatically bound label, the ionic strength of the system 
should affect the degree of non-covalent interactions. Therefore, the same 
conjugation reaction was carried out using a buffer of lower ionic strength 
throughout the whole conjugation procedure ie. reaction and dialysis .0.01M 
carbonate buffer pH 9.2 was used as opposed to the usual strength of 0.1 OM. 
Interestingly, a significantly lower conjugation ratio of 6  was realised, indicating the 
elimination of much electrostatically or loosely bound ruthenium. Furthermore, the 
chromatogram of this conjugate indicates purification was achieved with the 
reduction of peaks due to free label rendering the real conjugation ratio for this 
reaction as 6 and not 28. These experiments would therefore suggest that non- 
covalent binding of [Ru(L-L)2NCSphen]2+ increases with increasing hydrophobicity 
of the ancillary ligand i.e. where L = dpp, whereas covalent binding decreases due to 
an increase in steric hindrance. The same experiment was carried out for when 
L=bpy and phen, but there was little change in the conjugation ratio on decreasing 
the ionic strength. This is due to the significant difference in hydrophobicity between 
the ancillary ligands studied. A set of experiments studying the effect of non-covalent 
linkage of the labels to the biomolecules on their emission lifetime are described later 
in this section and significantly, the results confirm the theory suggested here.
As above, similar experiments were carried out for [Ru(L-L)2NH2phen]2+: 
BSAla and [Ru(L-L)2NH2phen]2+: PLGlu le whereby the effect of the ancillary ligand 
of the label on the conjugation ratio was assessed. The results from these 
experiments are tabulated in Table 3.9 and Table 3.10 respectively.
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Table 3.9 Conjugation ratios determined for [Ru(L-L)2NH2phen]2+:PLGlu 
conjugates.le
Original
Loading
Conjugation 
Ratio L = bpy$
Conjugation 
Ratio L=phen$
Conjugation 
Ratio L=dpp$
10:1 4 5 6
50:1 5 6 10
$ Protein concentration was determined by Glutamic acid assay.
Table 3.10 Conjugation ratios determined for [Ru(L-L)2NH2phen]2+:BSA 
conjugates. u
Original
Loading
Conjugation 
Ratio L=bpy $
Conjugation 
Ratio L=phen $
Conjugation 
Ratio L=dpp $
10:1 3 4 9
50:1 4 2 28 (15)
$ Protein concentration was determined by Folin-Lowry method. [12]
(  )  Conjugation ratio determined in 0 .0 1M carbonate buffer, pH  9.2.
Again, it is logical to compare any results obtained for the side chain 
modification of both synthetic biomolecules PLL and PLGlu. Table 3.9 shows that 
the maximum conjugation ratios for these PLGlu conjugates are similar but lower 
than those achieved for the analogous PLL conjugates, which would imply that the 
restricting factors found in the labelling of PLL are also true for PLGlu. In contrast
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to PLL, the dpp based label led to a smaller increase in modification than the others. 
The discrepancy may however be due to the greater reactivity of the more non-polar 
[Ru(dpp)2NH2phen]2+ to the non polar charged glutamic acid side chains, or indeed 
may merely be due to electrostatic binding of some label to the negatively charged 
molecule. The non-covalent interactions would not appear to be as significant 
however, as for BSA, probably due to the folded nature of BSA. Moreover, it is 
difficult to accurately compare conjugation ratios for PLGlu due to the necessity to 
activate the carboxylic acids prior to conjugation.
From Table 3.10 we can see that for the [Ru(L-L)2NH2phen]2VBSA 
conjugates la, the conjugation ratios determined for [Ru(dpp)2NH2phen]2+ are 
notably higher than with the other two labels, with a maximum labelling efficiency of 
approximately 30% i.e. 15 out of 50 possible labels per molecule of BSA compared 
to 4-5 for [Ru(bpy)2NH2phen]2+. This is quite a high conjugation ratio for such a 
specific conjugation process. Although the exact number of carbohydrate moieties 
on BSA are not known, the conjugation procedure used is known to be highly 
specific to such sites leading to homogenous labelling. Therefore, the contribution of 
electrostatic binding of the label to BSA to the overall conjugation ratio probably 
leads to the high values obtained for [Ru(dpp)2NH2phen]2+ as significantly lower 
conjugation ratios are achieved in lower ionic strengths. However, this phenomenon 
will be discussed in greater detail in section 3.2.5.
3.2.4.3 E  ffect o f nature o f label.
In the previous section, we studied the effect of varying the size and hydrophobicity 
of similar labels on the extent of conjugation reactions. In this section, a ruthenium 
label of a different nature was chosen and bound to the same binding sites of PLL 
and BSA as the isothiocyanate derivatives i.e. the side groups of the lysine residues. 
This was to confirm that the nature of the label was not the principal cause of such 
low loadings of PLL.
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ISection 2.1.3. describes the synthesis of [Ru(bpy)2(COOH2bpy)]2+ while 
section 2.3.2.3. outlines the conjugation procedure in binding the esterified 
derivative to the lysine residues of both PLL3a and BSA3a. Table 3.11 presents the 
conjugation ratios achieved for various loadings of the [Ru(bpy)2(esterbpy)] 
:PLL/BSA conjugates while comparing the results to the other side chain 
modification reagents used.
As can be seen from Table 3.11, for both PLL and BSA, the isothiocyanate 
derivatives leads to greater labelling efficiency than with the ester. This would not 
have been expected, however, as preliminary studies by Eleanor Ryan PhD. revealed 
conjugation ratios similar to the isothiocyanates [9], A possible explanation, 
however, may be related to the activation of the carboxylic acids to the ester form 
which again was not 10 0% efficient and so whose purity may affect the extent of the 
conjugation reaction.
Table 3.11. Conjugation ratios for 50:1 [Ru(bpy)2esterbpy]2+:PLL3a and 
[Ru(bpy)2esterbpy]2+:BSA3a conjugates.
Complex Conjugation 
ratio-PLL *
Conjugation
ratio-BSA*
[Ru(bpy)2esterbpy]2 6 10
[ Ru(bpy)2N C S phen]2 13 23
* Protein concentration was determined using the Folin-Lowry method [12].
3.2.4.4. Effect o f protein binding site.
As well as binding to the side groups of amino acid residues of poly-amino acids, 
ruthenium complexes were also covalently bound to the terminal groups of these 
biopolymers. In order to carry this out, the conjugation procedures were modified to
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permit binding to the terminal amine and carboxylic acid of the polypeptide chain 
backbone. Hence, [Ru(L-L)2NH2phen]2' was bound to the terminal carboxylic acid 
of the PLL chain 16 and [Ru(L-L)2NH2phen]2+ bound to the terminal amine of the 
PLGlu chains 2b, both via amide bonds.
In addition to binding to the lysine residues of BSA, a second side-chain 
modification reaction was carried out, whereupon ruthenium complexes were bound 
to the acidic glutamic acid residues present in the biomolecule. Labels were not 
bound to the terminal groups of BSA however, as due to the presence of both 
carboxylic acids and amines in the side groups of various amino acids, specific 
modification of the terminal binding sites could not be ensured. The conjugation 
ratios of such bioconjugates were calculated and are presented below in Table 3.12 
and Table 3.13.
As well as assessing the success of the individual conjugation reactions, the 
estimation of such conjugation ratios are useful in the verification of the selectivity of 
the various conjugation procedures.
Table 3.12 Conjugation ratios of 50:1 [Ru(L-L)2NH2phen]2+:PLL ld and [Ru(L- 
L)2NCSphen]2+:PLGlu.2b
Conjugate Conjugation 
ratio L = bpy
Conjugation 
ratio L = phen
Conjugation 
ratio L = dpp
Ru(L-L)2NH2phen:PLL* 1 2 3
Ru(L-L)2NC Sphen: PLGlu5 2 1 4
* Protein concentration was determined using the Folin-Lowry method [12], 
$ Protein concentration was determined using the glutamate assay.
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Very low conjugation ratios would be anticipated on binding labels to the 
terminal carboxylic acids and amino groups of biomolecules as there is only one 
terminal carboxylic acid and amine per polypeptide chain, as opposed to 57 lysine 
residues in the protein BSA, 750 lysine residues in PLL and 640 glutamic acid 
residues in PLGlu, which are theoretically the number of binding sites available for 
previous conjugation reactions studied.
From Table 3.12 we see that for PLL and PLGlu, an average conjugation 
ratio of 1 was achieved with the nature of the label having little effect on the extent 
of the reaction. This would be expected due to the uniqueness of such binding sites 
per polypeptide chain. Slightly higher loadings achieved with [Ru(dpp)2NH2phen]2+ 
may be due to the apparent lower efficiency of dialysis of hydrophobic molecules. 
Nevertheless, these universal low loadings suggest that the conjugation method 
developed to exclusively modify the terminal groups of the polymer chains is indeed 
selective. It must be noted that there are means to detect the terminal groups of 
proteins and such methods could be used in future studies to confirm such site- 
selective binding processes.
The conjugation ratios of [Ru(L-L)2NH2phen]2+: BSA bound via the glutamic 
acid residues ib are outlined in Table 3.13. A loading of 1 was obtained for both 
[Ru(bpy)2NH2phen]2+:BSA and [Ru(phen)2NH2phen]2+:BSA compared to 23 labels 
per biomolecule when bound via the lysine residues, which is surprising considering 
there are 67 glutamic acid residues per BSA molecule compared to 57 lysine 
residues per biomolecule. However, with [Ru(dpp)2NH2phen]2', upto 20 glutamic 
acid residues appear to be modified, in this case showing these labels to be much 
more efficient in this particular labelling procedure, in particular the latter. However, 
this high labelling efficiency appears again to be due to extensive non-covalent 
binding of the label. On reducing the ionic strength of the buffer system throughout 
the complete conjugation procedure, a high loading of 18 was still achieved 
indicating that a decrease in ionic strength merely improved the efficiency of dialysis 
but did not remove the tightly bound label. As discussed in page 129 dialysis also 
appears to be less efficient when separating hydrophobic molecules rationalising the
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unusually high apparent conjugation ratios here. However, it may also be possible 
in this case, that the more hydrophobic label is more reactive to these binding sites.
As already mentioned, the lysine residues are normally more accessible and 
reactive than the glutamic acid residues, due to the higher reactivity of the E-amino 
group of its side chain and longer chain length, and so this would explain why, on 
average, the lysine residues are the most efficiently modified binding sites. 
However, unlike the lysine residues of BSA, the exact number of glutamic acid 
residues which are actually “ available” for modification per BSA molecule is not 
known, thereby rendering the comparison of the conjugation ratios of both amino 
acids difficult.
Table 3.13. Conjugation ratios for [Ru(L-L)2NH2phen]2+:BSA lb bound via the 
glutamic acid residues.
Complex L = bpy L = phen L = dpp
[Ru(L-L)2NH2phen]J+:BSA 1 2 20(18)
$ Protein concentration was determined using the Folin-Lowry method [12].
( ) Conjugation ratio determined in 0.01M carbonate buffer, pH  9.2.
3.2.4.5 Effect o f  reaction conditions.
The optimum reaction conditions used when carrying out various conjugation 
procedures are presented in Section 2.3.2., Chapter 2 [11, 15]. It was decided to 
investigate the effect of pH and temperature of reaction on the extent of conjugation 
reactions in an attempt to more clearly understand the reasons for low labelling 
efficiencies, particularly concerning the synthetic biomolecules, PLL and PLGlu. 
The topic concerning the effect of chemical denaturants is addressed briefly.
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The optimum pH for the conjugation of PLL and BSA via their lysine 
residues was initially investigated in the literature [9], It was found that pHs 7-9 gave 
similar conjugation ratios while conjugation was found not to occur at lower pHs. 
This increase in conjugation ratios as a function of pH was explained in the literature 
to be most likely due to the greater deprotonation of the amino group of the lysines 
at higher pH values, thereby providing additional sites for reaction with the 
isothiocyanate group of the label [17], The pH alone would not be an adequate 
explanation for the low binding to PLL as the lysines in BSA would be similar, 
although the presence of various amino acids in the chain would modify their pKa 
somewhat.
Significantly however, the pKa of the amino groups of lysines is very close to 
the pH at which the reactions were carried out for PLL and hence, PLL is known to 
be in a transitional state between a random-coil conformation and it's helical form.
In order to investigate whether the structural conformation of the poly-amino 
acids predominant under the reaction conditions would have a major effect on the 
extent of the reactions, conjugation reactions were carried out for both PLL and 
PLGLu, under conditions at which the poly-amino acids would be expected to be 
totally helical, to leam if more or less efficient labelling would be achieved under 
such conditions. Table 3.14 presents the conjugation ratios achieved for PLL, BSA 
and PLGlu conjugates at higher temperatures (where PLL is known to adopt a (3- 
sheet conformation), various pHs (pH 11 for PLL and BSA) (optimum pH 9.2) and 
pH 3 for PLGlu (optimum pH 4.8) where their helical forms are expected to prevail.
m  Effect of pH.
From Table 3.14 we can attempt to deduce the effect of the reaction pH on the 
extent of the conjugation process. A change in pH has many different effects on the 
reactants in a conjugation process. Firstly, the pH may affect the reactivity and
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stability of the labels as, for certain reactions, it may be the protonated/unprotonated 
form of the label that reacts with the binding site of the biomolecule.
The pKa of the binding sites of the biomolecule is also very important, 
notably in the reactions we are considering [16], For example, in the side-chain 
modification of PLL and BSA, it is the deprotonated form of the amino groups, of 
pKa 10, which react with the isothiocyanates to form a thiourea bond [16]. This 
explains why no conjugation was found to occur at acidic pHs whereas the optimum 
pH of conjugation was determined to be approximately pH 9, where the vast 
majority of amino groups would be deprotonated. The pH also obviously affects the 
most stable conformation of the biomolecule, in particular the more dynamic 
synthetic biopolymers. In addition to the pH sensitivity of the secondary structures of 
many poly-amino acids in solution, most proteins are found to become unstable and 
therefore may become unfolded to some extent above pH 11, while generally found 
in their most stable state around their isoelectric point.
Table 3.14 Conjugation ratios for [Ru(bpy) 2  (NCSphen)]2+:PLL, 
[Ru(bpy)2(NCSphen)]2+:BSA and [Ru(bpy)2 (NH2 phen)]2+:BSA(a) under 
extreme reaction conditions.
Conjugate (a) (b) (c) (d)
[Ru(bpy)2NCSphen]2+:PLL 14 2 2 4
[Ru(bpy)2NCSphen]2+:BSA 23 7 6 8
[Ru(bpy)2NH2phen]2 :BSA 6 2 2 4
(a) Conjugation ratios determined with initial loading o f 50:1, under optimum 
reaction conditions specified in Section 2.3.2.4. and 2.3.2.5.
(b) Conjugation was carried out at p H  11 for PLL & BSA. (c) Conjugation was 
carried out at 50°C. (d) 8  M  urea was added to the conjugation reaction mixture.
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From Table 3.14 we see that on carrying out the same conjugation at a 
higher pH of 11 for PLL, a significant decrease in the extent of reaction is apparent, 
with modification of only 2 sites achieved, as opposed to an optimum of 14. As the 
a-helix is the favoured conformation at pH 11 [10], this would suggest that more 
lysine residues are actually available for binding when PLL is in the random-coil 
conformation than when in the rigid a-helical form. However, as for proteins, under 
such extreme basic conditions, the polypeptide may become destabilised and hence 
less reactive to modification. A similar experiment was attempted on PLGlu at pH 3. 
However, as an amino label was used, it was necessary to elevate the pH in order to 
dissolve the label, rendering such a study difficult. Table 3.14 reveals that BSA is 
less well modified at pH 11, and this would be expected as BSA, an acidic protein 
would be somewhat denatured at such high pHs.
Hence, as preliminary experiments indicated, no conjugation took place 
under acidic conditions and we find less conjugation at pH 11 than at pH 9. This 
correlates well with initial reports that pH 9 is the optimum pH of such conjugation 
reactions.
This illustrates the importance of verifying the optimum pH of conjugation 
reactions and shows us that the pH and pH sensitive conformations of the 
biomolecules are not adequate explanations for such low labelling of PLL and 
PLGlu. Furthermore, this highlights the complexity behind conjugation reactions and 
the number of parameters affecting their success.
(2) Effect of temperature.
As stressed previously, PLL is known to adopt a (3-sheet conformation when heated 
to 50° C for 15 minutes [4], From Table 3.14, we see that, as for the pH modified 
conjugate, the conjugation reaction carried out at 50°C leads to significant loss in 
conjugation. This correlates well with our earlier theory that non-random 
conformations such as a-helix, P-sheet yield less efficient labelling. We would not 
expect to be able to differentiate between secondary structures of a similar nature
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such as the a-helix and P-sheet using ruthenium complexes as probes and therefore 
would expect similar results for both structural forms. Such information is not 
however known of PLGlu and so it would be difficult to interpret results here. On 
carrying out the same experiment on BSA conjugates, lower conjugation ratios were 
calculated, but less affected than with PLL. Another possibility is the lower stability 
of the labels at elevated temperatures although absorption spectra of heated labels 
did not show any changes. The most stable forms of proteins are temperature 
dependent, with most proteins becoming denatured beyond a critical temperature. 
BSA, like most serum albumins, would not be expected to be fully unfolded at a 
relatively mild temperature of 50 °C, and so it is not clear why lower conjugation 
ratios are achieved under such conditions. In short, this experiment yields little 
information on the thermostability of proteins/poly-amino acids but rather verifies 
the complexity behind such biological procedures. Nevertheless, the lower 
conjugation ratios would not appear to be due to the thermostabilty of the covalent 
bonds involved between label and biomolecule, i.e. thiourea and amide bonds, as 
further studies in the next chapter indicate the reversibity of the effect of heat, 
dismissing the idea of decomposition. Consequently, a method, such as DSC, to 
recognise unfolding of the protein, or CD spectra to differentiate between secondary 
structures, would be necessary to make more definite conclusions possible from such 
a fundamental study.
(3) Effect of chemical denaturants.
As pointed out earlier, the addition of some chemical denaturants to the reaction 
mixture may increase the extent of a conjugation reaction [11], To investigate this 
possibilty in our conjugates, 8 M urea was added to PLL, PLGlu and BSA 
conjugates. However, from Tables 3.14, the opposite effect was noted for all 
biomolecules, resulting in lessening the extent of such reactions particularly on 
binding to lysine residues of PLL and BSA.
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Denaturants such as urea and guanidine may denature proteins by increasing 
the solubility of non-polar molecules, such as amino acid side chains, thereby 
diminishing the magnitude of the hydrophobic effect by upto one third [2], This 
effect should be adequate to produce unfolding of proteins. Specific interactions 
between denaturant and protein is implied while urea molecules even permeate the 
interior, perturbing the close-packed interior by occupying small cavities [2],
Hence denaturation of BSA may occur, leading possibly to the lower 
reactivity of the binding sites in question. For [Ru(bpy)2NCSphen]2+: BSA 2a a 
significant drop in the number of labelled sites is implied, while only a slight decrease 
in modification is indicated for [Ru(bpy)2NH2phen]21 :BSA la. This may be due to the 
fact that the lysines and oligosaccharides, on different positions along the BSA 
molecule may be affected by varying degrees by any unfolding or local 
conformational changes induced by urea. However, on determining the lifetimes of 
conjugates prepared with urea, very little change was observed, which indicates little 
change in the local environment of the labels along the polymer chain, questioning 
any significant structural changes in the denaturation of BSA under such conditions. 
An important point to note is that denaturation does not necessarily induce 
detectable physical changes in proteins, but may rather involve influences on folded 
conformations of the polypeptide chain upon which its biological properties may be 
critically dependent [2],
Another point to note however, is that on studying the effect of urea on the 
decay behaviour of the unbound labels used, the decay lifetimes of the labels 
decreased, indicating that chemical denaturants affect the spectroscopic properties of 
the labels, which may subsequently affect their affinity to binding to the 
biomolecules. Therefore, the lower conjugation ratios may be merely due to the 
effect of urea on the reactivity of the labels. Again, simultaneous means to study 
conformational variances of such biopolymers in more depth would be a major 
advantage in such work.
Another likely explanation is that the thiourea bond formed between the 
lysines and label is rendered less stable by chemical denaturants than the stabilised
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amine bonds between label and carbohydrate moieties. This interpretation is 
strengthened by the fact that similar effects are seen for PLL as for the former BSA 
conjugates, i.e. dramatic drop in conjugation ratio, of which thiourea bonds are also 
involved in the conjugation. However, it is difficult to study the reversibility of the 
effects of urea as its removal is a prerequisite.
In brief, it must be concluded that the initial reaction conditions are indeed 
the optimum conditions for the reactions concerned. Also, any change in such 
conditions has a critical effect on the success o f the conjugation procedures, 
verifying the unpredictable and complicated dynamic behaviour of biomolecules.
3.2.5. UV/vis and emission spectroscopy.
The absorption and emission data on the unbound ruthenium complexes, in addition 
to their protein-bound forms are presented in Table 3.15, while Figures 3.13 and 
3.14 depict the absorption and emission spectra typical of unbound [Ru(II) 
complexes and their various bio-conjugate forms.
For all the compounds studied, the maximum wavelength of the lowest 
energy absorption occurs at 450-470 nm. Upon conversion to their isothiocyanate 
derivatives, the maximum of absorption (and emission) is shifted very slightly, in 
most cases to higher energies. Upon conjugation, the visible region in the absorption 
spectrum of the bioconjugates is not affected by absorbance by the biomolecules 
since this occurs in the ultraviolet region. Hence, any changes in the absorption in 
this area of the spectrum should reflect changes in the spectroscopic properties of 
the ruthenium complexes upon conjugation to biomolecules. All compounds studied 
emit at room temperature with emission maxima ranging from 600-625 nm.
On conjugation of the labels to the biomolecules, slight variations in the 
maxima of absorption and emission are induced, indicating subsequent changes in 
spectroscopic properties of the labels upon binding. Generally, binding to the protein 
BSA leads to more pronounced shifts in absorption/emission maxima than with syn­
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thetic biomolecules used, although even in most cases the shifts are only in the range 
2-5 nm, which are still minimal and indeed within instrumental error range.
Table 3.15. Electronic data for ruthenium complexes and bio-conjugate forms.
Compound Conjugate Absorption Em
[Ru(bpy)2(NH2phen)]2+ 456(4.15) 612
[Ru(bpy)2(NH2phen)] - BSA 460 615
poly-l-glutamate 458 610
poly-l-lysine 458 614
[Ru(bpy)2(NCSphen)]2+ 454 (4.18) 610
BSA 460 615
poly-l-lysine 458 615
poly-l-glutamate 456 614
[Ru(phen)2NH2phen]2+ 452 (4.24) 602
BSA 456 603
poly-l-glutamate 455 602
poly-l-lysine 456 604
[Ru(phen)2(NCSphen)]2+ 454(4.16) 608
BSA 460 605
poly-l-lysine 460 605
poly-l-glutamate 456 608
[Ru(dpp)2NH2phen]2+ 462 ( 4.32) 620
BSA (a) 475 625
(b) 465 618
poly-l-glutamate 478 625
poly-l-lysine 465 620
Ru(dpp)2(NCSphen)]2+ 460 (4.25) 618
BSA 470 624
poly-l-lysine 465 625
poly-l-glutamate 468 624
[Ru(bpy)2(COOHbpy)]2+ 460 (4.20) 642
[Ru(bpy)2 (esterbpy)]2+ 460(4.18) 655
BSA 465 655
poly-l-lysine 465 655
(a) All spectra and extinction coefficients (log s) were measured in 0.1 OM 
carbonate buffer, pH  9.2, at room temperature.
(b) Ruthenium complexes were firstly dissolved in a minimal volume o f  acetone.
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The conjugates of [Ru(dpp)2NH2phen]2+ and in particular [Ru(dpp)2NCSphen]2+, 
exhibit more significant changes, with the absorption and emission maxima of the 
label, changing by upto 6-8 nm upon conjugation, thereby indicating that the emit­
ting properties o f such labels are significantly affected by the bound biomolecule. 
This is possibly due to the tighter binding of the complexes and stronger electro­
static interactions involved with the folded protein.
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Figure 3.13. Typical absorption spectra o f  (1) [Ru(dpp) 2NCSphen]2+ and when co­
valently bound to (2) BSA, (3) PLL & (4) PLGlu.
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Figure 3.14 Typical emission spectra o f (1) [Ru(phen)2NH2phen]2+ and when 
covalently hound to (2) BSA, (3) PLL & (4) PLGlu.
3.2.6 Emission lifetime measurements.
The emission lifetimes of the ruthenium polypyridyl complexes, both when unbound 
and when covalently bound to selected biomolecules were measured using the 
system described in Section 2.2.8., Chapter 2. The measurements were carried out in 
aerated and degassed solutions, in 0 .10M carbonate buffer, pH 9.2, unless otherwise 
stated. As noted in the literature [9, 17], most of the protein-bound complexes 
display essentially double exponential decay behaviour, with one emitting component 
significantly longer than the other. Hence, from the preliminary experiments carried
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out in Section 2.2.9, equation 2.3 was deemed a suitable model for the analysis of 
such complexes [22]. However, it is necessary to recognise the physical limitations 
of this approximation, as this neglects the fact that the measured fluorescence decay 
profile is an average signal from all molecules excited by the light. Thus, if a 
fluorescent molecule is subject to a heterogeneous environment, one has to 
calculate the decay profile of fluorescence as an average over the distribution of 
relaxation rates [22]. In this study, a double exponential equation was found to 
suffice in most cases as described in equation 2.6.
In contrast, the excited state decay of the unbound ruthenium complexes can 
be fitted by single exponential kinetics. Hence equation 2.5, the monoexponential 
decay law may be used in data analysis of such compounds [22] (See Section 2.2.9). 
An emission decay profile typical of a ruthenium complex analysed using such a 
monoexponential decay model and equation 2.5 is depicted in Figure 3.15 while the 
decay profiles of a protein-bound label, analysed using the single and double 
exponential decay models mentioned above, are displayed in Figure 3.16 and Figure 
3.17 respectively. These clarify the reasoning behind differentiating between 
whether a single or multi-exponential decay model gives the best fit for a given 
sample, which was already discussed in Section 2.4.9.1. Figure 3.16 shows that on 
analysing the conjugate with the single exponential model, significant deviations 
are observed in contrast to the minimal error achieved for the unbound label in 
Figure 3.15 (See equation 2.7), confirming that this sample possesses more than one 
emitting component. On using the double exponential decay model for the same 
sample, the elucidation of two emission lifetimes lead to a very small error in the 
calculations as observed in Figure 3.17(b). The lifetimes of the free Ru(H) 
complexes obtained by using equation 2.5 are presented in Table 3.16 (a) when the 
samples are aerated, deoxygenated and oxygenated. Table 3.16 (b) discloses the 
lifetimes of the various emitting components of the protein-bound labels when 
aerated and deoxygenated which were calculated using the multi-exponential decay 
law (equation 2.6).
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Figure 3.15 (a) Emission decay profile o f  [Ru(dpp) 2NCSphen f  \
(b) Weighted residual plot for a single exponential fit.
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Figure 3.16 (a) Emission decay profile ofRu(dpp)2NCSphen:BSA.
(b) Weighted residual plot fo r  a single exponential fit.
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Figure 3.17 (a) Emission decay profile o f  Ru(dpp) jNCSphen:BSA.
(b) Weighted residual plot fo r a double exponential fit.
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3.2.6.1. Unbound ruthenium complexes.
As stated previously, all the free labels used display single exponential decay, 
thereby possessing a single emission lifetime. From Table 3.16 (a) it can be seen 
that the emission lifetimes of the complexes are efficiently quenched by oxygen, in 
particular the amino complexes and their isothiocyanate derivatives with the 
lifetimes being reduced by half on oxygenation.
Table 3.16 (a) Emission decay lifetimes for the unbound ruthenium complexes, 
measured in 0.10M carbonate buffer, pH 9.2.
Complex
a Oxygenated
Lifetimes (ns) 
Aerated a Argon
[Ru(bpy)2NH2phen]2+ 185 350 600
[Ru(phen)2NH2phen]2+ 230 530 800
[Ru(dpp)2NH2phen]2+ 430 700 1300
[Ru(bpy)2NCSphen]2+ 200 450 650
[Ru(phen)2NCSphen]2+ 230 550 1100
2+
[Ru(dpp)2NCSphen] 270 650
1300
[Ru(bpy)2(COOHbpy)]2+ 220 350 480
[Ru(bpy)2(esterbpy)]2+ 210 330 460
Samples were dissolved in acetone and made up in 0.10 M  carbonate buffer, pH 9.2. 
a 0.2ml sample was added to 0.1 OM carbonate buffer, pH 9.2, and the solutions were 
treated with argon/oxygenated for 30 mins.
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This is to be expected, as oxygen is one of the few species which efficiently 
quenches the excited state lifetime of [Ru(bpy)3]2+ and its derivatives. Furthermore, 
the lifetimes obtained correlate well with those in the literature [9]. The decay 
lifetime of the acidic complex [Ru(bpy)2(COOH2bpy)]2+ and its ester form appear 
to be less influenced by the quenching effects of oxygen which also correlates with 
findings for similar compounds in the literature [23],
3.2.6.2. Protein-bound ruthenium complexes.
As stressed earlier, upon binding to the biomolecules in question i.e. PLL, BSA and 
PLGlu, the ruthenium complexes display essentially double exponential decay 
kinetics. The first point to note from the aerated solutions in Table 3.16 (b), when 
compared to those of the free labels in Table 3.16 (a), is that in most cases the 
protein-bound labels possess one lifetime significantly longer than that of the free 
label and another lifetime of similar duration or shorter than that of the free label. 
For every label used, the BSA-bound form exhibits notably greater enhancements of 
lifetimes than found using the synthetic biomolecules, PLL and PLGlu. In 
particular, for the labels, [Ru(dpp)2NH2phen]2+ and [Ru(dpp)2NCSphen]2+ when 
bound to BSA, striking lifetime enhancements are evident, whereby the longer 
lifetime obtained is upto four times longer than that of the same free label, while 
the shorter lifetime is approximately of the same durationas that of the free label. 
This observation is in correlation with the more pronounced changes in the 
absorption and emission spectra of the same protein-bound complexes. This may 
again be due to the tighter binding of these complexes resulting from the stronger 
electrostatic interactions between the more hydrophobic labels and the proteins. 
However, although not to the same extent, all protein-bound labels studied do 
exhibit enhanced lifetimes to some degree when compared to their unbound 
counterparts.
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Table 3.16 (b) Emission decay lifetimes for protein-bound ruthenium 
complexes, measured in 0.10M carbonate buffer, pH 9.2.
Conjugate Conjugation ratio Lifetime (ns)
Aerated Argona
[Ru(bpy)2NH2phen] /  BSA (a) la 4 760 (65), 270(35) 1000 (40), 390(60)
[Ru(phen)2Nl Ijphen] / BSA (a) 5 930(60), 350 (40) 1100 (50), 380 (50)
[Ru(dpp)2NH2phen] / BSA (a) 15 2000 (60), 500 (40) 2800 (70), 650 (30)
[Ru(bpy)2NH2phen] /  BSA (b) lb 1 850 (70), 370 (30) 1100(60), 360(40)
[Ru(phen)2NHjphen] / BSA (b) 2 1000 (60) 360 (40) 1300 (50), 520 (50)
[Ru(dpp)2NH2phen] / BSA (b) 20 1800 (65), 270 (35) 2400 (70), 450 (30)
[Ru(bpy)jNCSphen] / BSA. u 21 930,(65), 250 (35 ) 950 (52), 350 (48)
[Ru(phen)2NCSphen] / BSA 25 1100 (65), 310 (35) 1200 (60), 390 (40)
[Ru(dpp)2NCSphen] /  BSA 28 3500 (65), 830 (35) 3700 (65), 820 (35)
[Ru(bpy)2(esterbpy)] / B SA 34 6 990 (25), 320 (75) 1200 (45), 500 (55)
[Ru(bpy)2NC Sphen] /  PLL2a 12 680 (65), 390 (35) 730 (70), 450 (30)
[Ru(phen)2NCSphen] /  PLL 15 1250 (60), 370 (40) 1100 (60), 400 (40)
[Ru(dpp)2NCSphen] / PLL 12 1650 (90), 410 (10) 1700 (80), 200 (20)
[Ru(bpy)2(esterbpy)] /  PLL 3“ 6 405 (80), 180 (20) 640 (50), 290 (50)
[Ru(bpy)2NH2phen] / PLLld 1 500 (85), 180 (15) 800(85), 290 (15)
[Ru(phen)2NH2phen] / PLL 2 750 (90), 270 (10) 1100 (75), 350 (25)
[Ru(dpp)2NH2phen] /  PLL 4 1050 (90), 490 (10) 1500 (80), 550 (20)
[Ru(bpy)2NH2phen] / PLGLu le 5 520 (80), 210 (20) 780 (80), 180 (20)
[Ru(phen)2NH2phen] /  PLGlu 6 670 (50), 400 (50) 1100 (50), 350 (50)
[Ru(dpp)2NH2phen] / PLGlu 10 980 (60), 280 (40) 1400 (60), 400 (40)
[Ru(bpy)2NCSphen] /PLGlu2b 1 520 (75), 240 (25) 840 (90), 240 (10)
[Ru(dpp)2NCSphen] /  PLGlu 4 1240 (85), 590 (15) 2100 (85), 580 (15)
a 0.2 ml sample was added to 0.1 OM carbonate buffer, pH 9.2, and deoxygenated under 
argon for 30 mins.
Figures in (  )  represent the proportion o f each emitting species determined from the pre­
exponential decay functions, as described in equation 2.3.
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Before more detailed studies could be carried out on the decay behaviour of 
the protein-bound labels, it was necessary to verify that the double exponential 
behaviour of the conjugates was indeed due to the covalently bound label and not 
merely electrostatically bound forms. For this purpose, a set of experiments were 
carried out whereby free Ru(II) complexes were mixed with free protein under 
conditions not apt for covalent bond formation, and the immediate effect of the 
non-covalently bound protein on the emission lifetime of the label was investigated. 
Similar concentrations of both label and biomolecule were used as for the 
conjugation reactions in an attempt to keep conditions constant. Table 3.17 below 
displays the results of such studies.
Table 3.17 Effect of mixing ruthenium complexes with proteins on the emission 
lifetime of the label in aerated 0.10M carbonate buffer pH 9.2.
[Ru(L-L)2NH2phen]i+
[ns]
Lifetime
(ns)
label + PLL.
Lifetime (ns) 
label + PLGlu
Lifetime (ns) 
label + BSA
L = bpy, [350] 350 380 320
L = phen, [530] 450 490 430
L = dpp [800] 780 1000 (70) 
400 (30)
1500(70) 
260(30)
( )  Figures in brackets represent the pre-exponential factors o f the emitting 
components as determined from the decay function *&(0 = [(Al(l-exp(-kjt))+(A2(l- 
exp(-k2t))J [22].
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The information outlined in Table 3.17 is quite significant in two respects. 
Firstly, it reveals how the emission lifetime and single exponential decay behaviour 
of the labels are unaffected by the presence of the synthetic biomolecule PLL. This 
verifies that the double exponential nature o f decay of their conjugates is primarily 
due to covalently bound label and not induced by electrostatically bound complex. 
However, on mixing [Ru(dpp)2NH2phen]2+ with PLGlu, double exponential kinetics 
become apparent, with one lifetime slightly elevated when compared to that of the 
unbound label. As regards the natural protein BSA, the decay lifetimes of the 
complexes [Ru(bpy)2NH2phen]2+ and [Ru(phen)2NH2phen]2+ are also unperturbed 
by the presence of this protein. The interesting discovery in this study is the striking 
effect that unmodified BSA has on the decay behaviour of the free label 
[Ru(dpp)2NH2phen]2+. Double exponential decay kinetics of the non-covalently 
bound ruthenium complex results from the presence of BSA, where the longer 
lifetime is almost twice that of the free complex and whose shorter lifetime is 
significantly less than that of [Ru(dpp)2NH2phen]2+. This observation would appear 
to substantiate our assumption that [Ru(dpp)2NH2phen]2+, due to bulkier ancillary 
ligands and increased hydrophobicity, partakes in significant electrostatic 
interactions with the protein. Table 3.18 summarises the lifetimes obtained for 
[Ru(dpp)2NH2phen]2+:BSA linked in both non-covalent and covalent manners.
The greater enhancement of the longer lifetime of the complex when 
covalently bound to BSA indicates that this enhanced lifetime is indeed due to a 
combination of covalently and electrostatically bound label along the biopolymer. 
As the double exponential decay appears to originate from a composite of several 
decays from labels at various positions along the protein, the shorter lifetime may 
be a quenched bound form of the label, possibly linked electrostatically as this 
lifetime is little affected by covalent linkage. The similar but less obvious effect 
noted for the decay of [Ru(dpp)2NH2phen]2+:PLGlu may be due to the electrostatic 
interactions between Ru(II) complexes and the negatively charged PLGlu.
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Table 3.18 Effect of ionic strength on conjugation ratio and emission lifetimes 
of [Ru(dpp)2NH2phen]2+: BSAla lb and [Ru(dpp)2NCSphen]2+: BSA 2a.
Conjugate Conj.Ratiol, lifetimes 1 (0.1M ) Conj Ratio2, lifetimes2 (0.01M )
[Ru(dpp)2NH2phen]2+: BSA (a) 28:1 2400 (60), 650 (40) 15:1 2000 (70), 500 (30)
[Ru(dpp)2NH2phen]2+: BSA (b) 20:1 2200 (65), 320 (35) 18:1 1800 (65), 270 (35)
[Ru(dpp)2NCSphen]2+:BSA 15:1 3500(65), 830(35) 6:1 2900 (70), 600 (30)
() Figures in brackets represent pre-exponential factors o f  the emitting components 
from the decay function & ( 0  = I 0  -exp(-kjt))+ (^ 2 ( 1  -exp(-k2 l))] [2 2 ],
* Conjugation ratios determined according to Nairn [1].
As mentioned earlier, the scale/strength of electrostatic interactions seems to be 
affected by the ionic strength of the system. However, on mixing ruthenium 
complexes and biomolecules under the same conditions but at a lower ionic 
strength using 0.01M carbonate buffer, similar lifetime enhancements result, 
indicating that a decrease in ionic strength only removes the more loosely bound 
label.
Salt is often used to increase the ionic strength of a system. Interestingly, 
NaCl was added to the mixture of [Ru(phen)2NH2phen]2+ and BSA. Although the 
lifetime of the label was unaffected by the non-covalently bound protein under 
standard conditions, double exponential decay resulted in the presence of NaCl, 
indicating that the electrostatic interactions indeed increase with ionic strength.
The double exponential nature of the decay of such bio-conjugates as 
observed in Table 3.16 has been attributed to the presence of labels on the same 
binding sites but along different locations of the biomolecule, thereby possibly 
under different local environmental effects, to which Ru(II) complexes are very 
sensitive. This being the case, PLL conjugates may be expected to display single
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exponential decay behaviour, as PLL is made up of only lysine residues, indicating 
homogenous environments for the labels, regardless of their position along the PLL 
molecule. Double exponential analysis was required for the best fit for most PLL 
conjugates, however one significant feature is that these conjugates are not as 
clearly “ double exponential “ as the BSA conjugates, in the sense that single 
exponential analysis gave a reasonable fit. This is more evident from the analysis of 
decay curves obtained from the single exponential decay analysis o f such samples 
than from the fractions of each emitting component estimated from the relevant 
pre-exponential factors using double exponential analysis. This would be explained 
by the fact that BSA is composed of several types of amino acids along a chain and 
hence, labels bound to one particular type of binding site may still have variances in 
their surroundings, depending on their exact location along the polymer chain. It is 
important to remember the nature of the analysis of multi-exponential decays as it 
is merely a mathematical approach to solving an equation. Hence, the apparent 
single exponential nature of the lifetimes of such conjugates may actually be due to 
the less significant difference between both lifetimes in the more homogenous 
environment of PLL, to which the functions used are less sensitive (See 2.4.9.1) 
However, the uneven distribution of the labels along the PLL polypeptide chain may 
lead to heterogeneity of these labels, thereby rationalising the double exponential 
nature of the decay. In brief, it is likely that the emission decay of the conjugates is 
much more complicated and complex than treated and therefore the elucidation of 
two lifetimes is merely an averaging process.
The exact nature of the various emitting components of the protein-bound 
labels is uncertain. The enhanced lifetimes of the protein-bound labels, as suggested 
in the literature [17], may be due to a combination of factors. One important 
component is (1) a decrease in vibrational activity of the label when held in the 
more rigid environment of the biomolecule. This would appear to be a fundamental 
contributing factor, despite the uncertainty of the extent of increase of rigidity of 
such complexes as opposed to when in the free form. Based on results, BSA would 
appear to hold the labels more rigidly than the synthetic polypeptides, which is very
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likely, due to the compact folded nature of such albumins, in contrast to the more 
open nature of the polypeptide chains of PLL and PLGlu as well as the capacity for 
stronger electrostatic interactions. However, this factor alone would not adequately 
explain variances in degrees of enhancements between different labels bound to 
various sites on the same biomolecule. Moreover, the rate of enhancement may 
depend on the predominant conformation of the biomolecule under the reaction 
conditions. This rationalisation would explain results obtained in the chapter 5, 
whereby the degree of enhancement of the lifetime of the bound label appears to be 
noticeably influenced by the local conformational variances inherent in the 
biomolecule involved, evident on studying secondary structural variances in 
synthetic poly-amino acids and denaturation of BSA.
Another factor influencing the enhancement o f lifetimes, on binding to large 
biomolecules, may be (2) the protection of the label from quenching, by 02 in 
particular, in the sheltered environment of the biomolecule. BSA, a natural globular 
protein has a more complex folded structure than the regular poly-amino acids and 
therefore contains more sheltered pockets, incorporating in essence a hydrophobic 
core and hydrophilic surface. Hence, a combination of theory (1) and (2) would 
explain the greater enhancement of the BSA-bound labels when compared to those 
bound to other biomolecules. Assuming (2) is particularly true for BSA, by 
removing oxygen from the BSA-bound labels their longer lifetimes should be less 
influenced than those in the more open environments of the PLL/PLGlu-bound 
labels, which is indeed observed in most cases (See Table 3.16). However, the 
degree of enhancement of the lifetimes and the quenching efficiency of oxygen on 
the label varies with the site of attachment of the label on the biomolecule, 
probably due to different affinities of the binding sites towards various labels 
involved. Moreover, the specific conformation of the biomolecule at the binding 
site and hence the local environment surrounding the label would appear to be an 
important determining factor in the degree of enhancement and sensitivity of the 
lifetimes. As an example, one can compare and contrast the lifetimes of a side- 
chain modified and a site-specific modified biomolecule when aerated and
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degassed. For example, the longer lifetime of a label bound to the side chains of 
PLL i.e. [Ru(L-L)2NCSphen]2+ is more enhanced but less efficiently quenched than 
that of a label bound to the end of the polymer chain i.e [Ru(L-L)2NH2phen]2+. 
Furthermore, the longer lifetimes of the conjugates, notably those of BSA are much 
less effectively quenched by oxygen than those of the unbound labels. This supports 
the former evidence that the spectroscopic properties of the labels are greatly 
affected by the close approach of the biomolecules.
An important phenomenon noted for these conjugates however, is the fact 
that the degree of conjugation actually affects the longer lifetime of the label. This 
is most evident on analysing the lifetimes of conjugates of similar nature but with 
different numbers of labels covalently bound. One example is 
[Ru(phen)2NCSphen]2+:PLL whereby lifetimes of 1200 ns and 370 ns are noted 
with 15 labels bound while lower lifetimes of 810 ns and 300 ns are obtained with 6 
labels bound. This denotes the notable effect of the loading of label on lifetimes of 
certain conjugates, particularly the longer lifetime, and indicates that this 
phenomenon may actually be a primary contributing factor for the lower lifetimes 
of [Ru(L-L)2NH2phen]2+:PLL (1-3 labels) compared to [Ru(L-L)2NCSphen]2+:PLL 
(12-15 labels). However, the sensitivity of the lifetime and quenching efficiency of 
the label to the conformation of the biomolecule and/or the local environment of 
the label will be explained and discussed in greater detail in chapter 5.
Another consideration with such lifetime studies is (3) an increase in the 
energy gap between the emitting state and the metal centred deactivating states of 
the label upon binding to the biopolymer, the extent of which may vary between 
labels. This proposal may explain why, on binding various types of label to the 
same binding sites on say BSA, the lifetimes of certain labels are more significantly 
affected than others. As well as (1) and (2), the further increase in lifetime observed 
for such conjugates may be consistent with differences in the spectroscopic 
characteristics of the excited state complex. A change in the term Ajexpf-AE/RT) 
which describes the population of the anti-bonding d-d state may lead to the 
inhibition of the deactivating pathway due to the MLCT—»dd transition. To
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investigate this proposal, temperature dependent lifetime analysis would be 
necessary, which was not actually carried out, as low temperature work on aqueous 
samples is very difficult.
A more likely explanation however, for the striking lifetimes of [Ru(L- 
L)2NH2phen]2+ and [Ru(L-L)2NCSphen]2+ bound to BSA is the contribution of non­
covalent binding of the more hydrophobic labels to the longer lifetime. As already 
mentioned, the presence of the bulkier and more hydrophobic ancillary ligand dpp 
leads to greater stacking capacity and stronger electrostatic interactions of the labels 
with biomolecules. Hence, the most enhanced lifetime may be a composite of 
several decays, emanating from covalently and electrostatically/intercalatively 
bound labels at different locations along the protein molecule. This suggests that an 
electrostatically bound label may possess similar photophysical properties to the 
covalently bound label.
Spectroscopic characterisation of the protein-bound labels has already 
indicated significant electrostatic interactions between the more hydrophobic labels 
and the protein BSA. Indeed, the possibility of intercalative binding cannot be 
dismissed. As mentioned earlier, on decreasing the ionic strength of the buffers in 
the conjugation reactions, it is possible to reduce electrostatically bound labels to 
BSA. To study the effect of non-covalently bound Ru(II) on the lifetimes of the 
BSA-bound labels, the lifetimes of the conjugates in both 0.01M and 0.10M 
carbonate buffer are listed in Table 3.18 on page 154.
Significantly as anticipated, the [Ru(dpp)2] based conjugates are the only 
ones whose lifetimes vary significantly with ionic strength and these same labels 
bound to PLL or PLGlu do not show such sensitivity to ionic strength changes. On 
removing much of the electrostatically bound ruthenium by decreasing the ionic 
strength of the buffer throughout, notable decreases in lifetimes are found for the 
corresponding conjugates, indicating their contribution to the longer lifetime, in 
particular. However, this effect could be predominantly due to the greater efficiency 
of dialysis in removing the loosely bound label in lower ionic strengths and hence 
the lower lifetimes resulting from lower conjugation ratios.
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The next debatable question, the nature of the shorter lifetime of the 
protein-bound labels has already been addressed briefly. Again, the main 
possibilities include the presence of unbound label or a non-covalently bound form 
susceptible to quenching, probably of an electrostatic nature. The presence of a 
quenched bound species would be the most likely explanation, based on the 
assumption that dialysis would have removed most of the unbound ruthenium. 
However, on using size exclusion chromatography to determine the purity of the 
bio-conjugates prepared, although most conjugates were determined to be at least 
90% pure, there was in most cases still small amounts (< 5%) of unbound labels 
which had not been removed even by extensive dialysis. However, even for these 
samples, only approximately 70% of the decay emanates from the longer lived 
species, and so it is unlikely that these minute impurities are the sole reason for 
double exponential decay kinetics displayed by such conjugates. Dialysis would 
appear to be least effective in the removal of the more hydrophobic molecules, 
notably the labels [Ru(dpp)2NH2phen]2+ and [Ru(dpp)2NCSphen]2+. For this reason, 
buffers of lower ionic strengths were used throughout the whole conjugation 
procedures to further purify such conjugate solutions. Interestingly, the shorter 
lifetimes of most of the conjugates studied appear to be much less effectively 
quenched by oxygen than those of unbound label, further indicating a quenched 
bound form, Nevertheless, the possibility that the short lifetimes of the conjugates 
are partly due to unbound label cannot be dismissed. For the majority of conjugates 
prepared, the longer lived emitting component constitutes between 60% and 80% of 
the total decay. However, the behaviour of the shorter lifetimes varies with the 
protein and so its nature appears to be quite complex. It is more likely that the 
shorter lifetime is primarily due to unbound label interacting in some form with the 
protein, most probably in an electrostatic manner. Although the PLL and PLGlu 
conjugates do not appear to interact electrostatically in a significant way, there are 
probably still some weak interactions taking place, particularly with the negatively 
charged PLGlu polypeptide.
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Effect of protein binding site.
( l )B S A
The lifetimes obtained for the BSA-bound labels, bound to three different sites-(l) 
the lysine residues; (2) the glutamic acid residues; and (3) the carbohydrate moieties 
are quite similar, although in all three cases, the longer lifetimes of the complexes 
bound via the lysine residues are slightly longer than via the other two binding sites. 
This may be due to the various environments of the different binding sites. Glutamic 
acid and asparagine residues, to which it is assumed that the carbohydrate moieties 
are attached, are non-polar charged amino acids, lysine being basic while the other 
two are acidic [10]. The difference in charge of the binding sites on binding of the 
postively charged Ru complex may result in some sites being more hydrophobic than 
others and hence more sheltered in the protein interior. Albumins, being globular 
proteins, undergo compact folding with very little internal space for water molecules, 
whereby much of the hydrophobic R groups on the amino acid side chains are 
situated in the interior, and the vast majority of the hydrophilic R groups are located 
on the exterior. However, all the amino acids chosen here as binding sites are 
relatively hydrophilic and the difference in lifetimes may be due rather to the higher 
number of labels bound to the lysine residues. This is consistent with reports that the 
lifetimes of such complexes seem to depend on the affinity of the medium (in this 
case, the side groups of amino acids) for the hydrophobic ligands of the labels. The 
amino groups of the lysine residues of BSA are indeed the most reactive towards 
modification [1, 17], Preliminary studies showed that for equivalent conjugate types, 
the lifetimes of the more extensively labelled biomolecule are accordingly higher, 
thereby rationalising the higher lifetimes of the more extensively labelled lysine 
residues. Another contributing factor may the greater influence of electrostatically 
bound label due to the longer chain length of lysine residues.
All three types of BSA conjugates are equally influenced by the removal of 
oxygen, with slight increases in both lifetimes apparent. As anticipated, the lifetimes
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are less influenced than that of the free label, probably due to sheltering and their in­
creased rigidity when bound to proteins. Interestingly however on oxygenating the 
samples, much more efficient quenching of labels bound to the lysine residues is evi­
dent. The higher quenching rates would be explained in terms of the longer side 
groups of lysine residues, which would render the labels more accessible to the 
quenching effects of oxygen, in particular
(2 ) PLL
On comparing the lifetimes of the complexes bound to the lysine residues 2a to those 
bound to the terminal groups of the polypeptide chain ld, one can see from Table 
3.16(b) that in most cases both lifetimes are higher when bound to the lysine residues 
Again, this may be merely due to the more extensive binding of the labels to such 
sites. Also, the complexes bound to the end of the chains display almost single expo­
nential decay kinetics, with the higher lifetime incorporating 90% of the decay, in 
some cases. This may be due to the smaller number of terminal groups and hence the 
more unique environment of the label. These complexes also appear to be more ef­
fectively quenched by oxygen, perhaps because they are not as susceptible to the 
sheltering effect of the side groups of the lysine residues. The shorter lifetime shows 
little change on degassing, which would suggest this is not unbound label, which is 
itself very effectively quenched by oxygen. Again, however, due to the complexity of 
the decay of such conjugates and the problems associated with their analysis, a 
definite explanation is impossible.
(3) PLGlu
On comparing the lifetimes of the complexes when bound to the glutamic acid resi­
dues to those bound to the end of the chains, the lifetimes are similar for both sites, a
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sites, a contributing factor possibly being the low labelling efficiency of both sites. 
However, the complexes bound to the end of the chains are more efficiently 
quenched by oxygen, as for PLL, as well as the longer lifetime contributing to upto 
90%. This again would be anticipated due to the regular primary structure of PLGlu 
and the positioning at the end of the chain which is more open than the side groups 
of the glutamic acid residues. Overall however, the longer lifetimes are more 
sensitive to oxygen quenching than those bound to BSA as anticipated due to the 
absence of sheltered pockets in the synthetic biomolecules.
3.3 Conclusion.
The ultimate objective of work carried out in this chapter was the extensive 
characterisation of Ru(II) polypyridyl complexes when covalently bound to proteins 
prior to investigation into their potential as fluorescent probes capable of monitoring 
conformational variances of the bound biopolymers. This is essential as extensive 
knowledge of the spectroscopic and luminescent properties of both the free labels 
and those covalently bound to the proteins as well as their purity is a prerequisite to 
understanding their probing characteristics.
Firstly, both the unbound ruthenium polypyridyl complexes and their protein- 
bound forms are characterised using chromatographic and spectroscopic techniques. 
A chromatographic procedure based on size exclusion is developed to determine the 
purity of the resultant bio-conjugates and hence this proves useful in determining the 
success of the various conjugation reactions attempted. Such studies indicate that 
although some conjugates still contain small amounts of unbound label, not 
quantified but approximately < 5%, this would not appear to have a significant effect 
on the probing capabilities of the samples.
The electronic measurements o f the labels and their protein-bound forms 
confirm earlier work done, namely that absorption and emission characteristics of the
162
labels are not significantly affected by such binding. However, as reported in the 
literature [17] significant changes in the decay behaviour of the labels are noted on 
conjugation in the form of double exponential decay kinetics and enhanced 
lifetimes. However, it is important to note that the multi-exponential analysis of the 
decay lifetimes of the conjugates is merely a mathematically based solution and the 
elucidation of two lifetimes for most bioconjugates may be a result of the averaging 
of several lifetimes. These same studies indicate that the enhanced lifetimes of the 
conjugates are indeed mainly due to both the decrease in vibrational activity of the 
label when held in the more rigid environment of a biomolecule, and the protection 
of the label from quenching effects in the sheltered environments of the 
biomolecules. This would explain why the conjugates of BSA, a rigid and compact 
globular protein, with many sheltered pockets, yield the most enhanced lifetimes, 
least affected by quenching effects of oxygen, in particular. Our studies further 
suggest that the variances in the decay behaviour of various protein-bound labels 
are indeed due to the nature of the specific modification sites chosen on the 
biomolecules, that is the local environment of the biomolecule, as well as the 
absolute conformation of the bio-polymer in question. This strongly indicates that 
the decay kinetics of the label will be susceptible to conformational variances of the 
bound biopolymers and therefore give rise to their probing potential.
The most dramatic increases in lifetimes are noted for [Ru(dpp)2NH2phen]2+ 
and [Ru(dpp)2NCSphen]2+ bound to BSA and this appears to be partly due to 
extensive electrostatic interaction between these hydrophobic molecules and the 
protein. The shorter lifetime appears to be due to a quenched bound form of label, 
probably bound in a non-covalent manner. The possibility of intercalation taking 
place also cannot be dismissed.
Labels are bound to various sites on three biomolecules, BSA, PLL and 
PLGlu. Very efficient binding is achieved on the natural protein BSA, whereby the 
lysine residues are found to be the most accessible and reactive, as anticipated. Low 
labelling efficiencies are achieved on both synthetic polypeptides, PLL and PLGlu, 
the reasons for which are not definite but which appear to be due to the marginal
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stability of their conformational forms, and hence the lower accessibilty of the 
binding sites.
A method is developed to selectively modify terminal groups on the 
biomolecules as well as their side groups permitting the comparison of the potential 
of site-selective and side-chain modification reagents as probes of protein structure, 
subsequently dealt with in the following chapter.
The eifect of reaction conditions, such as pH, temperature, and reagents on 
the extent of various conjugation reactions is studied. This study confirms the fact 
that optimum pH and temperature had been originally chosen for all conjugation 
reactions studied and that any deviations from these optimum conditions dramatically 
reduce the number of binding sites labelled, possibly due to induced 
unfolding/conformational variances of the biomolecule. However, no definite 
information regarding the stability of the biomolecules involved could be deduced 
without the simultaneous use of other characterisation methods commonly used for 
proteins.
In brief, the groundwork behind understanding the spectroscopic and 
luminescent properties of the bio-conjugates has been accomplished, allowing us to 
move on to study and compare the potential of these various labels as probes, 
capable of monitoring conformational variances these biomolecules undergo in 
solution, which is addressed in the next chapter.
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The pH sensitivity of the absorption and emission spectra of protein- 
bound Ru(H) polypyridyl 
complexes.
Chapter 4.
1 6 6
4.1 Introduction.
In earlier chapters, we have described various procedures involved in labelling poly­
amino acids and proteins with ruthenium based fluorescent complexes and also have 
characterised all protein-bound complexes prepared. In the remaining chapters, our 
aim is to investigate the potential of such fluorescent labels to monitor conforma­
tional changes which the bound biomolecules undergo in solution, thereby acting as 
probes of their dynamic behaviour. In this chapter the sensitivity of the absorption 
and emission spectra to conformational changes of the bound biomolecules, induced 
by pH changes and chemical denaturants are monitored, while chapter 5 will deal 
with the potential of the decay lifetimes of the labels as probes.
However, in order to understand how the label may function as such a probe, 
a discussion on the properties of a good fluorescent probe is undertaken and the 
particular advantages displayed by ruthenium complexes will be summarised. Finally, 
a summary of the physical properties of the biomolecules in solution is necessary in 
order to visualise the phenomena we wish to monitor before an in depth study of 
their probing capabilities are discussed.
4.1 . 1 . Properties o f a goodfluorescent probe [I].
As the aim of this thesis is to use ruthenium polypyridyl complexes as fluorescent 
probes, one must consider the requirements for such probes, thereby ensuring the 
applicability of such complexes in our area of interest;
(1) The fluorochrome should possess chemical groups which will form stable 
covalent bonds with protein molecules or be easily converted to such a 
reactive form without destroying the fluorescent structure. It should not 
possess any other groups which might react with the primary reactive group 
or give any unwanted by-products.
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(2) It should be easy to separate unbound from the bound fluorescent probe.
(3) The probe should possess a high quantum yield of fluorescence, which 
should not decrease upon conjugation.
(4) It should be possible to conduct the conjugation reaction under mild 
conditions so that the conformation of the biomolecule is not disturbed.
(5) The probe should be photo stable/stable under normal storage conditions 
not differing materially in its properties from the unconjugated protein.
(6) The probe should exhibit a large Stokes shift so that the scattered 
analysing light does not interfere with the signal.
(7) The conjugation procedure should be as simple and as rapid as possible.
The incorporation of spectroscopic and fluorescent labels has been 
extensively investigated and developed in recent years, in particular to characterise 
certain structural features of proteins. This is due to extensive attempts to substitute 
radioactive labels with nonradioactive counterparts, the prime examples including 
enzymatic, fluorescent and spectroscopic labels [2], Although radioactive labels are 
quite versatile and can be detected at very low concentrations, they are expensive, 
hazardous, and their use requires sophisticated equipment and trained personnel [3], 
The choice between fluorescent probes or radioactive isotopes is governed 
by the type of information sought. Where the material to be detected is present in 
minute amounts, radioactive labelling would normally be chosen, due to the
decreased sensitivity obtained with fluorescence, partly due to the samples own
fluorescence (autofluorescence) [3], The intense background has however been 
overcome by the use of time-resolved fluorescence and labels with a long emission 
decay, including some Ru(II) polypyridyl complexes [4], Some other problems 
associated with fluorometric analysis include the scattering of light and quenching of 
the fluorescence by oxygen, heavy atoms and concentration quenching due to the 
location of probes in close proximity to each other [3, 5],
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Nevertheless, for most purposes, the greater convenience and the greater 
safety of the fluorescence technique is preferred. A commonly used label for pro­
teins, such as insulin, is the dye fluorescein isothiocyanate (FITC) extensively used in 
various fluorescence immunoassay methods and in fluorescence microscopy. How­
ever FITC is susceptible to fading in the presence and absence of oxygen, found to 
be due to organic peroxides, hydroperoxides and oxyradicals [4], Intensely fluores­
cent conjugates have also been prepared from l-dimethylaminonaphthalene-5- 
sulphonic acid (DANS) and rhodamines which show a less intense fluorescence than 
FITC conjugate but are more stable to photobleaching (fading) [6], Lanthalide 
chelates due to their much extended decay lifetimes and the large Stokes shift they 
exhibit are also used in time-resolved fluorimetry [7],
Fluorescence is used, as well as for labelling biomolecules, in immunology, 
mainly in fluorescence microscopy for studying various types of cells, tissues, bacte­
ria, etc. [8], Usually the sample to be analysed is detected with an antibody which is 
labelled with a fluorescent species. Quantitative fluorescent immunoassay techniques 
include fluorescence polarisation methods, fluorescence quenching methods, fluores­
cence enhancement techniques and fluorescence excitation transfer methods.
Ruthenium polypyridyl complexes fulfil the requirements of a good fluores­
cent probe, in addition to absorbing strongly in the visible region and yielding long 
lived emission, rendering them suitable as fluorescent probes of biomolecules. Varied 
methods of binding such complexes to enzymes, antibodies and other proteins have 
found important applications in their labelling and in fluorometric immunoassays. 
However, these will be discussed in greater detail in chapter 5.
4.1.3 Physical properties o f  poly-amino acids.
Polypeptides are long chains of amino acids bound together while poly-amino acids 
are basically simple models of proteins with a regular primary structure ie. amino 
acid composition. Proteins are much more complex with up to 20 different amino
acids bound together. For this reason, much work has been carried out on studying 
and understanding polypeptide structures in order to further our understanding of the 
complex nature of protein structure and properties.
The most natural state of a polymer is considered to be a random coil con­
formation. However, other conformations will be adopted if sufficient interactions 
are possible, within or between molecules [9], Many synthetic poly-amino acids 
adopt a few such regular conformations that are also found in natural proteins re­
sulting from the regularity of the primary structure. In brief, the secondary structure 
of polypeptides are basically structures due to hydrogen bonding on forming a three 
dimensional structure, examples being a-helices and P-sheets which are illustrated in 
Figure 4.1.
The a-helix is the most predominant of polypeptide regular secondary struc­
tures with the atoms of the backbone packed closely together, making very favour­
able Van der Waals contacts. Both a-helices and P-sheets are involved in main chain 
amino and carboxyl groups participating in hydrogen bonds to each other, with a- 
helices having 3.6 residues per turn and hydrogen bonds between carboxyl groups 
and the amino groups three amino acids ahead of it, thus leaving only the first amino 
group and the last carboxyl group not involved in hydrogen bonds [9], This leads to 
a net dipole that gives a partial positive charge at the amino end and a partial nega­
tive charge at the carboxyl end. This is known to be the most stable secondary 
structure for proteins [10], The polypeptide properties stabilise the molecule into this 
more rigid form by (a) hydrogen bonds, (b) ionic bonds and (c) hydrophobic interac­
tions [9],
The side chains project out of the helix conformation and do not interfere 
with the stereochemical properties of the a-helix. Although considered the most 
natural conformation for polypeptides, it is, however only marginally stable in solu­
tion and amino acids differ in their propensity to adopt this conformation [11], For 
example, alanine, glutamine and methionine are good a-helix formers while serine, 
proline, glycine and threonine are very poor.
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In general, uncharged groups on the side chains permit the formation of 
stable a-helical units while charged groups of like sign, such as the COO" ions of 
carbonyl glutamyl residues and the NH3+ groups of the lysyl/arginine residues cause 
the destabilisation as a result o f charge repulsion. Although apparently rigid 
structures, a-helices are usually dynamic systems in solution, being rapidly formed
and unfolded 10^ to 10^ times/sec. a-helix to random coil transitions can occur in 
polypeptides upon changing temperature or solvent, or by altering the pH of the 
medium, where the equilibrium can be shifted from a totally random to totally helical 
form [10].
to
Figure 4.1. Structural form s o f  (a) a-helix and (b) parallel (3-sheet [11].
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This is a very abrupt and fast process (10‘5 to 1 0"^ Sec) and is a co-operative 
system. The initiation of the a-helix in a random coil is the slowest and energetically 
the most unfavoured step, whereas the subsequent growth of the a-helix nucleus is 
rapid and relatively favoured. Owing to the difficulty of nucleation, individual 
polypeptide molecules tend to be either entirely helical or disordered [11].
By gradually varying the nature of the medium, say by adding strongly 
interacting solvent (eg. trifluoroacetic acid) or pH changes in aqueous solution, or a 
change in temperature, a sudden change in physical properties results in a 
conformational change in the polymer molecule from the rigid helical structure to the 
non-rigid random coil structure [10].
Most synthetic polypeptides can be induced into a-helices by dissolving in 
dichloroacetic acid whereas [3-sheets are favoured in solutions of formic acid [10], 
Where side chains can ionise, the pH is important as electrostatic repulsions drive the 
ionised form into the random coil state where the distance may be maximised [10], 
For example, poly-l-lysine is found to be in the random coil conformation below pH 
10. In explanation of this phenomenon, the pKa of the side group of lysine in poly-l-
lysine is pH 10 so that, above this pH, all the amino groups are deprotonated, (See 
equation 4.1) thus allowing a-helical formation (due to the absence of charge
repulsion of the NH3 + groups) [11].
NH3+ o  NH2 + H+ (4.1)
The effect of pH on the secondary structure of PLL, monitored by changes in the 
polypeptides optical rotation is illustrated in Figure 4.2. PLL conjugates also have 
varied applications from their use as polar tracers for cell lineage tracing in 
embryonic cells [12], to displaying antiviral and anticancer activity [13], to acting as 
powerful agents for aggregation of blood platelets [14],
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Poly-l-glutamate (PLGlu) also possesses an ionisable group on its side chain, 
in this case a carboxylic acid on the giutamic acid residues.
COOH o  COO' + H+ (4.2)
The pKa of the carboxyl group is pH 4.8 so above this pH, the COOH group is
converted to COO' and the random-coil conformation would then be favoured. This 
correlates well with the fact that PLGlu is found in the helical form at pH 4 whereas 
at pH 7 the random coil form is favoured [15],
pH
Figure 4.2 Effect o f pH  on the secondary structure o f  PLL.
173
The aim of the work in this thesis is to investigate the ability of ruthenium 
polypyridyl labels to monitor such structural changes in biomolecules, via their 
luminescent properties, under conditions at which conformational changes of the 
bound biopolymer in solution are induced. In this chapter, the effects of pH and 
chemical denaturants on the energy and intensity of the absorption and emission 
spectra are investigated.
Similar studies were carried out on a natural protein, bovine serum albumin, 
of which much less is known of its pH dependent dynamic behaviour. As expected, 
the interpretation of the results is a lot more difficult due to the complexity of its 
structure. As well as various forms of secondary structures present, proteins have 
tertiary or three dimensional structural forms, as well as undergoing a folding 
process, constituting their quaternary structure.
4.1.3. Physical properties o f proteins.
Protein structure is usually discussed in terms of four levels. The primary structure 
is the amino acid sequence while the secondary structure is any regular local 
structure of a linear segment of polypeptide chain. More specific to natural proteins 
are the tertiary structure i.e. the overall topology of the folded polypeptide chain 
and the quaternary structure which is the aggregation of the polypeptides by specific 
interactions [9],
The molecular state in real polymers differs from the hypothetical 
unperturbed state, in that such polymers have finite dimensions as well as attractive 
and repulsive forces, both within the molecules and with the solvent [11], Most 
proteins have helical regions of varying length interspersed with regions of random 
coil. Most proteins of biological significance differ dramatically from synthetic 
polypeptides of random or simple repetitive conformation and from structural 
proteins. These globular proteins have a smaller diameter in solution, being nearly 
spherical in shape. These physical properties do not change in a continuous manner
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as the environment is altered, for example, by changing temperature, pH, pressure, 
as do random polypeptides. Instead, they exhibit little or no change, until a point is 
reached where there is a dramatic change in physical properties, and invariably a 
loss in biological function. This leads to protein denaturation, which leads to a 
structure much more like a random polypeptide than like the original protein.
The secondary structure in proteins is generally somewhat distorted. 
Generally, there are various classes of secondary structures found in proteins. 
Amino acids with branched or bulky side chains, such as valine, ileucine and 
threonine, or aromatic rings, such as phenylanaline, threonine and tryptophan occur 
most frequently in (3-sheets [11], The remainder most often occur in a-helices, 
except for those with short polar (serine, aspartine, aspartate) or special side chains 
(glycine, porcine) most often found in reverse turns.
As with polypeptides, the forces involved in the maintenance of secondary 
and tertiary structure include interpeptide and side chain hydrogen bonds, ionic 
bonds and hydrophobic bonds [15], It is believed that there is a relationship 
between primary and higher order structures of proteins. As a result, the restoration 
of proteins to their native states following the initial loss of native structure, 
indicating a non-random process is observed.
As the distribution of the a-helix is one of the most important features of the 
process of protein denaturation [10], poly-amino acids are simple models of 
proteins and are ideal substrates for model processing of protein denaturation. The 
aim of folding polypeptide chains is to arrive at a more stable structure in aqueous 
solution, collapsing into a conformation where hydrophobic interactions dominate 
[11].
The stable conformation will remain until perturbed by a change in conditions. As 
the folded conformation of certain proteins is only marginally stable under the best 
of conditions, it may be disrupted merely by change in environment, a rise in 
temperature, variation of pH, increase in pressure or addition of denaturant. Thus, 
there are many conformations between the native state of a protein molecule and 
that in which the protein chain is completely denatured.
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As the environment is altered towards conditions favourable for unfolding, 
there is initially little change with increases in flexibility, but within a rather limited 
range of conditions it then becomes fully unfolded [11]. For example, nuclease 
experiences acid-induced unfolding over a pH range of 0.30 pH units. As for 
random coil to helix transitions in model polypeptides, this is a co-operative 
transition where each of a number of groups can be ionised only if all do so 
simultaneously. Unfolding is a two state phenomenon with only fully folded and 
unfolded states present.
Denaturation does not require the rupture of covalent bonds i.e. cleavage of 
the primary structure and hence it is sometimes possible to reverse denaturation by 
the removal of the agent. It rather involves the disruption of some folded 
conformation of the polypeptide chain upon which it's biological properties are 
often critically dependent [9], A particular treatment of a protein may, for example, 
drastically alter biological activity though extensive physical measurements reveal 
slight or no change in structure. Examples of denaturation by heat is frequently 
irreversible but by urea is usually reversible [15],
When a protein has substantial net charge, electrostatic repulsion between 
ionised groups might cause unfolding since such repulsion would be minimised in 
the unfolded state. The unfolded state may approach random-coil state for 
disordered polypeptides for urea, nonrandom conformation is apparent for acid and 
heat denatured states while denaturation by ultraviolet irradiation, organic solvents, 
guanidinium chloride, LiBr and detergents may lead to very different denatured 
states [15].
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4.2 Results and Discussion.
From the above discussion, the complexity of the dynamic behaviour of proteins in 
solution is evident. Nevertheless, the significant effect of parameters such as pH, 
solvent and temperature on the physical properties of biomolecules has been 
emphasised. This chapter deals with inducing conformational changes in the 
proteins labelled with ruthenium complexes by varying the pH in particular but also 
temperature and reagents, and monitoring corresponding variations in the 
spectroscopic properties, namely the energy and intensity of the absorption and 
emission spectra of the bound label. In this respect, it will be possible to deduce the 
potential of these fluorescent complexes as probes of biological structures. The 
unbound ruthenium complexes are used as controls to ensure that any variations in 
the spectroscopic properties o f the bound label are indeed due to conformational 
variances of the bound protein and not merely due to the behaviour of the free 
complexes.
4.2.1. pH  sensitivity o f  absorption spectra.
As mentioned earlier, the absorbance of UV light is not very sensitive to 
conformation or environment, and so is limited in its potential to follow changes in 
the folded conformation of a protein in solution [11]. Nevertheless, the polypeptide 
backbone absorbs in the UV region 240nm, with the absorbance intensity of the 
protein dependent to some extent upon the conformation on the biomolecule. 
Folded proteins are also known to exhibit significant absorbency in the UV region 
250-300nm [9], Figure 4.3 illustrates the absorption spectrum of BSA at various 
pHs, verifying the pH sensitivity of absorbency of proteins at 240 nm, presumably 
due to conformational changes/unfolding of the protein under such extreme 
conditions. Although variations are apparent these are not sensitive enough to yield 
information on conformational changes and it is exactly for this reason that the
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highly fluorescent ruthenium complexes absorbing strongly in the visible region were 
bound to the biomolecules.
Wavelength (nm.
Figure 4.3. p H  sensitivity o f the absorption spectrum o f BSA.
Prior to studying the pH sensitivity of the absorption spectra of the protein- 
bound labels, a study of the variability of absorbencies of the unbound labels in the 
range 290-700 nm was studied from pH 2 to pH 12 both to investigate any evidence 
of protonation/deprotonation effects and to check the stability of such complexes 
under such conditions. This has the additional purpose of ensuring that any changes 
in the absorption spectra of the protein-bound labels are not merely due to the 
decomposition of the free label. Figure 4.4 illustrates the effect of pH on the 
absorption spectrum of [Ru(bpy)2NH2phen]2+ while Figure 4.5 depicts the pH 
sensitivity o f the absorption spectrum of the isothiocyanate derivative 
[Ru(bpy)2NCSphen]2+.
178
Figure 4.4 Effect ofpH  on the absorption spectrum o f  [Ru(bpy) ?NH?phenf~.
Wavelength (nm.)
Figure 4.5 p H  sensitivity o f the absorption spectrum o f [Ru(bpy) 2NCSphen]2+.
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From Figure 4.4 above, it is evident that the absorbencies of the complexes 
[Ru(L-L)2NH2phen]2 r in the visible region are almost totally insensitive to pH in the 
range pH 2-12 in that the wavelengths and intensities of maximum absorbance are 
not shifted. This indicates the stability of such complexes even at pH extremes but 
also provides no evidence of protonation of the amino group present on one ligand 
as may be expected. The UV/vis spectra of the isothiocyanate derivatives on the 
other hand reveal a change in form in terms of the intensity of absorbance peaks and 
the energy of the peaks on increasing the pH as depicted in Figure 4.5. Above pH 9, 
the energy of the absorption spectrum in the MLCT and MC region changes and the 
form appears to return to that of the amino precursor, indicating that decomposition 
of the complex to its amino precursor may take place under such conditions. This 
correlates with reports in the literature [17], that the complexes are not very stable in 
aqueous solution reverting back to the precursor amino complex under such 
conditions.
In contrast both the energy and intensity of the absorption spectra of both 
[Ru(bpy)2COOH2bpy]2^  and its ester form i.e. [Ru(bpy)2(esterbpy)]2+ are very 
sensitive to pH, due to protonation/deprotonation effects. On increasing the pH of 
[Ru(bpy)2COOH2bpy]2+ above pH 2, the form of absorbance spectrum changes with 
the main absorbance peak of the label increasing in intensity while its wavelength 
shifts from 460 nm to 480 nm. This phenomenon has already been reported for 
similar acidic complexes in the literature [16], Such characteristics are explained in 
terms of the presence of the carboxylic acids on the label. The pKa of these groups is 
approximately 2, and above this pH the two carboxylic acids present are in the 
dissociated state, displaying different spectroscopic behaviour to the non-dissociated 
state. The ester form displays similar unusual pH dependent spectroscopic behaviour 
shown in Figure 4.5. However the increase in intensity and shift in absorbance 
maximum occurs above pH 3, indicating a shift in the pKa of the carboxylic acid, 
perhaps due to the modification of the neighbouring group. A possible explanation 
for the protonation influences observed in the absorption spectrum of the “ester“ 
would be the hydrolysis of the ester in acid and/or base leading to its decomposition
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to its acidic precursor. However the reversibility noted for the changes in the 
absorption spectra imply otherwise, indicating the stability of the ester under such 
conditions. Rather, the esterification of only one of the reactive carboxylic acids 
appears to be the cause of such absorbencies. The pH sensitivity of the UV spectrum 
of the “ester” is depicted in Figure 4.6.
• v  v -  ——-------■ —     —-------------------—-—  
2 9 0 . 0  4 0 0 . 0  6 0 0 - . 0  8 0 0
Wavelength (nm.)
Figure 4. 6  Effect o f pH  on the absorption spectrum o f [Ru(bpy) 2esterbpy f +
As previously stressed, upon conjugation the visible region in the absorption 
spectrum of ruthenium complexes is not notably affected by the absorbencies due to 
the bound biomolecules, as these occur in the UV region. Absorption spectra were 
obtained for the various protein-bound labels from pHs 2-12. These were run for the 
following purposes; (1) to observe how the binding of the protein to the relevant 
functional group (NH2, NCS, ester) o f the label influences the ligand on the labels
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absorbencies due to their protonation effects; (2) to ensure that decomposition of 
the bioconjugate does not occur at pH extremes and (3) to observe the sensitivity of 
the labels absorption in the visible region to acid-induced conformational variances 
of the bound biomolecule. Figure 4.7 depicts the absorption spectrum of 
Ru(dpp)2NH2phen:BSA upto 1200 nm where absorbencies due to the protein may 
be evident while Figure 4.8 illustrates the pH sensitivity of the absorption spectrum 
of Ru(phen)2NCSphen:PLL, restricted to the visible region where the label absorbs 
strongly (290-700 nm). As for the unbound label, the absorbencies of the protein- 
bound label Ru(dpp)2NH2phen:BSA reveal very little sensitivity to pH with the 
absorption peaks merely appearing broader and of different intensity at lower pHs. 
Otherwise, the effect of the protein binding on the UV-visible spectrum of the label 
is negligible indicating as expected that the absorbencies of the label are not 
sensitive to any conformational variances of the protein. The spectrum of 
Ru(phen)2NCSphen:PLL in Figure 4.8 shows that the variations for the unbound 
label observed for the isothiocyanate at 350 nm possibly due to its decomposition 
are no longer apparent. This would be anticipated as the binding of the NCS group 
to the protein would lead to its stabilisation. Slight variations in the absorption 
spectra of the protein-bound labels are observed particularly at 300-400 nm but 
appears to be merely due to the turbidity of the protein solution at certain pHs.
It is apparent from these spectra that the covalent bonds formed between 
label and biomolecules are stable and resistant to pH extremes. This is a 
prerequisite to their use as probes of biological structures, particularly when the 
acid-induced conformational variations of the biomolecules are to be followed. 
Finally, as suspected, although some variations in absorption intensities in the 
ultraviolet region are noted due to conformational effects of the proteins, variations 
in the visible absorbencies of the protein-bound label are almost negligible, 
deterring their use as a probe in the detection of their acid-induced conformational 
variances.
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Wavelenqth (nm.)
Figure 4.7 pH  sensitivity o f  absorption spectrum ofRu(dpp)2NH2phen:BSA.
2 9 0 . 0  4 0 0 . 0  6 0 0 . 0  800
Wavelength (nm.)
Figure 4.8 pH  sensitivity o f  absorption spectrum ofRu(phen)2NCSphen:PLL.
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4.2.2. pH  sensitivity o f  the emission spectra.
Proteins are the only biopolymers that are known to fluoresce, due to the presence of 
the natural fluorophores tyrosine and tryptophan [18], Such residues have a low 
quantum yield and are very sensitive to the polarity of the surrounding solvent with 
the emission maximum for tryptophan ranging from 330 nm in a hydrophobic 
environment to 355 nm in water [18]. Recently it has been deemed possible to reveal 
protein dynamics by fluorescence methods involving anisotropy measurements and 
fluorescence quenching [18], However, as we are interested in the fluorescence of 
the labels bound to proteins the molecules are excited at 450-470 nm and the 
emission observed at 600-620 nm is that of the label with no interference from the 
unmodified protein.
For reference however, the influence of pH on the emission characteristics of 
the unmodified proteins was firstly examined. Figure 4.9 depicts the effect of pH on 
the emission spectrum typical of BSA whose emission maximum occurs at 320-360 
nm. One notes that the intensity of the emission is very low. As expected, the 
emission intensity and wavelength varies from acidic to basic pHs with 
conformational changes possibly due to unfolding apparently inducing the variations 
at pH extremes, particularly striking under alkaline conditions. On the other hand the 
emission spectrum of the synthetic biomolecule poly-L-lysine is less affected by pH 
extremes, presumably due to the fact that PLL does not actually “unfold”, being a 
synthetic biomolecule which has no quaternary structure but rather experiences 
changes in its secondary structure. Indeed, a study of the pH sensitivity of the 
emission intensity of the fluorescence of proteins reveals more clearly the sensitivity 
of their fluorescence to acid-induced conformational changes. The quantum yields of 
the fluorescence of the proteins used in this study are calculated by comparing the 
emission intensity of their fluorescence to that of tryptophan after normalising their 
absorption intensity close to their A^ ax- The pH sensitivity of the intrinsic 
fluorescence of the various biomolecules concerned is tabulated in Table 4.1.
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It is assumed that the sensitivity of the fluorescence intensity of the protein 
bovine serum albumin to pH changes reflect its sensitivity to acid induced 
conformational changes due to the sensitivity of the emitting species to its local 
environment. The emission intensity of BSA is particularly reduced above pH 8, 
indicating structural changes and possibly unfolding at such pHs. This is more 
significant than the drop at acidic pHs, probably due to the fact that BSA is an acidic 
protein and hence would be expected to become fully unfolded at basic pHs. Figure 
4.10 contrasts the effects of pH on the emission intensity of the natural fluorescence 
of proteins and poly-amino acids.
Figure 4.9 p H  sensitivity o f  the intrinsic fluorescence o f BSA.
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Table 4.1 pH sensitivity of the emission intensity of the fluorescence of (a) 
bovine serum albumin, (b) poly-l-lysine and (c) poly-l-glutamate.
Protein Quantum yield of emission (X = 330-350 nm)
pH 2 pH 4 pH 6 pH 8 pH 10 pH 12
Bovine serum albumin 0.22 0.25 0.74 0.48 0.045 0.015
Poly-L-lysine 0.032 0.20 0.20 0.20 0.35 0.75
Poly-L-glutamate 0.10 0.12 0.10 0.12 0.15 0.10
The quantum  y ie ld  va lu es  g iven  are  the em ission  in ten sitie s  o f  the flu o re scen ce  o f  the p ro te in s  
co m p a red  to th a t o f  f r e e  tryptophan  o f  the sam e abso rb a n ce  using  the equation  <j>em =  (As /  A rej)  
w here A  s a n d A ref  are  the in teg ra ted  a rea s  /  h e ig h ts  o f  the em ission  b an d  o f  sam ple  an d  referen ce  
com plex  respec tive ly .
Figure 4.10 pH  sensitivity o f the quantum yields o f  emission o f the proteins (1) BSA
(2)  PLL and (3) PLGlu.
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In general, the fluorescence is less intense for the poly-amino acids. Indeed 
PLL/PLGlu would not be expected to fluorescence as they do not possess tyrosine 
or tryptophan residues the prime fluorescent residues. However, as a wavelength 
not unique to the absorption of such residues was used to excite the proteins, other 
low emissions were picked up. The use of tryptophan as a reference for all proteins 
despite the fact that PLL/PLGlu do not contain these may explain the pH sensitivity 
of the low emission of the synthetic biomolecules. Nonetheless less dramatic pH 
induced variations would be expected as it is not a question of unfolding but of 
local secondary structural changes occurring. These studies merely confirm what 
was anticipated, including the low intensity of the fluorescence of the proteins, the 
difficulty of quantitative analysis and the significant effect of solvent but also the 
sensitivity of the intrinsic fluorescence of proteins to conformational variances.
However, as the fluorescence of the labels is the issue here, the next step 
involved determining the potential of the emission spectra of the labels when bound 
to proteins to monitor their acid-induced conformational variances. Hence the 
emission spectra of the unbound labels are initially studied. The intensities of all 
the emission spectra of the free labels used are quite sensitive to pH while the 
energies of the emission maxima are not shifted significantly. Figure 4.11 illustrates 
how the intensity of the emission of [Ru(dpp)2NH2phen]2+ is at a minimum at very 
acidic pHs. Although the general trend shows the intensity to increase with 
increasing pH, the maximum emission intensity is observed from pH 7-10. 
Furthermore, A,max shifts to a slightly lower wavelength at very basic pHs, although 
the shift is probably within instrumental error (2-4 nm). The decrease in emission 
intensity at acidic pHs which was found to be reversible on addition of base is 
consistent with the effects of protonation of the emitting ligand on the emission 
spectrum for Ru(II) complexes. As variations in the absorption spectrum due to 
protonation effects are not apparent, the possible protonation effects noted in the 
emission spectrum indicate that the excited state of the complex is probably more 
basic than that of the ground state. It would be indeed possible to calculate the 
excited state pKa* of the complex by using the following equation;
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pKa* = pH; + log ( x a/T b )  (4.1)
where pH, is the inflection point of the emission intensity vs pH curve. This is 
called the “apparent pKa* “ as these values need to be corrected if the protonated 
(xa) and deprotonated ( tb) complexes have different emission lifetimes.
Figure 4.12 represents the pH susceptibility of the emission of [Ru(L- 
L)2NCSphen]2+ whereupon a decline in emission intensity is noted at high pHs i.e. 
above pH 10. Again, in correlation with the observations of the absorption spectra, 
this may be due to reversion of the complex back to its amino precursor. However 
the same is probably not true for [Ru(bpy)2esterbpy]2+. Above pH 3, a change in the 
form of the emission spectrum is evident whereby an increase in emission intensity 
and striking shift in emission maximum from 680 nm to 656 nm is observed, again 
indicating the dissociation of COOH. As the pKa of the excited state complex is 
higher than that of the ground state it would appear that the excited state complex is 
less acidic. Again, the variations in the emission spectrum observed are reversible 
with further addition of acid/base, dismissing the possibility of decomposition of 
the complex and further confirming that both carboxylic acids were not successfully 
reacted with the hydroxysuccinimide (see section 2.2.3).
Figure 4.11 pH  sensitivity o f  emission spectrum o f [Ru(dpp) 2NH2phen f +.
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Figure 4.12 pH  sensitivity o f the emission intensity o f  [Ru(dpp) 2NCSphen] +.
Another important issue concerning the emission of these ruthenium complexes is 
the effect of conjugation to proteins on their quantum yield, as a minimal effect is 
desired to render these complexes suitable as fluorescent probes. The quantum yield 
of a compound is defined as the fraction of molecules that emit a photon after 
excitation by the source [19] and is determined by comparing the emission intensity 
of a sample to that of a reference compound whose quantum yield is known, in this 
case [Ru(bpy)3]2+ at a wavelength where both samples absorb equivalently. The 
estimation of the quantum yield of emission of the protein-bound labels and 
comparison to those of the free labels is rendered difficult due to the fact that the 
free label possesses only one emitting species while the protein-bound forms 
display multi-exponential decay kinetics. Therefore, changes in the contributing 
ratios of the two emitting components of the protein-bound labels would influence
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the quantum yield determination and render comparison difficult. However, a brief 
study was carried out to approximate the effect of conjugation on the apparent 
quantum yield of emission of these labels (<j)em).
Firstly, the (j)em of the Ru(II) complexes, unbound and when bound to 
proteins were determined according to the method of optically dilute measurements 
described by Demas and Crosby [19] and as outlined in section 2.4.1. [Ru(bpy)3]2+ 
whose quantum yield is known to be 0.028 is suitable as the reference compound as 
it has no overlap between absorption and emission, is soluble in the same solvents 
(hence there is no need for refractive index correction) [19], and has similar 
absorption and emission spectra to the complexes being studied.
Table 4.2 Effect of protein-binding on the apparent quantum yields of 
emission of Ru(II) complexes in 0.10 M carbonate buffer, pH 9.2.
Complex/Conjugate Quantum yield
[Ru(bpy)2NH2phen]2+ 0.025
[Ru(bpy)2NH2phen] :BSA 0.025
[Ru(phen)2NH2phen]2+ 0.020
[Ru(phen)2NH2phen] :B S A 0.018
[Ru(phen)2NH2phen] :PLGlu 0.024
[Ru(phen)2NCSphen]2+ 0.040
[Ru(phen)2NCSphen] :BS A 0.060
N orm alisa tion  o f  absorban ce in tensity  w a s  ca rr ied  o u t p r io r  to  em ission  m easurem ent.
2
< ie m = 0 . 02S(As/A ref)(ns n^r e p  w here A s  a n d A ref  are  the in teg ra ted  a re a s  o f  the em ission  b a n d  o f  
the sam ple a n d  reference resp ec tiv e ly  a n d  ns  a n d  nref  are  the so lven t refractive  ind ices o f  the 
sam ple  a n d  reference so lu tion s resp ec tiv e ly  [19 ].
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The first point to note is that the quantum yields o f emission of the unbound 
labels at low concentrations are all quite similar i.e. 0.007 to 0.015 which is quite 
low. It is difficult to compare absolute quantum yield values of ruthenium 
complexes when bound to proteins as the exact concentrations of ruthenium is 
difficult to quantify and variations in concentrations are unavoidable. A table of 
quantum yields for free and various protein-bound labels is outlined in Table 4.2.
These results verify the minimal effect that the covalent linkage to proteins 
has on the quantum yields of emission of the Ru(II) polypyridyl complexes which is 
indeed a prerequisite to their successful application as luminescent probes. 
However, the extent and nature of the effect of the conformational variances of a 
protein bound to such complexes on their emission spectra will determine the 
probing capacity of their emission.
Figure 4.13 depicts the pH sensitivity of the emission of the label 
[Ru(bpy)2NH2phen]2+ when bound to PLGlu. The noticeable decline in emission 
intensity between pH 4 and pH 5 is all the more significant when one considers the 
transition from an a-helical conformation to a random-coil which poly-L-glutamate 
is known to undergo at approximately such a pH range [22]. Furthermore, the 
fluorescence of the unbound label [Ru(bpy)2NH2phen]2+ does not display such 
behaviour at pH 4-5 (See Figure 4.11), which suggests that such behaviour is indeed 
due to the changes in secondary structure of the biomolecule.
Figure 4.14 depicts the influence of pH on the fluorescence of the conjugate 
Ru(bpy)2NCSphen:PLL. Interestingly, the wavelength of maximum emission (A,max ) 
shifts slightly from 608 nm below pH 9 to 605 nm at pHs 9-12 while the intensity 
decreases significantly above pH 10, at approximately the pH at which the random- 
coil to a-helix transition occurs. However, on comparing with the behaviour of the 
corresponding unbound label ( See Figure 4.12) the variations are of the same 
nature as those of the unbound label in the sense that the intensity decreases 
dramatically above pH 9-10. However, on binding the NCS group to the proteins 
the unstability of such a complex (or indeed its protonation) should no longer be a 
phenomenon, suggesting that the decrease in emission intensity typical of the
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unbound label should no longer be evident. Therefore, it may be possible that such 
variations are indeed due to the conformational changes o f the bound polypeptide.
Figure 4.13 pH  sensitivity o f the emission spectrum o f  R ufbpy) jNHyphen :PLGl u.
Figure 4.14 pH  sensitivity o f  the emission spectrum o f  Ru(bpy) 2NCSphen: PLL
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Thus far, we have found that the emission spectra of the complexes [Ru(L- 
L)2NH2phen]2+ and [Ru(L-L)2NCSphen]2+ when bound to biomolecules are 
somewhat sensitive to the acid-induced secondary structure changes of the poly­
amino acids poly-L-lysine and poly-L-glutamate. However, as a result of the pH 
sensitivity of the emission spectra of the free labels some of the effects of the bound 
biomolecule may be masked thereby restricting its potential in certain pH ranges. 
An extreme case is the complex [Ru(bpy)2esterbpy]2+ whose absorption and 
emission spectra do not change significantly on the binding of the biomolecules. 
The spectra typical of carboxylic acid complexes for the protein-bound label is 
probably due to the fact that the unbound reactive group has not been esterified, 
hence interfering with any effects the protein may have on the other esterified 
group. For this reason, the remainder of this section concentrates on the study of the 
amino and isothiocyanate complexes.
The propensity of the emi ssion spectra of [Ru(L-L)2NH2phen]2+ and [Ru(L- 
L)2NCSphen]2+ to monitor acid-induced denaturation of a natural protein was also 
studied. As an example, the emission spectrum of Ru(dpp)2NCSphen:BSA from 
pHs 2 to 12 is depicted in Figure 4.15. In this case a dramatic decline in emission 
intensity is observed above pH 9 and below pH 3, indeed more dramatic than the 
decline seen for the corresponding unbound label. Although this indicates that such 
an effect may be due to the acid-induced unfolding of the protein as most proteins 
are most stable between pHs 4 and 9 (similar to pH range of maximum intrinsic 
fluorescence of BSA), the exact effects are vague and difficult to confirm, again 
due to the pH susceptibility of the labels fluorescence.
However, the use of the amino complex to bind the protein gives a clearer 
picture as the fluorescence of the complexes [Ru(L-L)2NH2phen]2+ does not 
decrease appreciably in intensity at pHs above pH 9, at which the protein is 
believed to become unfolded. Figure 4.16 reveals a notable reduction in emission 
intensity of [Ru(L-L)2NH2phen]: BSA above pH 9, which indicates that this does 
not merely mirror the spectroscopic effects of the unbound label but rather is 
associated with the conformational variability of the bound protein.
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Figure 4.15 pH  sensitivity o f the emission spectrum o f Ru(dpp)2NCSphen:BSA.
pH 3-4
Figure 4.16 pH  sensitivity o f  the emission spectrum o f Ru(bpy) 2NH2phen:BSA.
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Table 4.3 pH sensitivity of quantum yields of emission of [Ru(L- 
L)2NCSphen]:BSA and [Ru(L-L)2NH2phen]:BSA.
Conjugate
pH 2
Quantum yield (cp) 
pH 4 pH 6 pH 8 pH 10 pH 12
Ru(bpy)2N H2phen:B S A 0.006 0.005 0.018 0.022 0.02 0.008
Ru(phen)2NH2phen:BSA 0.006 0.004 0.006 0.017 0.002 0.003
Ru(<jpp)2NH2phen:BSA 0.0025 0.0045 0.003 0.003 0.002 0.0008
Ru(bpy)2NH2phen:BSA 0.006 0.005 0.018 0.022 0.02 0.01
Ru(bpy)2NCSphen:BSA 0.004 0.005 0.01 0.016 0.01 0.004
Ru(phen)2NCSphen:BSA 0.06 0.065 0.068 0.07 0.055 0.015
Ru(dpp)2NCSphen:BSA 0.028 0.035 0.070 0.040 0.008 0.003
pH
Figure 4.17 p H  sensitivity o f intensity o f  the fluorescence o f  
(a)Ru(dpp)2NH2phen:BSA and (b) (Ru(dpp)2NCSphen:BSA.
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Nevertheless, to clarify this effect of the bound protein on the emission intensity of 
the labels, Table 4.3 lists the quantum yields o f emission of Ru(II) complexes when 
bound to bovine serum albumin at various pHs, thereby outlining their sensitivity to 
pH changes. Again, these values are listed merely to give an indication of the 
absolute effect of the protein on the emission spectra of the labels.
This table of results basically highlights the fact that the apparent quantum 
yields of emission of the ruthenium complexes when bound to a natural protein such 
as bovine serum albumin are very sensitive to pH changes. The quantum yields of 
emission are significantly reduced at pH extremes in particular at very alkaline pHs 
i.e from pHs 9-12 as was already concluded for the emission spectra of the protein- 
bound labels. Significantly, this table together with Figure 4.17 reveal how the 
emission intensity of the Ru(II) complexes bound to proteins behaves in a similar 
fashion to the intrinsic fluorescence of such proteins (see Figure 4.10) at pH 
extremes.
As stated earlier, the reason for changes in emission intensity is likely to be 
due to unfolding or denaturation of the protein at both extremes of pH but 
particularly at basic pHs. It is not clear why exactly the emission intensity of the label 
decreases so dramatically when the bound protein unfolds but merely establishes a 
possible link between emission intensity variations of the fluorescent labels and the 
acid-induced conformational variances of both synthetic biomolecules and natural 
proteins. However, the pH susceptibility of the emission spectra of the unbound 
labels and possible protonation effects somewhat restricts their suitability to monitor 
structural variances of bound proteins.
Earlier studies have already revealed that the emission lifetime of the Ru(II) 
complexes is the luminescent property most affected by the subsequent binding to 
proteins. This, in addition to the fact that there is usually correlation between 
emission lifetime and emission intensity variations lead us to the study of the 
sensitivity of the decay lifetimes of the labels to the conformational variances of the 
bound protein.
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4.3 Conclusion.
The photophysical properties of ruthenium polypyridyl complexes when covalently 
bound to the natural protein bovine serum albumin and the synthetic poly-amino 
acids, poly-l-lysine and poly-l-glutamate are explored further in this chapter. The 
ultimate objective in this chapter is to assess the sensitivity of the spectroscopic 
properties, namely the energy and the intensity of the absorption and emission 
spectra of such fluorescent complexes to the acid-induced conformational variances 
occurring in the bound protein and hence to determine their potential to act as 
probes of such variations.
The absorption spectra of the unbound labels [Ru(L-L)2NH2phen]2+ are not 
susceptible to pH effects (pH 2-12), suggesting that protonation of the amino group 
does not take place but also indicating the stability of such complexes even at 
extreme pHs. The change in form of the absorption spectra of [Ru(L-L)2NCSphen]2+ 
indicate that these complexes may revert back to their precursor amino complexes at 
extremes of pHs while the succinimide ester of [Ru(bpy)2COOH2bpy]2+ possesses an 
absorption spectrum typical of its precursor, indicating that the two carboxylic acids 
were not successfully esterified. However, even though the pH sensitivity of the 
protein-bound labels reveal changes in absorption intensity and slight shifts in 
wavelengths of maximum absorbance (kmax) particularly at high pHs, not solely due 
to the unbound complex, these variations are not sensitive enough to successfully 
probe the bound proteins.
However, a study of the effect of bound biomolecules on the pH sensitivity 
of the emission spectra of the labels reveals changes in emission intensity which do 
not appear to be merely due to the behaviour of the unbound complexes but rather as 
a consequence of the acid-induced conformational variances of the bound proteins. 
For both poly-amino acids, PLL and PLGlu, significant decreases in the labels’ 
emission intensity appear to correlate with the pHs at which the transition from a - 
helix to random coil of the biomolecule is favoured. However, it must be noted that 
the emission spectra of the labels, particularly those of [Ru(L-L)2NCSphen]2+ are
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themselves somewhat susceptible to pH, thereby limiting their potential as probes of 
acid-induced conformational variations. In the case of the ester form of 
[Ru(bpy)2COOH2bpy]2H the emission properties due to the 
protonation/deprotonation effects of the carboxylic acid, indicating that only one of 
the COOH groups is esterified, are still evident on binding of the label to proteins 
and this restricts the use of these complexes as efficient probes.
Furthermore the amino and isothiocyanate complexes when bound to BSA, a 
protein most stable between pH 4 and 9, display diminished emission intensities at 
very acidic and highly alkaline pHs, probably due to the unfolding of the protein at 
such pH extremes. The greater pH sensitivity of the quantum yields of emission of 
the labels is used to illustrate more clearly the effect of the protein on the emission 
intensities of the label. However, due to the presence of two or more emitting 
components in the decay of the protein-bound label compared to the single 
exponential kinetics of the free label, the quantum^ yields of emission may not be a 
true representation.
The intrinsic fluorescence of the proteins is studied briefly in order to show 
the effect of conformational changes on the emission intensity, here described in 
terms of the quantum yield of emission, using tryptophan as a reference. BSA is the 
most fluorescent of the biomolecules studied and the most sensitive to pH extremes, 
presumably due to the unfolding process occurring under such conditions while less 
significant changes in the fluorescence of the synthetic poly-amino acids are 
apparent.
In brief, the emission spectra of the labels are indeed somewhat influenced hy 
the conformational changes of the bound proteins, whereby changes in the secondary 
structure from a-helical to random coil conformation for poly-amino acids and 
unfolding of the proteins appear to lead to significant reductions in their emission 
intensity. However, the pH susceptibility of the emission spectra of the labels and 
protonation/deprotonation effects themselves restricts their usefulness in this area 
and renders the study of the labels more difficult, leading to the subsequent study of 
the more sensitive emission lifetime of the labels in the following section.
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The use of decay lifetimes of protein-bound Ru(II) polypyridyl complexes as 
probes of conformational variances.
Chapter 5.
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5.1 Introduction.
In the preceding chapter it was concluded that the energy and intensity of both the 
absorption and emission spectra of ruthenium polypyridyl complexes studied are not 
suitable variables to monitor conformational variances of the bound proteins. This 
chapter concentrates on the use of the emission lifetimes of the labels as the 
reporters which were shown in chapter 3 to be the most influenced by protein- 
binding. The sensitivity of the decay lifetimes of the fluorescent labels to changes in 
secondary structures of poly-amino acids and unfolding of proteins induced by acid 
and chemical denaturants was investigated to determine the usefulness of such 
probes in real biological processes. In the final section, the labels were bound to the 
enzyme lysozyme allowing one to determine the effect, if any that the binding of 
labels has on the funciton of the enzyme. The effects of denaturation on the decay 
behaviour of the labels were also investigated by monitoring the effects of pH and 
chemical denaturants on the activity of the enzyme towards its substrate. The 
ultimate objective here was to identify the potential of such fluorescent complexes in 
real biological matrices.
Below is a summary of further applications of fluorescent complexes in 
naturaL biological processes stressing the wide range of possible applications. 
Various applications of synthetic macromolecules such as poly-l-lysine are also 
discussed which is of relevance to the work carried out in this thesis.
5.1.1. Use ofRu(II) polypyridyls as probes fo r  biomolecules.
Various ruthenium polypyridyl complexes have been prepared and coupled to 
proteins, albumins, antibodies and oligonucleotides. The use of the esterified
derivative of [Ru(bpy)2(COOH2bpy)]2f  where COOH2bpy = 2,2'- bipyridine-4,4'
dicarboxylic acid in the conjugation of the proteins bovine serum albumin and anti-
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rabbit immunoglobulin has been reported, with the immunological activity o f the 
antibody after conjugation shown to be retained by immunofluorescence [1], This 
complex has also found applications in a time-resolved fluorescence immunoassay
[1], (See Figure 5.1.) When bound to bovine serum albumin, detection was carried 
out using electrochemiluminescent techniques. Ruthenium concentrations of lxlO'11 
M were detected using this method.
A ruthenium polypyridyl sulphonyl chloride has also been conjugated to
human IgG [2] while [Ru(bpy)2 ((CONCS)2bpy)]^+ where CONCS = 
diacylisothiocyanate, has been conjugated to antibodies [2], Another such complex 
coupled to sheep and rabbit anti-mouse IgG is [Ru(bpy)2(4,4’-dichloro- 
methylbpy)]24 as depicted in Figure 5.2, which reacts with a free amino group that 
attacks the chloromethyl group and displaces the chloride [1], Retention of 
immunological reactivity is demonstrated by fluorimetric analysis.
Weber describes the use of some ruthenium complexes in 
photoelectrochemical immunoassays and also reports the use of the 3-0-morphinyl 
ester of [Ru(bpy)2(4,4’COOHbpy)]2+ as a label in determining morphine [3]. The
basis behind this is that the label transfers an electron to a quencher when 
photoexcited and the resulting oxidised molecule is subsequently reduced with an 
electron from an electrode of the flow cell held at the suitable potential. This electron 
is measured as photocurrent and hence the amount of free labelled analyte is 
determined by the photocurrent signal [3],
The use of various ruthenium complexes attached to immunologically active 
material for use in time-resolved immunoassays has also been reported [4], For such 
work, the lifetime of the luminescence is suitably longer than 20 ns such that it 
exhibits a lifetime substantially longer than that of the background luminescence of 
the assay environment. Hydroxysuccinimide esters, chloroformate, isothiocyanate 
and sulphonyl chlorides derivatives of ruthenium polypyridyl complexes were 
subsequently conjugated to anti-thyroid stimulating hormone and human IgG and are 
also applicable in time-resolved immunoassay techniques [4],
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Figure 5. J. Structure o f the di-N-hydroxysuccinimide ester o f the complex
[Ru(bpy) 2 (4 .4 VOOHbpy)]2+
Figure 5.2. Structure o f the complex [Ru(hpy)2(4 ,4 '-dichloromethylbpy)]2"
The use of ruthenium bathophenanthroline complexes to label 
oligonucleotides has previously been mentioned [4, 5], The products formed are 
measured by time-resolved fluorescence with a detection limit below 10'14 M. Decay 
lifetimes of the order o f (i sec are obtained. These complexes are thermodynamically 
very stable, chemically inert and show strong and long lasting fluorescence after 
excitation by light pulses of short duration, which renders them suitable for time- 
resolved measurement methods in their detection [5],
The covalent attachment of multiple fluorophores to DNA containing 
phosphorothionate diesters leading to the highly sensitive detection of single­
stranded DNA is reported [6]. The incorporation of multiple fluorophores or other 
nonradioactive labels into nucleic acids allows significant enhancement of detection 
limit by increasing the amount of signal present for a given quantity of nucleic acid 
while not altering the characteristics of the DNA [6],
Recently, the covalent linkage of ruthenium polypyridyl complexes to 
polypeptides and immunoglobulins has been reported to lead to significant changes 
in decay lifetime and behaviour of the label [7], prompting our investigation of the 
potential of related complexes as fluorescent probes in the study of biomolecules and 
their conformations.
5.1.2 Fluorescence in immunoassays.
Fluorescence immunoassays have been widely used for the detection of drugs, 
antigens and other biological molecules based on a number of spectral properties, 
including the use o f fluorogenic substrates in the ELISA assays, long lived emission, 
chemiluminescence, the use of fluorescence resonance energy transfer (FRET) to 
detect antigen-antibody association, fluorescence polarisation to measure changes in 
the rotational correlation times, and fluorescence quenching or enhancement.
Fluorescence lifetimes and quantum yields of many different fluorescent 
groups and their sensitivities to quenching by various substances can for example be
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used to evaluate environments close to the residues to which those groups have been 
attached. Fluorescence energy transfer measurements are also widely used to 
estimate distances between certain internal or intrinsic chromophores and various 
selectively introduced extrinsic fluorescent labels [8],
Fluorescence methods are also widely used to study the rotational dynamics 
of proteins and other macromolecules, the physical basis behind these measurements 
being the polarisation or anisotropy of the emitted light when the sample is excited 
with a vertically polarised light. The extent of polarisation of the emitted light 
depends upon the extent o f random Brownian motion of the molecules that occurs 
during their excited state lifetimes [9], As a labelled antigen binds to the antibody, its 
rotation slows down and the degree of polarisation increases. The polarised light 
from metal-ligand complexes possess many advantages to render them suitable in 
biophysical and clinical chemistry including a wide range of lifetimes, absorption and 
emission maxima obtainable by a suitable choice of metal and ligand. Information on 
the rotational motion is possible over a time range extending to about three times the 
fluorescence lifetime [10], which indicates that long lived ruthenium complexes can 
measure processes such as protein folding. Recent work by Demas et al. involving 
the direct measurements o f rotational correlation times of luminescent Ru(II) 
molecular probes has led to their use as dynamic probes of motions of 
macromolecular systems [10].
Initial studies by Terpetschnig and co-workers incorporated the study of the 
potential of certain ruthenium complexes as anisotropy probes [11], Symmetrical
species such as [Ru(bpy)3 ]2 + had not previously been used as anisotropy probes due
to their apparent low polarisation of luminescence. However, the less symmetrical 
Ru-complex [Ru(bpy)2 (dcbpy)]2+ was studied, where dcbpy = 2,2’-bipyridine-4,4’- 
dicarboxylic acid, as it displays high anisotropies in the absence of rotational motions
[11], The intensity and anisotropy decays of [Ru(bpy)2 (dcbpy)]2+, when covalently
bound to human serum albumin, concanavalin A  human immunoglobulin G (IgG) 
and ferritin were measured, demonstrating their ability to measure rotational motions
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on the 10 ns to 1.5 [is timescale [11]. Such studies confirm that the anisotropy 
decays of the Ru-labelled proteins are sensitive to the size and/or shape of the 
proteins. Furthermore, in solutions of increasing viscosity the Ru-complex displays a 
slower anisotropy decay as protein diffusion is slowed.
Based on these preliminary studies, Terpetschnig reports fluorescence 
polarisation [12] and FRET immunoassays [13], based on such ruthenium 
complexes. The steady-state polarisation of the antigen human serum albumin 
(HSA), labelled with [Ru(bpy)2(dcbpy)]2f where dcbpy = 4,4,-dicarboxyl-2,2’- 
bipyridine, is sensitive to the binding of its antibody anti-HSA, resulting in a 200% 
increase in polarisation [12], On labelling HSA with [Ru(bpy)2(NCSphen)]2+, its 
association with the antibody labelled with a non-fluorescent absorber, Reactive Blue 
is detectable by a decreased quantum yield of Ru-HSA, a decrease in its fluorescence 
lifetime and an increase in its fluorescence anisotropy [13],
Because the photophysical properties of [Ru(bpy)3]2+ are sensitive to local
environmental factors, it is also suitable as a luminescent probe of antibody binding 
pockets, according to Shreder and co-workers, involving the use of time-resolved 
luminescence in the photophysical investigation of polyclonal antibodies elicited via 
immunization with a [Ru(bpy)3 ]^+-methyl viologen hapten [14], Antigen-specific
polyclonal antibodies are produced when the immune system is challenged by 
infection or immunization. A complete characterisation of the functional distribution 
of such antibodies in a polyclonal immune response is vital in understanding how the 
immune system functions, having applications in several fields, from medicine to 
catalytic antibodies. Contrary to common belief that polyclonal immune responses 
are highly heterogenous, [Ru(bpy)3]2‘ when bound by the entire hapten-specific 
polyclonal IgG sample, exhibits surprisingly homogenous photophysical behaviour, 
indicating that the entire polyclonal response may be essentially monoclonal, with all 
the hapten-specific antibodies being genetically related. Alternatively, the different 
antibodies could be genetically unrelated but simply recognise the hapten in a similar 
fashion [14]. (See Figure 5.3)
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Figures.3 (1) [Ru(bpy)3]  + -methyl viologen hapten and (2) methyl violegen [14].
5.1.3 Applications o f poly-amino acids.
In addition to the use of certain poly-amino acids in the study of real biological 
processes due to their analogy to basic proteins, many poly-amino acids have found 
important applications in their own right. In order to establish the importance of such 
synthetic biomolecules in the areas of clinical and biomedical chemistry, a brief 
summary of various significant biological applications of such molecules is given 
below.
Synthetic macromolecules have great potential in a number of areas of 
clinical application including their use as carriers of drugs (for example, for cancer
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chemotherapy, antigenic determinants (for vaccines), hormones, and gamma emitting 
radionuclides (for use as radiopharmaceuticals) [15].
One such application important in biodistribution studies and 
radiopharmaceutical development involves the labelling of branched polypeptides 
with a poly-L-lysine backbone with radioiodines and radiometals [15], Groups of 
branched polypeptides , having the general formula poly[Lys-(Xj-DL-Alam)] (XAK)
are water soluble, biodegradable, and possess a large number of a-amino groups 
rendering them suitable for simple and efficient conjugation to drugs or other agents, 
while polycationic polypeptides (regardless of their branch structure) are cleared 
rapidly from their circulation [15],
Yoshimura and co-workers have reported the characterisation of thyroidal 
membrane-bound Mg-adenosinetriphosphatase, activated by trypsin or poly-L-lysine. 
This activation is reportedly due to an increase in the maximal velocity of the 
hydrolysing reaction without a change in the affinity of the enzyme for its substrate. 
Indications were that the alteration of ATPase activities is dependent on the basicity 
of the poly-amino acid, as acidic poly-amino acids had no effect [16].
Fiume and co-workers have reported the conjugation of the antiviral agent 
adenine arabinoside monophosphate (ara-AMP) with a low molecular mass 
lactosaminated poly-L-lysine. This led to an increase in the chemotherapeutic index 
of the antiviral drugs used in the treatment of chronic hepatitis B and more selective 
delivery to hepatocytes via Ashwell's receptor which recognises galactosyl 
terminating glycopeptides [17], The conjugate was also found to be devoid of acute 
toxicity even at high dose in contrast to free poly-L-lysines.
The toxic effects of poly-L-lysine itself are associated with its polycationic 
character and are probably caused by the binding of the electronegative charges 
present on the cell. Coupling of lactose molecules by reductive amination preserves 
the cationic character of lysine e-amino groups , but the bound lactose and coupled 
ara-AMP (negatively charged) probably hinder the binding of the conjugate to the 
electronegative groups of cell membranes. The conjugate is very soluble in water, 
allowing the administration of a pharmalogically active dose in a small volume [17],
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Another medical application of poly-L-lysine is its use in the study of the 
non-enzymic reaction between glucose and the free amino groups of proteins, which 
has significance due to its possible implication in the development of long-term 
diabetic complications [18]. Due to the large number of free s-amino groups (known 
as reactive sites in the glycation processes) in PLL, it was chosen as the model 
compound in order to increase the yield of the glycation processes. This glycation 
process is the first of a complex series of reactions that determine the formation of 
fluorescent insoluble products, the advanced glycation end products of melanoidins. 
The accumulation of such products on long-lived proteins is one of the most 
important damage factors determining diabetic complications. Lapolla and co­
workers have studied the products arising from the interaction of glucose and poly-1- 
lysine using pyrolysis/gas chromatography/mass spectrometry [18],
Studies have shown that PLL and other polycations influence endothelial 
functions and activate certain enzymes involved in the caseinolytic activity of the 
erythrocyte multicatalytic proteinase. Investigations of the physiological role of these 
enzymes are rendered difficult by complicated multi-stage purification processes. 
Here, the purification of CLP by a simple one-step method using poly-L-lysine was 
developed by Nagamatsu [19], In this study, low concentrations of PLL were found 
to stimulate the release o f elactase (CLP) and cathepsin G from leukocytes in vitro, 
and was particularly useful as a reagent for the fractionation of CLP in a simple 
chromatographic procedure.
Finally, an interesting application involving amino acids is their use as 
photoactivatable DNA-cleavage agents. Saito and Takayama report novel water- 
soluble 1-lysine derivatives possessing a naphthalimide chromophore that can induce 
efficient, highly specific selective cleavage of double stranded DNA upon 
photoirradiation at 320-380 nm [20],
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5.2 Results and discussion.
5.2.1. pH  sensitivity o f decay lifetimes.
It has been noted that the decay lifetime of the labels studied here is the luminescent 
property most influenced by their subsequent binding to biomolecules. The decay 
kinetics and lifetime are substantially changed upon conjugation. For this reason it 
was assumed that the decay lifetimes of the labels would be the most susceptible to 
conformational variances taking place in the bound biomolecule and in this sense 
they would act as the sensitive reporters. This section involves the pH sensitivity of 
the decay lifetimes of each label when bound to various biomolecules.
In section 4.1.3 the pH sensitivity of the conformational forms of two poly­
amino acids in particular was described. As their dynamic behaviour is well 
documented under such conditions [21], in addition to their use as model 
compounds to study more complex biological processes [15-20], such biomolecules 
were again chosen as model compounds to study the capability of Ru(II) complexes 
to follow regular structural changes of these bound biomolecules. In the first section, 
the acid induced conformational variances of regular synthetic poly-amino acids, 
namely their random coil to a-helix transitions were studied using the decay lifetimes 
of the labels as a probe. A similar study was then undertaken with a natural protein, 
bovine serum albumin, to assess the potential of such probes in natural biological 
processes while the last section involves the monitoring of the loss of activity of the 
enzyme lysozyme again using the decay lifetimes as the reporter.
In order to ensure that any fluctuations in the decay of the protein-bound 
label are indeed due to corresponding structural changes in the bound biomolecule 
and not merely due to pH susceptibility of that particular free label, a study of the pH 
dependence of the decay lifetimes of all the unbound ruthenium complexes was 
initially carried out. Table 5.1 and 5.2 list the lifetimes of the complexes [Ru(L- 
L)2(NH2phen)]2+ and [Ru(L-L)2(NCSphen)]21 where L=bpy, phen and dpp, at 
various pHs, when degassed and aerated. As stressed in chapter 3, all these
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ruthenium complexes exhibit single exponential decay behaviour. Figure 5.4 
compares the pH sensitivity of the decay lifetimes of the aerated 
[Ru(bpy)2NH2phen]2+, [Ru(bpy)2NCSphen]2+ and [Ru(bpy)2esterbpy)]2+. 
Approximately 1.1 O^M label was initially dissolved in DMF and diluted with 
Britton Robinson buffer. The pH was increased/decreased by the addition of 2 m 
NaOH/ 2 M Hcl, samples were taken at a range of pHs, allowed to stand at room 
temperature and then analysed. Degassing of the solution involved gently bubbling 
argon through the dilute label solution over a 30 minute period in cuvettes to 
remove the oxygen after which the cuvettes were sealed and the lifetimes of the 
samples analysed.
The decay lifetimes of aerated [Ru(bpy)2NH2phen]2+, 
[Ru(phen)2NH2phen]2+ and [Ru(dpp)2NH2phen]2+ show slight variations with pH 
with average lifetimes o f 350-400 ns, 500 ns and 700-750 ns exhibited respectively. 
[Ru(dpp)2NH2phen]2+ appears to be the most efficiently quenched by oxygen with 
the lifetimes increasing more than twofold, on treating with argon to remove the 
oxygen. When samples were deoxygenated in particular, a notable increase in each 
of the labels lifetimes was obtained above pH 6 and in correlation with the changes 
in the emission intensity of the labels at such pHs a likely explanation is that the 
protonation of the complexes leads to an increase in emission lifetime, allowing 
one to calculate the excited state pKa * of the complexes according to equation 4.1.
On comparing the results for the amino complexes, each isothiocyanate 
derivative possesses a longer lifetime than its respective amino precursor, ranging 
from 450ns (bpy) to 600ns (phen) to 850ns (dpp). Although these complexes 
display lifetimes not very sensitive to pH a decrease in the lifetimes is noted for 
each at pHs 10-12 which correlates with the pH range at which decreases in 
emission intensity and changes in the absorption spectrum were noted. This further 
indicates the decomposition of these complexes back to their amino precursors 
although the lifetimes at pH 10-12 are higher than the lifetimes of their respective 
amino complexes. Lower lifetimes could also however be due to protonation of the 
complex.
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Table 5.1 pH dependence of decay lifetimes of degassed and aerated 
samples of [Ru(L-L)2NH2 phen]2+.
pH L=bpy 
lifetime (ns)
L=phen 
lifetime (ns)
L=dpp 
lifetime (ns)
(a),(b) (a), (b) (a), (b)
2.0 500, 380 800, 500 1600,740
4.0 530, 360 820, 500 1800,720
6.0 620, 360 880, 520 1800, 750
9.0 630, 370 900,520 1700,800
11.0 620,340 890,500 1800,800
12.0 650,350 870,470 1500,750
13.0 680, 360 980,510 1480,730
(a) Samples were deoxygenated with argon for 30 mins; (b) Aerated samples. 
Error o f lifetimes calculated is approximated to be + -  5%.
Table 5.2 pH dependence of decay lifetimes of degassed and aerated 
samples of [Ru(L-L)2NCSphen]2+.
pH L=bpy L=phen L=dpp
lifetime 1 (ns) lifetime 1 (ns) lifetime 1 (ns)
(a), (b) (a), (b) (a), (b)
2.0 720, 490 990, 500, 1700, 800
4.0 700, 450 1060,600 1850,840
7.0 750, 460 1100,640 1700, 850
9.0 760, 450 1170,620 1600,860
10.0 740, 460 1120,630 1560, 890
12.0 700, 420 1000,580 1600, 830
(a) Samples were deoxygenated wtih argon for 30 mins.; (b) Aerated samples. 
Error o f lifetimes calculated is approximated to be +- 5%.
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[Ru(bpy)2esterbpy]2+ and its precursor show variability in their emission 
lifetimes, as in their absorption and emission spectra. As for the emission intensity, an 
increase in lifetimes was notable from pH 4-6 upwards. Again this jump is probably 
due to the deprotonation of the carboxylic acid and hence as the deprotonated 
complex has a longer lifetime than the protonated one, the real excited state pKa 
could be calculated taking the change in lifetimes upon protonation into account 
using equation 4.1. Indeed the excited state lifetime of the “ester” is at a minimum at 
less than 300 ns while a jump to 400 ns is noted at such a pH range. Another point 
to note is the minimal effect degassing of the samples has on the lifetimes, with the 
lifetimes only increasing by a third on degassing. This change in lifetime could also 
be explained by the hydrolysis of the ester in acid/base but the reversibility and 
reproducibility of the variations contradict this. The protonation effect o f the 
lifetimes of this label is illustrated in Figure 5.4 where it is compared to the pH 
susceptibility of the lifetimes of [Ru(bpy)2NH2phen]2+ and [Ru(bpy)2NCSphen]2+.
pH
Figure 5.4 pH  dependence o f luminescence lifetimes o f aerated (a) 
[Ru(bpy)2NH2phen]2+ (NHphen), (b) [Ru(bpy)2NCSphen]2+(NCSphen) and (c)
[Ru(bpy)2esterbpy] 21 (ester bpy).
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These preliminary studies of the controls would lead us to believe that while 
the amino and isothiocyanate complexes appear suitable to probe pH dependant 
conformational variances due to their immunity to pH influences, the irregular pH 
induced decay behaviour of the carboxylic acid derivative may complicate matters 
when used as probes of such variations.
5.2.1.1 Effect o f protein type.
For the lifetime analysis of the protein-bound labels, each conjugate solution was 
diluted further with Britton Robinson buffer (the dilution depended on the 
concentration of label in the conjugate). The pH was increased/decreased by the 
addition of 2 M NaOH/ 2 M HC1 and samples were taken at a range of pHs. These 
samples were allowed to stand at room temperature for the “aerated “ readings 
while “degassing” involved the bubbling of argon through each sample in cuvettes 
for 30 mins with care so as not to denature the protein. The cuvettes were then 
sealed and immediately analysed by laser excitation. Oxygenation of the samples 
involved bubbling oxygen through the solutions in cuvettes for 15 mins, sealing the 
cuvettes and immediately analysing by laser excitation.
(1) pH sensitivity of PLL-bound complexes.
Ruthenium complexes were bound to the side chains of the lysine residues of PLL 
using both isothiocyanate complexes and dicarboxylic acid derivatives. However, 
ruthenium amino complexes were also bound to the terminal carboxylic acid groups 
of the polypeptide backbone of PLL. This allowed the comparison of the probing 
capabilities of the labels when bound to different locations on the biopolymer. 
Table 5.3 lists the decay lifetimes of [Ru(bpy)2NCSphen]2+:PLL conjugates at 
various pHs, when degassed and aerated, while Figures 5.5 and 5.6 graphically 
illustrate such behaviour. The results obtained for the aerated and degassed
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[Ru(phen)2NCSphen]2+:PLL and [Ru(dpp)2NCSphen]2+:PLL conjugates are listed in 
Table 5.4. Although absolute lifetime values are higher in Table 5.4, we see that the 
trend is the same as we vary the ancillary ligand on the label, suggesting that the 
nature o f the additional polypyridyl ligand has no bearing on probing potential.
As previously noted, the two lifetimes obtained consist of one lifetime 
significantly longer than the free form while the shorter lifetime is slightly shorter 
than the free form. The longer lived species may be a composite of several decays 
from complexes bound to the same type of binding site but at different locations 
along the PLL molecule. However, taking all the parameters involved in the 
interaction of ruthenium polypyridyl complexes with biomolecules into account, it 
would be expected that the excited state decay behaviour of the conjugates may be 
quite complicated and impossible to define precisely and that, in this case double 
exponential analysis is the most suitable approach.
Figure 5.5 outlines how at room temperature the two lifetimes of the PLL- 
bound labels are relatively constant upto a pH of approximately 9 or 10, whereupon 
a significant drop in both is observed. Significantly as already explained, poly-1- 
lysine is known to be in a random-coil conformation at pH 7, but at pH 12, is 
known to be totally helical, with this random coil to a-helix transition occurring at 
approximately pH 10 [21], A likely explanation for the longer lifetime of the bound 
label below pH 10 is the protection from quenching by O2 in particular, in the 
sheltered environment of the polypeptide when in the random coil conformation. It 
is proposed that above pH 10, when PLL is in the non-random helical form, the side 
chains to which the ruthenium labels are bound, are protruding from the a-helix, 
rendering them more accessible to various quenching agents, particularly oxygen, 
leading to the observed reduction of emission lifetimes. On removing oxygen from 
the same samples with argon, multi-exponential decay is again found. However, in 
some cases triple as opposed to double exponential analysis gave a better fit, the 
reason for which is not clear. Interestingly, below pH 10 the labels decay behaviour 
is very similar to that of the aerated samples. To be noted is the fact that above pH 
10, all three lifetimes show little change across the entire pH range.
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Since on degassing the samples, the quenching affects of oxygen should be 
minimised, the bound labels' emission lifetime should be quite uniform over the 
whole pH range. This is indeed found and can be clearly seen from Figure 5.6. On 
the other hand, on oxygenating the samples, although all the lifetime components 
would be expected to be affected somewhat, an equivalent or indeed a more 
significant drop in lifetimes is anticipated at pH 9-10, as the label is more 
susceptible to oxygen quenching under the specified alkaline conditions. On adding 
oxygen, a significant drop is noted only for the longer lifetime, indicating that the 
shorter lifetime is a form of label quenched by some other means. Figure 5.7 depicts 
a molecular model of PLL labelled with one ruthenium complex when PLL is in 
the random coil conformation. This illustrates more clearly the projection of the 
complex from the a-helix when covalently bound to a side chain of the polypeptide.
An important experiment carried out was the confirmation of the 
reversibility of such variations, to ensure that any observations made were due to 
reversible structural conformational changes of the bound protein and to dismiss 
such possibilities as decomposition of the conjugate. Furthermore, these similar 
experiments carried out on the free labels permit us to conclude that the unusual pH 
dependent behaviour is indeed due to the pH dependent dynamic behaviour of PLL 
in solution.
An important question already addressed in chapter 3 is the nature of the 
lower lifetime of the protein-bound label. A lifetime similar to that of the unbound 
label may indicate such an explanation but the fact that this lifetime exhibits pH 
dependent decay behaviour different to that of the unbound label plus the fact that 
dialysis and/or size exclusion chromatography should have removed most of the 
unbound label would dismiss the possibility that the lower lifetime is merely due to 
the unbound label.
216
Table 5.3 pH dependence of decay lifetimes of 50:1 Ru(bpy)2 NCSphen:PLL in 
deoxygenated, aerated and oxygenated solutions.
PH Degassed Aerated Oxygenated
lifetimes 1, 2,3 (ns) a lifetimes 1, 2 (ns) b lifetimes 1, 2
2.0 90 (10), 350 (45), 700 (45) 250 (35), 900 (65) 200 (50), 660 (50)
4.0 80 (15), 390 (45), 690 (40) 260 (35), 940 (65) 170 (50), 680 (50)
8.0 40 (15), 260 (30), 820 (55) 240 (30), 860 (70) 170 (50), 610 (50)
10.0 40 (15), 350 (40), 860 (45) 220 (30), 790 (70) 180 (35), 540 (65)
11.0 50 (15), 340 (40), 790 (45) 190 (40), 530 (60) 150 (40), 250 (60)
12.0 45 (15), 370 (55), 900 (30) 120 (30), 410 (70) 160 (50), 280 (50)
13.0 50 (10), 340 (45), 790 (45) 70 (30), 400 (70) 140 (50), 240 (50)
* Values in parentheses are the emitting components pre-exponential factors in 
percent.
Table 5.4 pH dependence of decay lifetimes of aerated 
Ru(phen)2NCSphen:PLL and Ru(dpp)2NCSphen:PLL.
pH L = phen
Lifetimes 1, 2 (ns)
L = dpp
Lifetimes 1,2 (ns)
2.0 320 (35), 840 (65) 450 (25), 1200 (75)
5.0 340 (35), 810 (65) 420 (30), 1230 (70)
8.0 320 (35), 860 (65) 400(30), 1150(70)
10.0 250 (30), 690 (70) 280 (25), 1000 (75)
11.0 220 (25), 560 (75) 250 (25), 800 (75)
12.5 200 (25), 530 (75) 220 (25), 700 (75)
* Values in parentheses are the emitting components pre-exponential factors in
percent.
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Figure 4.12. pH  dependence o f luminescence lifetimes o f aerated 
Ru(bpy) 2NCSphen:PLL.
1000
Figure 4.13 pH  dependence o f  luminescence lifetimes o f degassed 
Ru(bpy)2NCSphen:PLL.
218
Figure 5.7 Computational model o f Ru-labelled PLL with PLL in the a-helical
form.
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At certain pHs of our studies the lower lifetime is actually significantly 
lower than that of the unbound label which would indicate that quenching of the 
label via either energy or electron transfer by the protein is taking place. However, 
there is no direct evidence to support this theory and it must be remembered that the 
analysis of the multi-exponential decaying samples is based on mathematics and 
hence the values are not absolute. A similar pH study was carried out for the PLL 
conjugate using the succinimide ester as the label. Before any analysis of results is 
possible, however, it must be remembered that this label displays spectroscopic 
properties highly sensitive to pH variations, with significant variances in absorption, 
emission maxima and emission lifetimes on increasing the pH (See Chapter 4). 
Table 5.5 presents the lifetimes of the conjugate in question over a wide pH range. 
Again, double exponential decay is apparent for the protein-bound label, however, 
the longer lifetime is on average only slightly higher than that of the unbound label 
form, while the lower lifetime of the bound label is considerably lower than the 
same. From Table 5.5, it is evident that there is a change in decay behaviour of the 
bound label between pH 7 and 9. Firstly, while the protein-bound label displays 
essentially single exponential decay behaviour at acidic pHs (the lower lifetime 
contributes to only 8%), double exponential decay is more noted under 
neutral/alkaline conditions. Furthermore, as well as an increase in the contribution 
of the lower lifetime both lifetimes are shown to increase in duration above pH 7, a 
phenomenon which was found to be reversible. On degassing the samples very little 
change in lifetimes is noted as for the unbound labels, indicating that the protein- 
bound labels has photophysical properties very similar to those of the free label. 
This again may be due to the presence of an unreacted carboxylic acid group of the 
label not bound to the biomolecule.
These results appear to be in direct contrast to the other side-chain 
modification reagents o f PLL whereupon a drop in lifetimes was obtained in 
alkaline conditions. Furthermore the changes are noted at the lower pH of 7 and 
hence would not appear to be due to the structural variances inherent of PLL. 
Rather, as for the other spectroscopic properties, changes at pH 7 would appear to
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correspond to the excited state pKa of a carboxylic acid of the label. As the label is 
bound to the PLL molecule via one of the modified carboxylic acids present the 
decay behaviour may actually be governed by the unusual decay behaviour of the 
other unbound and unreacted carboxylic acid. This indicates that in order for Ru(II) 
polypyridyls to be used as efficient labels, only one functional group should be 
present and the unbound label should not be sensitive to the conditions which one 
wishes to study.
Table 5.5 pH dependence of lifetime components of Ru(bpy)2esterbpy:PLL 
when degassed and aerated.
pH Degassed lifetimes 1,2 (ns) Aerated lifetimes 1,2 (ns)
2.6 190(65)370(35), 60 (10), 280 (90)
6.4 290 (55), 640 (45) 60 (10), 350 (90)
9.0 400 (65), 770 (35) 180 (30), 430 (70)
10 0 400 (70), 700 (30) 120 (15), 390 (85)
11.0 380 (70), 750 (30) 220 (35), 440 (65)
12.0 350 (70), 720 (30) 240 (45), 480 (55)
As emphasised earlier, in addition to binding labels to PLL via the side chains of the 
lysine residues, suitable labels and reaction conditions were chosen to lead to the 
binding of ruthenium complexes to the terminal carboxylic acid groups of the 
polypeptide chains via stable amide bonds. As before, the pH dependence of the 
decay lifetimes of such labels when bound to such binding sites was investigated, to 
determine the effect of the binding site of the label on the biomolecule on the 
probing potential of these ruthenium labels. Table 5.6 presents the data describing 
the pH dependence of the lifetimes of the complexes [Ru(L-L)2NH2phen]2+ bound 
to PLL, when degassed and aerated. It is evident that these labels behave in a 
different manner, compared to those bound to the PLL side chains. Firstly, under
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aerated conditions, the amino complexes actually display essentially single 
exponential decay behaviour with lifetimes simliar to those of the unbound labels.
The pH sensitivity of the decay behaviour o f the conjugates above is 
somewhat similar to that of the unbound form, in that the lifetime is not very 
sensitive to pH changes. However, on carrying out the appropriate protein assays, 
the actual binding of such labels to PLL was verified.
Table 5.6 pH dependence of decay lifetimes of aerated Ru(L-L)2NH2phen:PLL.
pH Lifetimes 1, 2 (ns)
L =  bpy L = phen L =  dpp
2.0 480 (90), 80 (10) 580 (80), 200 (20) 900 (90), 220 (10)
4.0 620 (90), 80 (10) 520 (85), 190 (15) 840 (80), 100 (20)
6.0 590(85), 100(15) 550 (80), 220 (20) 940 (85), 100 (15)
8.0 540 (90), 100 (10) 560 (80), 200 (20) 800 (75), 100 (20)
11.0 510 (90), 80 (10) 500 (80), 120 (20) 800 (75), 100 (25)
12.0 540 (80), 100 (20) 560 (60), 220 (40) 830 (85), 80 (15)
This would indicate that the labels, when bound to the terminal groups of 
polypeptide chains, are not subject to significant changes in local environment, 
despite the secondary structural variances taking place in the bound PLL molecule. 
This phenomonen may be explained in terms of the exact position of the binding 
sites of PLL in question, and how they are affected by corresponding 
conformational changes in the biopolymer. While the side chains of the amino acid 
residues in a polypeptide are known to be projecting out from the polypeptide 
backbone, the only carboxylic acid groups present in PLL are the terminal groups of 
each amino acid which bind to the terminal amino groups of another amino acid in 
the polypeptide chain to form peptide bonds, and so theoretically the only 
carboxylic acid available for binding to the labels in PLL is the terminal group of
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each polypeptide chain in a PLL molecule. As stressed previously, on binding the 
ruthenium labels to the protruding amino acid side chains, the labels susceptibility 
to quenching by oxygen, dramatically increases, as PLL undergoes a structural 
transition from a random-coil to rigid helical form. In contrast to this, the terminal 
groups would not be expected to experience much change in environment located at 
the end of polypeptide chains, and based on this assumption, a structural variance of 
the biomolecule should not lead to significant changes in the quenching rate of 
oxygen on the label. Furthermore as addressed in chapter 3, the predominance of 
the longer lifetime may be due to the more homogenous nature of the bound label 
due to the uniqueness of the binding site. On removing oxygen from such samples 
both lifetime components are not significantly affected, increasing only slightly. 
These results clearly indicate the limited potential of these labels when bound to the 
end of polypeptide chains and confirm the importance of the location of the label 
on the biomolecule in their use as sensitive probes of conformational variances 
inherent in the biopolymer.
(2) PLGlu-bound complexes.
To confirm our theory on the probing of PLL, poly-l-glutamate (PLGlu) was chosen 
and a similar line of investigation was carried out. Again suitable labels were 
chosen which could bind to the side chains of glutamic acid residues, and the pH 
dependence of the decay lifetimes of the protein-bound labels is examined. Table 
5.7, with Figures 5.8 and 5.9 reveal the pH susceptibility of the lifetime components 
of such protein-bound labels when aerated and degassed respectively. As before, 
double exponential decay kinetics is observed for the PLGlu conjugates. As 
anticipated, the decay lifetimes of the aerated samples in correlation with those 
bound to PLL, are shown to be greatly affected by the pH of the medium as revealed 
in Figure 5.8. This is in response to resulting conformational changes of PLGlu 
from an a-helix at pH 4 to random-coil conformation at pH 7 [22], which is 
illustrated in Figure 5.9 by the pH dependence of its optical rotation. In this case,
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the enhanced lifetimes from pH 4 upwards are induced when the biomolecule is in 
the random coil form. Figure 5.8 compares the lifetime of the unbound label to the 
two lifetime components of the PLGlu-bound label highlighting the effect of the 
polypeptide on the lifetime of the label. On studying the effect of removing oxygen 
from the samples there is no such jump in the longer lifetime component at any pH, 
however the shorter lifetime does show an increase after pH 5-6 indicating that the 
shorter lifetime experiences quenching effects other than oxygen. Nevertheless, 
from the sensitivity of the longer lifetimes to oxygen quenching it is apparent that 
the sensitivity of the excited state of these labels to their local environment in 
addition to the differential quenching by oxygen when the label is in various 
environments is the basis behind the propensity of these labels to monitor structural 
variances in poly-amino acids. As for PLL, the experiment was repeated for the 
larger labels [Ru(phen)2NH2phen]2+ and [Ru(dpp)2NH2phen]2+ to ensure that the 
probing nature of the label is not significantly affected. The results for such studies 
are presented below in Table 5.8. This reveals that the same observations are found 
for such labels with more enhanced lifetimes at each pH.
Table 5.7 pH dependence of decay lifetimes of Ru(bpy)2NH2phen:PLGlu 
conjugates in aerated and degassed solutions.
pH Aerated lifetimes 1,2 (ns) Degassed lifetimes 1, 2 (ns)
3.0 190 (25), 430 (75) 280 (30), 920 (70)
4.0 170 (20), 550 (80) 250 (25), 880 (75)
4.4 160 (25), 690 (75) -----------------------
5.0 230 (35), 870 (65) 230 (30), 830 (70)
6.0 245 (35), 780 (65) 480 (30), 900 (70)
8.0 220 (45), 800 (55) 440 (25), 880 (75)
10.0 200 (50), 700 (50) ------------------------
* Values in parantheses are the emitting components pre-exponential factors given 
in percent.
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Figure 5.8 p H  dependence o f  both lifetime components o f  aerated 
Ru(bpy) 2NH^phen:PLGlu.
X , m/i
Figure 5,9 Variation o f  optical rotation as a function o f  wavelength for poly-L- 
glutamate at pH  4 (helical) and pH  7 (random coil) [22J.
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Table 5.8 pH dependence of decay lifetimes of aerated 
Ru(L-L)2 NH2phen:PLGlu conjugates where L=phen and dpp.
pH
L = phen
Aerated lifetime (ns) 
L = dpp
3.0 60 (30), 430 (70) 200 (40), 840 (60)
4.5 120 (30), 500 (70) 210 (35), 820 (65)
5.0 110 (35), 510 (65) 230 (45), 800 (55)
6.0 300 (50), 940 (50) 240 (45), 820 (55)
7.0 450 (50), 850 (50) 600 (50), 1180 (50)
9.5 420 (45), 800 (55) 700 (50), 1220 (50)
11.0 460 (70), 870 (30) 600 (50), 1100 (50)
* Values in parantheses are the emitting components pre-exponential 
factors given in percent.
One interesting point to be noted from Tables 5.7 and 5.8 is that above pH 5-6 
where an enhancement of both lifetimes is observed, there is a corresponding 
increase in the contribution ratio of the shorter lifetime towards the total decay. A 
jump from 30% to 70 % is noted, the reason for which has not been ascertained.
Following the order of investigation carried out for the PLL conjugates, 
isothiocyanate derivatives were bound to the terminal amino groups, situated at the 
end of each polypeptide chain found in a PLGlu molecule. While Table 5.9 displays 
the lifetimes of the above conjugates, Figure 5 .10 displays the pH dependence typical 
of the lifetime components of Ru(dpp)2NCSphen:PLGlu when aerated.
From Figure 5.10 it is evident that the longer lifetimes are enhanced to a 
significant degree when compared to the lifetime of the corresponding unbound label 
verifying the influence of binding on the lifetime of the label. However, when 
comparing Figure 5.10 to Figure 5.8 one notes that the effect of pH on both lifetime 
components is negligible compared to the side-chain modified PlGlu molecule.
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Table 5.9 pH dependence of decay lifetimes of aerated 
Ru(L-L)2NCSphen:PLGlu where L= bpy and dpp.
pH lifetimes (ns) lifetimes (ns)
L = bpy L = dpp
2.0 160 (25), 700 (75) 380 (50), 1400 (50)
4.0 100 (30), 600 (70) 220 (55), 1220 (45)
6.0 180 (40), 540 (60) 390 (35), 1200 (65)
8.0 200 (40), 550 (60) 590 (20), 1240 (80)
10.0 280 (45), 590 (55) 600 (20), 1270 (80)
12.0 270 (35), 600 (65) 400 (20), 1150 (90)
* Values in parantheses are the components pre-exponential factors in percent.
pH
Figure 5.10 pH  dependence o f the decay lifetimes o f aerated 
Ru(dpp) 2NCSphen: PLGlu.
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As for PLL, this difference in behaviour is most likely due to the difference 
in sensitivity to oxygen quenching when the labels are situated on different binding 
sites along the biopolymer. On removal of oxygen, the longer lifetimes are 
significantly enhanced while the shorter lifetime components are only slightly 
increased further supporting the theory that the short lifetime component is due to 
some quenched bound form of label and not unbound label.
(3) BSA-bound complexes.
As labels bound to the side chains of poly-amino acids have proved successful in 
confirming changes in secondary structure already known, the next step was the 
labelling to a natural protein. The overall objective here was to investigate the 
possibility of monitoring more complex conformational variances unique to 
proteins, such as folding/unfolding processes.
The natural protein chosen for these studies was the globular protein, bovine 
serum albumin, whereupon both side chain and site-specifiic modification were 
effected using the same ruthenium labels. Table 5.10 presents the pH dependence of 
both lifetime components for the aerated forms of both Ru(L-L)2NCSphen:BSA and 
Ru(bpy)2esterbpy:BSA. Meanwhile Figure 5.11 depicts both their pH dependent 
decay behaviour under aerated conditions. In both cases here, the labels are bound 
to BSA via the lysine residues and so similar behavioural trends should be noted for 
both the labels, as the local environment of both would be under the same 
influences at pH extremes.
In contrast to the regular poly-amino acids, whereby the exact effect of 
specific pH changes on their conformation is well documented, the exact effect of 
pH on the structures of real proteins, such as BSA is much more complex and more 
difficult to follow or monitor. However BSA is an acidic protein, and being a serum 
albumin is most stable at acidic to neutral pH [22], As a protein is most stable
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around its isoelectric point [21], denaturation/unfolding probably occurs at more 
alkaline pHs. As anticipated, more complicated behaviour and less easily 
interpreted results are found for the BSA conjugates compared to that of PLL and 
PLGlu. As opposed to a step or jump in lifetimes being observed at a particular pH, 
the BSA conjugates do not exhibit such simple behaviour. However, as stated 
earlier, denaturation may only involve the disruption of some folded conformation 
upon which its biological properties may be critically dependent [21], This being 
the case, on denaturing with acid/base, no change in structure close to the label may 
be observable although their biological activity may be dramatically affected.
Table 5.10 pH dependence of decay lifetimes of Ru(bpy)2NCSphen:BSA 
and Ru(bpy)2esterbpy:BSA at room temperature, in aerated solutions.
pH Ru(bpy)2NCSphen:BSA  
lifetimes 1, 2 (ns)
Ru(bpy)2esterbpy:BSA 
lifetimes 1, 2 (ns)
2.9 200 (30), 810 (70) 120 (35), 480 (65)
4.0 230 (30), 800 (70) 240 (40), 750 (60)
7.0 150 (30), 710 (70) 180 (30), 680 (70)
9.0 210(25), 800(75) 220(35), 700(65)
10.0 130 (25), 790 (75) 180 (25), 620 (75)
11.0 130 (35), 580 (65) 90 (30), 390 (70)
12.0 100 (40), 480 (60) 100 (25), 400 (75)
13.0 130 (30), 390 (70)
* Values in parentheses are the pre-exponential factors given in percent.
229
permit us to recognise unfolded states simply from variations in the decay lifetimes 
of the protein-bound labels.
Significantly, when aerated, both labels bound to the side chain lysine 
residues exhibit similar decay patterns across a wide pH range which was 
anticipated. On removing oxygen however from these samples, although lifetimes are 
enhanced to a certain degree, there is little change in the overall trend with the 
lowest lifetimes still achieved at basic pHs. This is in contrast to the effects seen for 
the polypeptides PLL/PLGlu which indicates that the contributing factors are more 
complex for natural proteins. Figure 5.12 illustrates the more striking changes in 
lifetimes induced by variations in pH for the label [Ru(dpp)2NCSphen]2+ indicating 
that this label is more sensitive to environmental changes and therefore would have 
greater potential as a probe for biological structures. However, such effects may be 
also more pronounced for such labels due to significant electrostatic interactions that 
these hydrophobic complexes appear to undergo with proteins. Furthermore 
interchalation may also be a contributing factor as would be suggested when a 
change in ionic strength leads to lower conjugation ratios (See Table 3.18) as the 
ionic strength of a system affects the propensity of a complex to interchalate into a 
biological structure.
As already discussed, it is possible to target ruthenium complexes to the 
glutamic acid residues present in BSA. Although the labels are bound to different 
sites along the biopolymer similar effects are observed on varying the pH except that 
the lifetimes are enhanced, but this was previously dealt with in Chapter 3. This 
would be anticipated as our probes would not be expected to be sensitive enough to 
differentiate between various amino acid residues along the biopolymer.
The next step involved the study of the pH sensitivity of Ru(II) complexes 
bound to carbohydrate moieties present on the biomolecule i.e. the conjugates Ru(L- 
L)2NH2phen:BSA(a), constituting site selective modification. Table 5.12, together 
with Figure 5.13 represent the pH sensitivity o f the emission lifetimes of such 
samples.
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Table 5.11 pH dependence of decay lifetimes of degassed and 
aerated Ru(dpp)2NCSphen:BSA conjugates.
pH Lifetimes (ns)
Degassed Aerated
2.5 710 (40), 2900 (60) 650 (45), 2800 (55)
5.0 830 (40), 3200 (60) 910 (40), 3300 (60)
7.0 750 (30), 3700 (70) 970 (30), 3900 (70)
9.0 820 (30), 3700 (70) 830 (30), 3500 (70)
10.0 850 (30), 3100 (70) 600 (30), 2800 (70)
11.0 870 (30), 3140 (70) 470 (35), 2260 (65)
12.0 520 (30), 2330 (70) 250 (25), 1200 (75)
pH
Figure 4.19. pH  dependence o f  both lifetime components o f  aerated 
Ru(dpp) 2NCSphen:BSA.
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Table 5.12 pH dependence of decay lifetimes of Ru(L-L)2NH2phen:BSA 
at room temperature in aerated solutions where L=bpy and dpp.
pH L=bpy
lifetimes 1, 2 (ns)
L=dpp
lifetim es 1, 2 (ns)
2.0 70 (25), 680 (75) 220 (45), 1080 (55)
4.0 370(25), 1130(75) 410(45), 1900(55)
6.0 295 (30), 930 (70) 380 (40), 1700 (60)
8.0 270 (35), 760 (65) 520 (40), 2250 (60)
9.0 300 (20), 620 (80) 420 (50), 1600 (50)
10.0 80 (20), 560 (80) --------------------------
11.0 90 (20), 480 (80) 300 (45), 1200 (55)
12..0 120 (20), 470 (80) 210 (40), 880 (60)
Again, for the more hydrophobic labels of the form [Ru(dpp)2NH2phen]2+, more 
pronounced variations in lifetimes of their protein-bound form induced by pH 
variations. Again a contributing factor may be the substantial electrostatic effects 
and/or intercalation which these complexs experience with proteins. When 
compared to labels bound to the lysine residues as revealed in Figure 5.12, the 
lifetimes are more notably affected in very acidic conditions when bound to the 
carbohydrate moieties, showing significant reduction. This difference may be due to 
the difference between the local environments of both binding sites when denatured 
in acidic conditions. Certain local conformational changes may occur at low pHs 
which affect the carbohydrates more than the lysine residues. However, this theory 
is difficult to verify and more advanced studies would be necessary to confirm such 
proposals.
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pH
Figure 5.13 pH  dependence o f  both lifetime components o f  aerated 
Ru(dpp)2NJ-f phen: BSA (a)
One can conclude from the above study that our probes are more effective in 
the monitoring of predictable and regular conformational variances of simple 
biomolecules. As there are many more complicating factors involved in the 
structural deviations of natural proteins such as BSA with much less known of their 
exact nature one would not expect our fluorescent probes to give us detailed 
information on their pH dependent dynamic behaviour. All that is apparent from 
our studies is that extremes of pH, particularly alkaline conditions lead to structural 
variances which lead to a reduction of the labels lifetimes, the reason for which is 
unclear. This would be expected as serum proteins would be quite acidic and 
sensitive to pH, with unfolding expected to occur at such pH extremes. Later in this 
section, studies on denaturation of such proteins by chemical denaturants will be 
carried out in an attempt to determine the usefulness o f our probes in examining 
such unfolded states.
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5.2.1.2 Effect o f  reaction conditions.
fl)  Temperature effects.
So far in our work, the conjugation reactions studied have involved mild conditions 
such that the native structure of the biomolecule should not be disturbed, thereby 
permitting us to study the natural conformational variances inherent in the 
biomolecules in question. The ultimate objective in this section is the manipulation 
of some of these conditions in an attempt to induce variations in the natural 
structural forms of the biomolecule. Thereafter, the effect of such variations on the 
decay behaviour of the bound labels are monitored. The variables chosen include 
temperature and reagent effects and after labelling the proteins under such extreme 
reaction conditions the same pH dependent lifetime studies are carried out on the 
modified bio-conjugates taking note of any significant changes.
Certain conjugation reactions were carried out at an elevated temperature of 
50 °C, namely the side-chain modification of PLL and BSA. For this study the 
conjugation procedure was carried out as normal (i.e. at 4 °C), samples were taken 
at various pHs and each sample was then heated to 50 °C, in order to maintain the 
required temperature while analysing the samples by laser excitation. The lifetimes 
for heated Ru(L-L)2NCSphen:PLL are presented in Table 5.13.
The first point to note is the fact that shorter lifetimes were obtained at 
higher temperatures for both PLL and BSA, which was anticipated due to the 
increase of efficiency of deactivation pathways of Ru(II) complexes at such 
elevated temperatures [23], However, the most significant observation of this study 
is the fact that at 50°C, the lifetimes are no longer sensitive to pH variations for 
Ru(L-L)2NCSphen:PLL. This correlates well with the fact that PLL at 50°C does not 
undergo a pH dependent structural transition, but rather adopts a non-random type 
P-sheet conformation somewhat similar to the a-helical form earlier discussed [24], 
These probes would not be expected to be sensitive enough to differentiate between 
two such similar non-random conformations as a-helices and (3-sheets. Hence, the
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label when bound to PLL in the (3-sheet conformation would be expected to behave 
in a very similar fashion to when in the helical form due to the equivalent local 
environments of the labels when bound to both. Another significant observation is 
the reversibility of this experiment which indicates that these heat induced 
structural variations are indeed reversible and that PLL reverts back to its random 
coil conformation on cooling down the conjugate solution. Such an effect would 
further support our theory and would make the decomposition of the bioconjugate 
an unlikely explanation for any effects noted at such elevated temperatures.
Table 5.13 pH dependence of emission lifetimes of
aerated Ru(L-L)2NCSphen:PLL at 50°C where L=bpy and phen.
pH L= bpy
lifetime 1, 2 (ns)
L=phen
lifetime 1, 2 (ns)
3.0 60 (20), 360 (80) 200 (20), 500 (80)
6.0 45 (15), 420 (85) 190 (20), 530 (80)
9.0 65 (30), 390 (70) 220 (15), 530(85)
11.0 60 (35), 370 (65) 220 (15), 510 (85)
12.0 65 (30) 400(70) 120(15), 480 (85)
For the heated samples of Ru(L-L)2NCSphen:BSA the lifetimes of the samples at 
every pH are shorter than the corresponding sample at room temperature as for the 
PLL conjugates, again explained by the spectroscopic properties of the label [23], 
and not due to any conformational effects of the bound protein. However, no 
significant change in the pH sensitivity of their luminescence lifetimes is evident in
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that the lifetimes still show dramatic reduction at pH extremes, particularly at pHs 9- 
12. It was anticipated that if the chemical were to unfold the protein the acid-induced 
denaturation effects would no longer be evident. This is not the case however, which 
would indicate either that the temperature of 50° C is not high enough to cause 
denaturation in BSA or that the heat induced structural variations are minimal and of 
a different nature to the acid-induced conformational changes. This renders such 
studies on proteins inconclusive and in order to complete such studies much higher 
temperatures should be used in an attempt to folly denature the protein BSA
(2) Effect of chemical denaturants.
As discussed in chapter 3, the various proteins were treated with denaturing agents 
including urea and guanidine by allowing them, both in solution form, to react 
together at 4 °C and the normal procedure of conjugating the labels to the resulting 
protein solution was carried out (See section 2.3). In section 3.2.4.5, the effect of 
chemical denaturants on the success of the conjugation reactions has been discussed, 
whereas this section incorporates the study of the effect of the denaturing agents on 
the acid-induced conformational variances of the bound biomolecules.
Firstly a study of the pH sensitivity of the lifetimes of conjugates prepared 
with 1 M solutions of chemical denaturants added (guanidine/urea) was carried out. 
On comparing the acid-induced decay behaviour of Ru(L-L)2NCSphen:BSA when 
treated with urea to the normal conjugate as described in Table 5.11 the trend 
observed is very similar in that significant drops in both lifetime components are still 
evident at alkaline pHs. The similar pH sensitivity in the presence of urea indicates 
either of two main possibilities, one being the ineffective denaturation of the protein 
using urea possibly due to the requirement of a higher concentration of urea. This 
would mean that the lifetime reductions judged to be due to denaturation at pH 
extremes would still be evident. The second explanation may be that the denaturation 
induced by urea may not lead to significant structural disruptions and hence the acid-
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induced denaturation would still be evident in such conjugates, having a stronger 
effect on the label. However, on removing oxygen from all urea treated samples, the 
resulting increases in both lifetime components are more significant than those not 
treated with urea. This indicates that the urea treated samples are more susceptible 
and accessible to the quenching effects of oxygen most likely due to some form of 
structural disruption having taken place. In the case of Ru(L-L)2NC Sphen: PLL very 
little change is observed in their acid induced decay behaviour on treating with urea, 
except that again the samples appear more accessible to the quenching effects of 
oxygen.
To establish the concentration of denaturant required to affect the lifetimes of 
the labels and thus possibly alter the proteins conformational properties, the effect of 
increasing concentrations of guanidine on the emission lifetimes of the protein-bound 
labels was determined and is described below. Table 5.14 outlines the influence of 
various concentrations of guanidine on the emission lifetimes of both conjugates 
Ru(dpp)2NH2phen:BSA and Ru(dpp)2NCSphen:PLL.
Table 5.14 Effect of increasing concentrations of guanidine (Guan) on the 
lifetimes of Ru(dpp)2 NH2phen:BSA and Ru(dpp)2 NCSphen:PLL, pH 9.2
Cone Guan Ru(dpp)2NH2phen:BSA Ru(dpp)2NCSphen:PLL
(mol/1) Aerated lifetimes 1, 2 (ns) Aerated lifetimes 1, 2 (ns)
0.0 1650 (55), 380 (45) 800 (65), 300 (35)
2.0 1370 (60), 270 (40), 820 (80), 210 (20
4.0 1340 (65), 290 (35), 850 (65), 330 (35)
6.0 1270 (80), 340 (20) 820 (75), 290 (25)
10.0 1240 (75), 390 (25) 780 (75), 260 (25)
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It was anticipated that one may possibly be able to estimate the approximate 
concentration of denaturant necessary to unfold the protein by observing the gradual 
reduction of the lifetimes of the labels to a minimum level with increasing 
concentrations of denaturant. Essentially, we can deduce from Table 5.14 that the 
longer lifetime of the BSA-bound label is significantly reduced after adding 2.0 M 
guanidine whereas the shorter lifetime varies less appreciably The longer lifetime 
continues to decrease further but much more gradually upto 10 M guanidine and as 
the errors in the lifetimes are approximately 5% these changes in lifetime at 2 M 
guanidine are insignificant. The most significant lifetime reductions with 2 M 
added would suggest that the chemical has unfolded/denatured the protein at such a 
concentration assuming the minimisation of the emission lifetimes is an indication 
of complete denaturation.
Table 5.14 also reveals the contrasting effect the denaturant has on the PLL- 
bound label at various pHs. In contrast to the reduction of the decay lifetimes for 
the BSA conjugate, a slight increase in the longer lifetime is noted with the addition 
of denaturant, however the variations are within the range of experimental error. 
However, it must be noted that the emission lifetimes of the same PLL-bound label 
at a higher pH of pH 12 experience significant enhancements. This may be due to 
the recognised effect of denaturants such as guanidine and lithium chloride on the 
conformation of PLL [25], Although PLL is a synthetic biomolecule which does not 
undergo the same unfolding process as natural proteins, reports reveal that both 
chemical denaturants and other salts do indeed affect the secondary conformational 
changes inherent in PLL [25], which are closely related to its biological activity
[15]. This proposedly occurs by making PLL unstable in water via the destruction or 
minimisation of the hydrogen-bonded structure of water surrounding the non­
ionised peptide [25], Hence the guanidine may de-stabilise the a-helix favoured at 
pH 12, thereby restoring PLL to a random coil conformation where the more 
enhanced lifetimes of the bound labels have been evident. On the other hand, PLL 
at pH 9 is probably still in the random coil conformation which would not be 
affected by the denaturant.
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Hence, one can see that the denaturation induced by chemical denaturants 
may possibly be monitored by the reduction in decay lifetimes of the protein-bound 
labels but only if an optimal concentration of denaturant is added which depends on 
the chemical used and the nature of the protein. This would explain the minimal 
effect of 1 M guanidine on the pH sensitivity of the PLL and BSA bound 
complexes. In contrast, on increasing the concentration of guanidine to where a 
decline in decay lifetime of the label is noted, the influence on the pH sensitivity of 
the labels is probably due to the unfolding of the protein in the presence of 
guanidine. From these studies it is evident that the higher concentration of 
guanidine greatly decreases the pH sensitivity of the decay lifetimes of the labels 
when bound to both PLL and BSA. In the case of Ru(bpy)2NCSphen:PLL with urea the 
emission lifetimes from pH 2 to pH 12 are quite similar, being of similar duration to 
those of the conjugate at acidic to neutral pHs when PLL is in the random coil 
conformation. This would indeed be anticipated if  as suggested the guanidine does 
destabilise the a-helix returning it to the random coil form. This being the case, 
PLL would be in the random coil form at all pHs in the presence of guanidine 
explaining the similarity of the decay lifetimes of the PLL-bound labels at all pHs.
On the other hand the emission lifetimes of the BSA-bound labels are 
reduced, rendering them of similar duration to those normally achieved at highly 
alkaline pHs in the absence of urea. This is probably due to the unfolding effect of 
the denaturant guanidine on the protein. The difference in the effect of 1 M and 5 M 
guanidine on the pH sensitivity of the decay lifetimes of the protein-bound labels 
would appear to be due to the fact that 1 M guanidine is not concentrated enough to 
affect the conformational forms of the proteins while 5 M is sufficiently 
concentrated to exert its reducing affect on the protein. Hence the labels are 
somewhat sensitive to the denaturation which the proteins undergo in the presence 
of chemical denaturants such as urea and guanidinium chloride although they 
appear to be less sensitive than for acid-induced conformational variances of the 
same proteins.
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5.2.2 Lysozyme activity studies.
5.2.2.1 Introduction.
Although the capability of the emission lifetimes of the ruthenium complexes to 
detect conformational changes of the protein BSA has been indicated in the previous 
section, some of the major restrictions include the inability to establish the effect of 
the label on the function and natural structure of the protein and the lack of 
information on and understanding of the conformational properties of BSA. Under 
extreme reaction conditions such as pH extremes it was merely assumed that 
unfolding of the protein had taken place and therefore that any changes in emission 
lifetime/intensity of the bound label were likely to be due to structural variances of 
the biomolecule emanating from the unfolding process.
In this section, the same labels are covalently bound to the enzyme, 
lysozyme. Lysozyme is present in tears, nasal mucus, tissues and milk and acts by 
catalysing the hydrolysis of a polysaccharide that is a major constituent of the cell 
wall of certain bacteria [26], The polymer is formed from (3 (l-4)-linked alternating 
units of W-acetyl glucosamine (NAG) and TV-acetylmuramic acid (NAM) as depicted 
in Figure 5.14 and the hydrolysis of these 1,4-P linkages by lysozyme destroys the 
cell walls of many airborne gram positive bacteria [26], Lysozyme contains small 
regions of pleated sheet, little a-helix and large regions of random coil. The molecule 
has a deep central cleft that harbours a catalytic site with six subsites that bind 
various substrates and inhibitors [26]. The cleft contains nonpolar side chains of 
amino acids for binding the nonpolar regions of the substrate, and hydrogen-bonding 
sites for the acylamino and hydroxyl groups. Small distortions occur in the enzyme 
structure at the active-site binding cleft when the inhibitor is bound ie. the enzyme 
undergoes a small conformational change [27], The binding sites of lysozyme are 
approximately complementary in structure to the structures of the substrates as the 
nonpolar parts of the substrate match up with nonpolar side chains of the amino
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acids [21]. The reactive part of the substrate is firmly held by this binding next to 
acidic, basic or nucleophilic groups on the enzyme.
The enzymatic activity of lysozyme, which is dependant on its structure can 
be measured by determining the loss of substrate in this case the bacteria M. 
lysodeikticus per unit of time and was determined using modified methods of Shugar
[28] and Perkins [29], subsequently described in section 2.5.4. The primary 
objectives of this study were twofold; (1) to determine the effect if any of the 
covalently bound label on the natural stability and activity of the enzyme (and hence 
on its original conformation); (2) to investigate the correlation between the 
deactivation of the enzyme and changes in decay lifetimes of the protein-bound label, 
thereby determining the potential of these complexes in biological applications.
Cleavage
R = C H o - C H - C O O H  
J I
Figure 5.14 The polysaccharide substrate o f  lysozyme found in bacterial cell walls.
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5.2.2.2. Results and discussion.
Firstly, the effect of pH and protein denaturants on the activity of pure lysozyme was 
determined to ascertain the conditions under which the enzyme becomes totally 
deactivated. The Ru(II) complexes were bound to the enzyme via the carbohydrate 
moieties (Ru(L-L)2NH2phen:LYS) and the lysine residues (Ru(L-L)2NCSphen:LYS) 
as was done for BSA and PLL (See sections 2.3.1 & 2.3.5). The effect of the label 
on the activity o f the enzyme was determined under similar conditions in order to 
ensure that the labels do not have adverse affects of the natural conformation 
variances of the protein. The sensitivity of the decay lifetimes o f the lysozyme 
(LYS)-bound labels to pH changes and to chemical denaturants was then studied in 
attempts to find correlations between deactivation of the enzyme and a decrease in 
decay lifetime of the label. Table 5.16 lists the loadings achieved and the decay 
lifetimes of the various lysozyme conjugates prepared.
Table 5.16 Conjugation ratios and lifetimes of 10:1 Ru(L-L)2NH2phen:LYS 
and Ru(L-L)2NCSphen:LYS, 0.05M carbonate buffer, pH 8.2.
Conjugate Conjugation
ratio
Decay lifetimes 1, 2 
(ns)
Ru(bpy)2NH2phen:LYS 1 650 (70), 250 (30)
Ru(phen):NH:phcn:LYS 1 700 (70), 280 (30)
Ru(dpp)2NH2phen:LYS 3 800 (75), 350 (25)
Ru(bpy)2NCSphen:LYS 3 750 (80), 260 (20)
Ru(phen)2NCSphen:LYS 3 780 (70), 300 (30)
Ru(dpp)2NH2 phcmLYS 1 850 (75), 380 (25)
Conjugation ratio was calculated according to Nairn [30],
The protein concentration was determined using the Folin-Lowry assay [31].
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As seen from the information above, very low loadings are achieved for all 
labels bound to lysozyme. The less efficient binding compared to BSA may be due 
to the smaller number of lysine residues per lysozyme molecule ie. 6 and/or the 
more compact structure of the enzyme. As with all protein-bound labels studied, 
double exponential decay kinetics is evident. However, as was found for the same 
labels bound to BSA, on mixing the label [Ru(dpp)2NH2phen]2+ with lysozyme and 
analysing immediately (hence, no covalent linkage has occurred), double 
exponential decay kinetics results, indicating substantial electrostatic interactions 
between such labels and the enzyme. Indeed a possibility may be the intercalation 
of the label into the folded structure of the enzyme, a phenomenon already 
witnessed, particularly between Ru(II) complexes and DNA [32] and which already 
has been proposed to occur between Ru(II) labels and the protein BSA. For this 
reason, the other smaller labels were used mainly in the remainder of this section. 
One unusual aspect is the low lifetimes obtained for Ru(dpp)2NH2phen:LYS, both 
when this label is bound to lysozyme via the carbohydrate moieties and glutamic 
acid residues. This suggests that the label has some adverse affect on the enzyme, 
but this topic will be addressed subsequently.
(1) pH effect:
A correlated study between the pH sensitivity of the enzyme activity of pure and 
labelled lysozyme and the decay lifetimes of the lysozyme-bound labels was carried 
out. The deactivating effect of pH on the various lysozyme conjugates is outlined in 
Table 5.17 where they are compared to the behaviour of the non-labelled lysozyme. 
This study allows one to determine the effect of such modification on the activity of 
the enzyme and the effects of modification on the conformational stability of the 
protein at extremes of pHs.
When the activity of enzymes is measured at several pH values, the optimal 
activity is typically between pH 5 and pH 9 [27], This was indeed the case for
244
lysozyme whereby it was most active at breaking down the cell wall of the bacteria 
M. lysodeikticus between pHs 5 and 8 while almost totally inactivated at more 
extreme pHs (See Table 5.17(a)). There are two likely explanations for such 
behaviour. (1) Enzyme denaturation may occur at pHs lower and higher than the 
optimal pH range. (2) Alteration in the charged state of the enzyme and/or substrate 
with pH may lower the reaction rate [27], The enzyme may undergo changes in 
conformation when the pH is varied. A charged group distinct to the region may be 
necessary to maintain the active tertiary or quaternary structure. As the charge is 
changed with pH, the protein may unravel, become more compact causing a decline 
in activity. Depending on the severity the activity may or may not be restored when 
the enzyme is restored to the optimal pH. In this case the activity of lysozyme is 
partially restored when the pH is brought back to the optimal pH 6-7.
Table 5.17 pH sensitivity of the activity of (a) lysozyme (b) 
Ru(bpy)2 NH2phen:LYS,(c)Ru(bpy)2NCSphen:LYS,
(d)Ru(phen)2NH2phen:LYS, (e)Ru(dpp)2NH2 phen:LYS(a) and (f) 
Ru(dpp)2NH2phen :LY S(b).
pH
(a) (b)
Enzyme activity 
(c) (d) (e) (f>
2.6 0.001 0.001 0.001 0.005 0.001 0.000
4.6 0.001 0.002 0.002 0.010 0.001 0.000
6.2 0.009 0.002 0.004 0.008 0.001 0.002
8.2 0.005 0.004 0.002 0.000 0.000 0.001
9.2 0.001 0.000 0.004 0.000 0.000 0.000
10.2 0.001 0.000 0.002 0.000 0.000 0.000
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On studying the activity of the various lysozyme conjugates, the first point 
to note is the general reduction of maximum activity which may be merely due to 
the physical affect/steric hindrance of the label on the reaction with the substrate. 
However the optimal pH range where maximum activity of the enzyme is noted to 
be still approximately between pH 4 and pH 8, indicating the minimal effect of 
most of the covalently bound labels on the stability and pH susceptibility of the 
enzyme. The fact that most of the labelled forms of lysozyme behave similarly to 
the unmodified lysozyme indicate that the binding sites of the labels on the enzyme 
are not located on the active site, critical to the binding of the enzyme to the 
substrate. Lysozyme modified by labels bound to the carbohydrate moieties and 
lysine residues is still quite active indicating that these sites are not critical to the 
activity of the enzyme.
pH
Figure 5.15 The pH  sensitivity o f the activity o f lysozyme and various lysozyme 
conjugates, (a) Ru(bpy)2NH2phen:LYS (b) Ru(phen)2NH2phen:LYS and (c)
Ru(dpp)2NH2phen:LYS(a).
One exception however appears to be the label [Ru(dpp)2NH2phen]2+ when 
bound to lysozyme via the glutamic acid residues (Ru(dpp)2NH2phen:LYS(b)) and 
via the carbohydrate moieties (Ru(dpp)2NH2phen:LYS(a)) whereby the enzyme 
appears to be almost totally inactivated with only low activity observed at pHs 6-8. 
This suggests that the hydrophobic complex adversely affects the stability and 
conformational properties of the enzyme. Another possibility is that the binding of 
such a large molecule to lysozyme may cause steric hindrance, thereby preventing 
the substrate from binding as efficiently. Another possible explanation is the 
importance of glutamic acid residues in the binding of the enzyme to substrate which 
is confirmed by reports whereby the modification of all the carboxylic acids of the 
glutamic acid residues by treating with aminomethanesulphonic acid and 
carbodiimide results in a total loss of activity of lysozyme [33], The effect of the 
bound Ru(II) complexes on the pH sensitivity of lysozyme activity is outlined in 
Figure 5.15.
Although the lysine residues and carbohydrate moieties do not appear to be 
critical to the activity of lysozyme, Figure 5.15 reveals a slight difference in the 
activity patterns of lysozyme. The labelling of lysozyme via lysine residues (Table 
5.17(c)) appears to activate the enzyme at high pHs whereas the modification of the 
carbohydrate moieties has an activating effect on the enzyme at low pHs. This is 
probably due to the change in charge that these labels impose on the sites.
On determining the significance of pH on the activity of lysozyme, the pH 
sensitivity of the lifetimes of Ru(II) labelled lysozyme was determined. To illustrate 
this phenomenon, the pH sensitivity of the emission lifetimes of 
Ru(bpy)2NCSphen:LYS is tabulated in Table 5.18 and graphically represented in 
Figure 5.16. The decrease in lifetimes particularly at high pHs is evident for both 
conjugates of lysozyme as was found for the labels bound to the protein BSA earlier 
in this chapter. Again this indicates denaturation or some unfolding or change in 
conformation of the enzyme at extremes of pH. The emission intensity of these 
protein-bound labels is also very sensitive to pH variations with the most intense 
emission at acidic to neutral pHs (i.e. pH 3-6), in correlation with the pH range
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where lysozyme in free and labelled form is at its most active and where the labels 
display the longest lifetimes.
Table 5.18 pH sensitivity of decay lifetimes of (a) Ru(bpy)2NCSphen:LYS and 
(b) Ru(phen)2NCSphen:LYS, 0.01 M carbonate buffer pH 8.2.
pH (a) Decay lifetimes 1,2 
(ns)
(b) Decay lifetimes 1,2 
(ns)
4.0 800 (70), 250 (30) 900 (75), 300 (25)
6.0 880 (70), 280 (30) 1000 (70), 280 (30
8.0 900 (70), 250 (30) 950 (75), 250 (25)
10.0 700 (65), 200 (35) 850 (70), 240 (30)
12.0 600(70), 150 (30) 650 (70), 200 (30)
pH
Figure 5.16 pH  sensitivity o f the emission lifetimes ofRu(bpy) 2NCSphen:LYS.
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Hence, these results confirm that there is indeed a close association between 
the loss of activity of the enzyme lysozyme due to either denaturation at pH 
extremes or conformational changes due to changes in charges and the decline in 
decay lifetimes of the enzyme-bound labels. This correlates well with the promising 
results found in the monitoring of the acid-induced denaturation of the protein BSA 
using the decay lifetimes of the bound labels.
(2) Effect o f chemical protein denaturants:
This section involves the determination of the deactivating effect of chemical 
denaturants on the enzyme lysozyme in an attempt to correlate such deactivation 
with changes in the decay lifetimes of the labels bound to the same enzyme, as was 
confirmed previously in the case of acid-induced denaturation. One of the primary 
objectives is the elucidation of the approximate concentration of guanidine 
necessary to deactivate/denature the enzyme when unmodified and when labelled 
with Ru(II) polypyridyls. This should allow one to estimate the effect of such 
protein modification on the stability of the protein under such adverse conditions. 
An illustration of the effects of denaturants on both the activity of the labelled 
lysozyme and the emission lifetimes of the label bound to lysozyme is given in the 
following section. Table 5.19 and Figure 5.17 reveal the effect of guanidine on the 
activity of the labelled enzyme while Table 5.20 and Figure 5.18 illustrate the 
susceptibility of the emission lifetimes of the labels to such a chemical denaturant. 
Table 5.19 reveals that although the addition of the denaturant guanidine leads to 
loss of activity of lysozyme, there is a minimum concentration of the chemical 
required to fully deactivate the protein, below which little loss of activity of the 
enzyme is noted. This is probably due to the co-operative nature of the denaturation 
of the protein as discussed in section 4.1.4. Figure 5.17 discloses that approximately 
2 M guanidine is necessary to deactivate the natural lysozyme. While the enzyme is 
still 95% active after adding 1.2 M guanidine an increase of another 1.2 M leads to
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almost total loss of activity. In the case of the labelled enzyme, slightly higher 
concentrations (3.6 M) of denaturant are necessary to induce total loss of activity of 
lysozyme and the denaturation curve reveals a less abrupt loss of activity. This 
suggests that the labelling of the enzyme with these Ru(II) complexes actually has a 
stabilising effect on the enzyme against the reducing properties of the denaturant, 
possible due to steric hindrance.
Table 5.19 Effect of guanidinium chloride (Guan) on the enzyme activity 
of lysozyme (LYS) and lysozyme conjugates pH 8.2.
Lysozyme/conjugate Enzyme activity (vs [Guan])
0.00 M 0.90 M 1.20 M 2.40 M 3.60 M 4.80 M
lysozyme 0.013 0.013 0.011 
Ru(bpy)2NH2phen:LYS(a) 0.008 0.007 0.007 
Ru(bpy)2NCSphen:LYS 0.005 0.005 0.006
0.001 0.001 0.004 
0.005 0.001 0.001 
0.004 0.000 0.000
Error of activity is approximately =-0.001
Table 5.20 Effect of guanidinium chloride on the emission lifetimes of 
lysozyme conjugates pH 8.2.
Cone. Guan. (mol/1) Ru(bpy)2NH2phen:LYS Ru(bpy)2NCSphen:LYS
0.00 M 900 (70), 250 (30) 
1.20 M 880 (75), 260 (25) 
2.40 M 800 (70), 230 (30) 
3.60 M 740 (65), 200 (35) 
4.80 M 650 (65), 190 (35)
950 (75), 250 (25) 
960 (75), 260 (25) 
900 (75), 240 (25) 
780 (70), 200 (30) 
700 (65), 180 (35)
250
0.014 - r -
Cone. Guan. (mol/1)
Figure 5.17 Effect o f  guanidine (Guan) on the enzyme activity o f  (1) lysozyme, (2) 
Ru(bpy)2NH2phen:LYS (NH2phen:LYS) and (3) Ru(bpy)2NCSphen:LYSpH 8.2
(NCSphen;LYS)
Cone. Guan (mol/l)
Figure 5.18 Effect o f  guanidine on the emission lifetimes ofRu(bpy)2NCSphen:LYS
pH  8.2.
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Regarding the effect of chemically induced denaturation on the labels bound 
to lysozyme, the sensitivity of the emission lifetimes of the same labelled enzymes 
outlined in Table 5.20 and presented in Figure 5.18 reveals that the longer lifetime 
in particular is affected by guanidine. The emission lifetime of one label of duration 
950 ns when bound to the 100% active enzyme diminishes to a minimum duration 
of 700 ns after the addition of approximately 4 M guanidinium chloride, a 
concentration sufficient to totally deactivate the enzyme as verified in Figure 5.17. 
A levelling off of the lifetime above concentrations of 3.6 M indicate that total 
deactivation/denaturation of the enzyme has indeed been achieved. As for the 
deactivation by pH, this study appears to confirm the association between the loss 
of activity or denaturation of the enzyme and the reduction of decay lifetimes of the 
labels bound to the deactivated enzyme.
In conclusion, the results of these studies allow us to emphasise the 
following interesting points. Firstly, they indicate that the labels do have some 
effect on the stability and activity of the enzyme which varies depending on the 
nature and position of the binding sites in relation to the active site of the enzyme. 
In particular the labels bound to the glutamic acid residues have adverse affects on 
the enzyme, causing almost a total loss of activity, proposed to be due to the critical 
positioning of such residues in the active site of lysozyme. However, the 
conformational variations of the enzyme induced by both pH and chemical 
denaturants do not appear to be affected by the covalently bound labels which is 
very important in the probing of such “inherent” variances. Furthermore, there are 
indeed correlations between loss of activity and possible denaturation of lysozyme, 
and the reduction of the decay lifetimes of the covalently bound labels which had 
earlier been proposed for the protein BSA. This thereby strongly strengthens our 
case regarding the potential of these labels in monitoring denaturation of proteins in 
real biological processes as well as the more fundamental secondary structure 
changes in synthetic poly-amino acids.
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5.3 Conclusion.
Studies in chapter 4 verified that while the emission spectra of the protein-bound 
Ru(II) complexes are influenced by the conformational variances of the bound 
biomolecule the variations in intensity are not sensitive or specific enough to be used 
as efficient probes. This chapter investigates the potential of the emission lifetimes of 
the labels as probes to the proteins conformational variations, whereby various 
conformational changes are induced in the proteins and the sensitivity of the emission 
lifetimes of the bound labels to such variations are investigated.
As the influence of pH on both the secondary structure of polypeptides and 
the 3-D structure of proteins is widely known, these are the conformational changes 
primarily studied. As anticipated the sensitivity of the decay lifetimes to pH is 
striking and appears to be dependent on the form of bound biomolecule. This 
phenomenon is explained to be due to the fact that the lifetimes of the ruthenium 
complexes are affected by their local environment and hence local structural 
variations of the bound biomolecule are discerned by subsequent modification in the 
decay kinetics of the bound labels. The propensity of the labels to differentiate 
between random and non-random secondary structures including random coil and a- 
helices in synthetic poly-amino acids is verified as such structural variances lead to 
significant changes in emission lifetimes. This capability appears to be primarily due 
to the greater sheltering effect of the biomolecule of random structure on the 
ruthenium complex from certain quenching effects in particular oxygen. In this 
respect their probing qualities are based on the difference in the efficiency of oxygen 
quenching on the lifetime of the labels excited state due to changes in their 
immediate surroundings. The next step incorporated the study of the efficacy of such 
probes to monitor more complex structural variations in real proteins such as 
folding/unfolding processes. The decay lifetimes of the labels also appear to be 
susceptible to the unfolding process of natural proteins, induced both by pH 
extremes and by chemical denaturation. Certain folding/unfolding processes of the 
protein studied, in particular acid-induced denaturation apparently lead to reduction
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of the lifetimes of the bound labels, probably due to the more open and accessible 
structure of the protein when unfolded rather than local environmental effects noted 
for the synthetic biomolecules. However, due to the unavailability of more thorough 
biological procedures the unfolding of the protein by extremes of pH and by 
chemical denaturants was not confirmed but can only be assumed.
For this reason, the second main objective was to broaden our scope on the 
study of real biological processes by investigating the labelling of the active enzyme, 
lysozyme with the same Ru(II) complexes. Firstly, the effect of labelling on the 
activity of the enzyme is determined to ensure that such modification does not de­
stabilise, deactivate or induce structural deviations in the protein which would 
adversely affect our studies. In order to verify that unfolding or denaturation of the 
enzyme does indeed take place, the loss of activity of lysozyme towards a specific 
substrate is used as the indicator of denaturation. The enzyme remains active on 
binding the various labels, however the nature of the binding site of the label on the 
enzyme does affect its activity, probably due to the various positions of the site in 
relation to the active site of the enzyme. On binding to the glutamic acid residue, a 
total loss of activity results, thereby indicating that certain glutamic acids are 
essential in the binding of the enzyme to substrate, which correlates with reports in 
the literature [33], Furthermore, the label [Ru(dpp)2NH2phen]2+ deactivates the 
enzyme to a significant degree, possibly due to its large size and/or its hydrophobic 
nature causing conformational variations.
The denaturation of the labelled lysozyme by pH and chemical denaturants is 
followed and the decay lifetimes of the labels are simultaneously monitored to 
investigate the influence of protein deactivation on the lifetimes of the labels. 
According to our studies, both natural lysozyme and its various labelled forms are 
most active at pHs 4-8 and significantly, the most enhanced lifetimes of the protein- 
bound labels are indeed evident at such a pH range. Furthermore, the denaturing 
effect of guanidine is revealed by the combined loss of activity of the enzyme and 
decline in emission lifetimes of the label. This study allows one to approximate the 
concentration of denaturant required to deactivate the enzyme. Such results are
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promising as they indicate the possibility of using such labels in real biological 
matrices without adverse effects on the protein nature.
In conclusion, the fluorescent Ru(II) complexes chosen appear to be 
successful as probes of certain conformational variances of the bound biomolecules 
whereby the decay lifetime of the excited state of the fluorescent label acts as the 
sensitive reporter, both of secondary structure changes of polypeptides and unfolding 
processes of natural proteins. This appears to be primarily due to the sensitivity of 
the labels excited state to the local environment in addition to its susceptibility to 
quenching effects, particularly that of oxygen. Finally, in most cases the labels appear 
to have little effect on the natural conformational properties of the proteins 
concerned which is a critical factor in their use of probes of real biological systems. 
However this obviously depends upon the position of the label on the biomolecule 
concerned and should be examined prior to any probing studies.
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Chapter 6. 
Final remarks.
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This thesis involves the investigation of the photophysical properties of a range of 
Ru(H) polypyridyl complexes when covalently bound to various synthetic and 
natural biomolecules. Chapter 1 gives a general introduction into several aspects 
involving ruthenium chemistry. Firstly, an introduction into the various spectroscopic 
properties of Ru(II) complexes is given, with particular emphasis placed on the 
advantages these complexes possess to render them suitable as luminescent probes. 
A literature survey on current applications of such complexes in biological matrices 
is carried out, including the interactions of Ru(II) polypyridyls with DNA, their use 
in cancer treatment and various uses when bound to enzymes and antibodies from 
stabilising agents to models of novel drugs. This aims to illustrate the wide range of 
applications possible and their potential in the probing of biological materials. Finally 
the various techniques involving the covalent modification of proteins are discussed 
in order to understand the methods used and reactions involved in covalently binding 
the labels to the proteins in this thesis.
Chapter 2 deals with the synthesis of the ruthenium complexes and the 
specific procedures used in the conjugation of these labels to the proteins. In this 
chapter, the experimental details of the different physical measurements used for the 
elucidation of the properties of the ruthenium complexes both in the free form and 
when bound to proteins are given. Finally, studies were carried out on the decay of 
ruthenium complexes to investigate the accuracy and reliability of the 
functions/models used to analysis the nature of the decay and determine the emission 
lifetimes of the various emitting components of the luminescent probes. From this 
study the suitability of the single exponential decay law to elucidate the lifetime of 
the unbound labels and a multi-exponential decay law for the lifetimes of the various 
emitting species of the protein-bound labels is confirmed.
The ultimate objectives behind this thesis include the covalent linkage of 
Ru(II) polypyridyl complexes to proteins via specific binding sites and the 
investigation into the potential of these complexes as fluorescent probes capable of
6.1 Summary and final remarks.
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monitoring conformational variances which the bound biomolecules undergo in 
solution, in particular the secondary structure changes in polypeptides and the 
unfolding processes in real proteins.
In chapter 3, the methods developed to selectively bind Ru(II) complexes to 
the (1) lysine residues (2) carbohydrate moieties (3) glutamic acid residues and (4) 
terminal amino/carboxylic acid groups of the biomolecules studied were carried out 
and the spectroscopic and the luminescent properties of such protein-bound labels 
were investigated as extensive characterisation of the complexes and the assessment 
of their probing properties were prerequisites to any further applications as 
luminescent probes. There were therefore three main aims behind the work carried 
out in chapter 3. Firstly, it was intended to successfully bind labels to the specific 
sites mentioned on each biomolecule in a covalent manner. Secondly, the verification 
of the purity of both the free complexes and their protein-bound forms was essential 
to deem any results obtained reliable. Finally, extensive analysis of the spectroscopic 
and luminescent characteristics of the fluorescent labels in their free form and when 
bound to proteins was fundamental in understanding the sensitivities of their various 
spectroscopic properties to changes in their surroundings, namely in the form of 
conformational variances of the bound biomolecules.
The most important conclusions from the studies carried out in chapter 3 are 
summarised herein. Firstly, methods were developed to bind the labels selectively to 
both the side groups of the amino acid residues and to the terminal groups of the 
polypeptide chain of both synthetic and natural proteins. A chromatographic method 
was developed based on size exclusion to distinguish the unbound from the protein- 
bound label. It had previously been assumed that most conjugates would be pure as 
dialysis should have removed all unbound label. However, small amounts of 
impurities due to free label (< 5%) were identified but as quantitative analysis was 
not carried out, the exact purity of the conjugates was not ascertained. Nonetheless, 
for the purpose of the remainder of the work, the conjugates were deemed to be 
adequately pure to be studied as probes as the presence of unbound label in minute 
quantities did not appear to adversely affect the probing capabilities of the labels.
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The emission lifetime of the label revealed the greatest potential as a sensitive 
reporter of the bound biomolecules as in most cases the duration and kinetics of the 
lifetime were significantly affected when bound to a protein. The change from single 
to multi-exponential decay kinetics and the enhancement of lifetimes of the labels 
when bound to proteins were proposed to be most likely due to a combination of 
factors, including the decrease in vibrational activity of the label when held in the 
more rigid environment of the biomolecule and the protection of the label from 
various quenching effects, particularly that of oxygen. Further studies concluded that 
the specific binding site chosen on the protein as well as the absolute conformation 
of the protein in question have an important bearing on the changes incurred on the 
decay lifetimes of the protein-bound labels. Evidence from size exclusion 
chromatography and conjugation ratio calculations suggested that the larger more 
hydrophobic complexes such as [Ru(dpp)2NH2phen]2+ experience strong electrostatic 
interactions with proteins in addition to the anticipated covalent linkage whereas this 
was not the case for the synthetic biomolecules studied. Therefore, although these 
hydrophobic labels appear to be the most sensitive to conformational variances of the 
bound proteins, the probing potential may be adversely affected or indeed 
exaggerated by the interference from electrostatically bound label.
The labelling efficiency of various Ru(II) complexes to selected proteins was 
studied, concluding that the success of conjugation varies notably between synthetic 
and natural biomolecules and between various labels, with evidence of very efficient 
labelling of bovine serum albumin, particularly on the lysine residues. In contrast low 
loadings were achieved on the same sites on poly-L-lysine. The reason for this 
discrepancy is not evident but may be related to the reactivity of the biopolymer. In 
summary, the main achievements of these studies include the discernment of all 
relevant properties of the ruthenium complexes to be used as labels and the 
successful site and side chain modification of both natural and synthetic biomolecules 
which led the way to the investigation of their probing capabilities and limits in 
chapter 4 and 5.
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In chapters 4 and 5, more detailed studies are carried out involving the 
determination of the potential of these labels to monitor conformational variances of 
the bound biomolecule in solution using various spectroscopic and luminescent 
properties of the label as the probes. The overall aim in these two chapters therefore 
was to study the effect of conformational variances of the conjugated biomolecules 
on various spectroscopic properties of the complexes, including their absorption and 
emission spectra and their emission lifetimes. The effect of pH and denaturants on 
such spectroscopic and luminescent properties of the protein-bound labels were 
investigated as these two parameters in particular are known to induce significant 
conformational changes in polypeptides/proteins. Chapter 4 concentrated on the 
investigation of the sensitivity of the absorption and emission spectra of the labels to 
the conformational variances of the proteins while Chapter 5 incorporated the study 
of the emission lifetimes of the labels.
The reason for choosing the pH as a variable was because the predominant 
form of secondary structure of the synthetic poly-amino acids poly-L-lysine and 
poly-L-glutamate, the subject of our studies, are known to be highly dependent on 
pH. The secondary structure of the basic PLL changes from random-coil 
conformation to an a-helical form above pH 10 approximately, due to the 
deprotonation of the amino groups of the lysine residues permitting such a regular 
structure to form. In contrast, the random coil conformation is the predominant form 
of PLGlu at neutral and basic pHs (i.e. above pH 5) due to the repulsion of the 
deprotonated carboxylic acid groups of the glutamic acid residues preventing the 
formation of a-helical structure. An important point to note is the similarities in 
conformational variances of synthetic polypeptides and proteins, hence their use as 
models in the study of protein unfolding and furthermore their structure is critical to 
their biological activity as is found for proteins. Finally, although definite information 
on the exact structural forms of the proteins BSA and the enzyme lysozyme are not 
given at various pHs, it is known that some denaturation/unfolding of such proteins 
takes place at very low and high pHs.
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By studying the pH sensitivity of the absorption and emission spectra of the 
protein-bound labels, the limit of these properties to monitor conformational 
variances of the proteins was realised. In particular the absorption spectra of the 
labels were not influenced to any significant extent by any structural changes of the 
bound biomolecule. The pH sensitivity of the emission spectra of the labels were 
however found to be influenced by the bound protein, presumably due to its acid- 
induced conformational variances. However the exact effect of the protein on the 
emission spectra was difficult to evaluate due to the complex pH sensitivity of the 
emission spectra of the free labels.
In Chapter 5, the potential of the emission lifetimes of the labels of the form 
[Ru(L-L)2NH2phen]2' and [Ru(L-L)2NCSphen]2‘ as probes was realised with 
promising results while the label [Ru(bpy)2esterbpy]2+ was no longer studied due to 
the complex pH sensitivity of its absorption and emission properties displayed in 
Chapter 4. Significantly, it was concluded that as the acid-induced random coil- a- 
helix/ a-helix-random coil transition of the polypeptides PLL and PLGlu in solution 
took place, the emission lifetimes of both emitting components of the bound labels 
decreased/increased dramatically, strongly supporting the theory that the lifetimes of 
such labels act as sensitive reporters to such conformational variances. However, an 
important discovery is the fact that such monitoring was only successful on binding 
the labels to the side groups of the polypeptides. This is proposed to be due to the 
more noticeable change in environment of such groups on occurrence of 
conformational changes when compared to the labels bound to the groups at the end 
of the polypeptide chains.
Similar studies on BSA revealed significant enhancement of lifetimes 
approximately between pHs 3-8 while notable lifetime decreases were evident at pH 
extremes, particularly above pH 9, where the protein is at its least stable. However, 
although such decreases in lifetimes of the labels were likely to be due to unfolding 
of the protein at both extremes of pH particularly noticeable under alkaline 
conditions, there was no proof that unfolding did take place. In contrast to the 
polypeptides, such observations did not vary significantly with the site of attachment
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of the label on the protein, probably due to the global effect of the unfolding on the 
protein and all labels.
In brief, the promising results obtained in this section verify the success of 
the fluorescent complexes in monitoring certain conformational variances of proteins 
but also indicate that more definite proof is required. Due to the uncertainties 
associated with the nature of unfolding of the protein BSA, the final section in 
chapter 5 dealt with similar denaturation studies carried out on the enzyme lysozyme 
whereby loss of enzyme activity was used as an indication of protein denaturation. 
Furthermore, a study of the effect of labelling on the natural conformational 
properties of the enzyme was possible by comparing the activity of the unbound and 
modified lysozyme at various conditions. Combined studies of the emission lifetime 
of the bound labels and the enzyme activity at pH extremes and in the presence of 
chemical denaturants were carried out in order to establish an association between 
protein denaturation and decay lifetime reduction of the labels and hence verifying 
the promising results indicated with BSA.
Indeed, as anticipated there was found to be a relationship between the 
reduction of the decay lifetimes of the labels when bound to lysozyme and loss of 
activity of the enzyme (i.e. denaturation). Both acid-induced denaturation and 
unfolding in the presence of guanidine were verified by the total loss of activity of 
the enzyme towards its substrate which indeed correlated with significant reductions 
in the decay lifetimes of both emitting species of the enzyme-bound label. As would 
be expected the nature of the label and binding site on the enzyme did influence the 
effect of modification on the enzyme activity and perhaps even its conformational 
properties. However, most labels bound to the lysine residues and carbohydrate 
moieties had a minimal effect on the stability and conformational properties of the 
enzyme while the loss of activity of the labelled enzyme may have been due to 
modification of binding sites near the active site which would influence the binding 
of the substrate. The importance of the position of the binding site on the enzyme 
was demonstrated by the loss of activity of lysozyme when a label was bound to the 
glutamic acid residues as these sites are known to be crucial in the binding between
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enzyme and substrate in the active site. Studies of the pH sensitivity o f the activity of 
lysozyme concluded that the enzyme was most active at pHs 5-8 as found for most 
proteins and this was not influenced significantly by the bound labels in most cases. 
This is of critical importance as the aim was to study the natural structural changes 
of the enzyme in solution rather than merely monitor the effects of the bound label 
on its dynamic behaviour.
By analysing the emission lifetimes after increasing quantities of denaturant a 
levelling off of lifetime appeared to indicate the approximate concentration of 
denaturant required to denature the enzyme. This phenomenon was already 
suggested for BSA and was indeed confirmed for lysozyme where a good correlation 
between the complete deactivation of the enzyme and the minimisation of the decay 
lifetimes of the labels was evident. Contrasting effects were earlier noted for the 
PLL-bound labels whereby the addition of denaturants when PLL was in the a- 
helical form actually led to enhancements of lifetimes, proposed to be due to their 
destabilising effects on the hydrogen bonded a-helix and subsequent return to the 
random-coil conformation, where the labels display enhanced decay lifetimes.
In conclusion, the emission lifetimes of most Ru(II) polypyridyl complexes of 
the form [Ru(L-L)2NH2phen]2H and [Ru(L-L)2NCSphen]2+ when bound to 
biopolymers were found to be particularly sensitive to the secondary structure 
changes of synthetic polypeptides but also denaturation of natural proteins and loss 
of activity of enzymes induced both by pH variations and chemical denaturants. As, 
in the majority of cases the labelling of the proteins did not appear to adversely affect 
the conformational properties of the protein, the results of these studies are 
promising in the use of such labels in the probing of real biological matrices but 
emphasise the importance of studying the nature of the label and the position of the 
binding site on the protein beforehand.
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6.2 Future work.
Our photophysical studies of various protein-bound ruthenium(II) polypyridyl 
complexes in solution have unveiled the potential certain such complexes display in 
relation to their ability to monitor conformational changes which the bound proteins 
undergo via variations in the emission lifetimes of the bound fluorescent labels. 
However, the limit to their applications in their own right must be appreciated. In 
this thesis, some assumptions are made as regards the conformational variances 
which these proteins are undergoing. For example, it is assumed that the protein 
bovine serum albumin becomes unfolded at pHs above 9. Future work of this nature 
could be substantiated by the combined use of protein characterisation techniques. 
Such methods include differential scanning calorimetry (DSC. )  which analyses the 
energetics of unfolding or circular dichroism studies (C.D.) for polypeptides as the 
optical rotation of polypeptides is dependent on its secondary structure, allowing the 
differentiation of a-helix, 3-sheet and random-coil conformations. This would allow 
more definite conclusions to be made regarding the sensitivity of the labels to the 
unfolding/conformational changes of the bound proteins. Nevertheless, initial studies 
involving the labelling of the enzyme lysozyme proved successful, yielding promising 
results. However, the investigation of the unfolding processes of enzymes and 
proteins, (eg. to substantiate the relationship between the unfolding of lysozyme and 
its loss of activity) combined with such protein characterisation methods would be 
invaluable to the study of such probes.
Another important area which was not approached but may prove invaluable 
is polarisation studies of the protein-bound labels which allow the study of the 
rotational dynamics of proteins and other macromolecules based on the polarisation 
or anisotropy of the emitted light when the sample is excited with a vertically 
polarised light. The extent of polarisation of the emitted light depends upon the 
extent of random Brownian motion of the molecules that occurs during their excited 
state lifetimes. One of the unclear issues in this thesis is the nature of the shorter 
lifetime of the decay of the various protein-bound labels and the use of polarisation
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studies may allow the determination of the nature of such a lifetime, often similar to 
that of the unbound label. This technique may also allow one to differentiate between 
electrostatically and covalently bound labels which is of critical importance in 
determining the true potential of such fluorescent complexes as probes of biological 
matrices.
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